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ABSTRACT 
 
The mechanism of mercury toxicity is still not known, hindering the identification of 
appropriate biomarkers predictive of toxic effects. The inhibition of the thioredoxin system by 
mercury was shown in vitro and the selenoenzyme thioredoxin reductase (TrxR) was 
particularly sensitive to mercury. Given the importance of the thioredoxin system for several 
cellular functions it is hypothesized that its inhibition is a key step in the development of Hg 
toxicity in vivo.  
Fishes were used as an animal model and exposure to MeHg, showed a significant reduction in 
the activity of the thioredoxin system in the liver (TrxR: 40%; Trx: 70% of control) and in brain 
(TrxR: 75%; Trx: 70% of control). Activity of GR showed increased levels (>120%) when TrxR 
was low, suggesting complementarity between both systems.  
In fishes exposed to mercurials, a correlation between TrxR activity and histopathological 
changes in liver and kidney was observed, with Hg
2+
 being the strongest inhibitor and causing 
the more severe lesions. Co-exposure to Hg
2+
 and Se prevented TrxR inhibition in the liver and 
reduced the severity of lesions. Selenium did not prevent inhibition of TrxR by MeHg. TrxR 
was shown to be more sensitive to mercurials than GPx due to the higher accessibility of the Sec 
in the active site.   
In HepG2 cells, important differences were noted between the toxic behavior of MeHg and 
Hg
2+
. MeHg was more cytotoxic and increased the activity of caspase-3 (115% of control) 
indicating the onset of apoptosis, while Hg
2+
 did not. Nevertheless, Hg
2+
 was a stronger inhibitor 
of TrxR activity than MeHg (45 vs. 29% inhibition at 2.5 µM of Hg
2+
 and MeHg, respectively). 
Inhibition of Trx was similar for both mercurials (45 and 49 % at 2.5 µM of Hg
2+
 and MeHg). 
Additionally, it was observed that MeHg affects similarly the thioredoxin system in the 
mitochondrial and cytosolic fractions, while Hg
2+
 targets primarily the Trx system in the 
mitochondria. Co-exposure to Se prevented the inhibition of TrxR by mercurials increasing its 
activity (>140% of control). Selenium co-exposure only prevented Trx inhibition in the case of 
exposure to Hg
2+
. Selenium exposure increased TrxR1 mRNA 3 fold. Mercurials also increased 
TrxR1 mRNA albeit Hg
2+
 more significantly (3-fold) than MeHg. The increase in TrxR1 
mRNA reached 6-fold when low doses of Se (2 µM) were provided along with Hg
2+
 (5 µM). 
Co-exposure to MeHg and Se did not increase further TrxR1 mRNA transcription. TrxR2 
mRNA was not changed by exposure either to Se or mercurials. 
 
 
KEYWORDS: mercury; thioredoxin; thioredoxin reductase; selenium; biomarkers; 
methylmercury 
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RESUMO 
 
O mercúrio é um poluente global sem função biológica conhecida. A principal via de exposição 
dos humanos a este xenobiótico é através do consumo de peixe, onde o mercúrio se encontra na 
forma de metilmercúrio (MeHg). A exposição a compostos inorgânicos de mercúrio (Hg
2+
) 
acontece principalmente em contextos ocupacionais onde exista vapor de mercúrio (Hgv
0
) ou 
pela libertação deste da superfície de amálgamas dentárias e sua subsequente oxidação a Hg
2+
 
no organismo. Quer o MeHg quer o Hgv
0
 conseguem atravessar a barreira hemato-encefálica e 
causar efeitos neurotóxicos, bem como efeitos a nível de outros órgãos como os rins, sistema 
cardiovascular ou sistema imunológico. Os compostos de mercúrio conseguem também 
atravessar a placenta e podem ser agentes teratogénicos. Não obstante, o mecanismo molecular 
pelo qual a toxicidade do Hg se desenvolve é ainda bastante desconhecido. O MeHg e o Hg
2+
 
mercúrio são electrófilicos e ligam-se aos grupos tiol (SH) dos resíduos de cisteína (Cys) de 
péptidos e enzimas. No entanto, os grupos selenol (SeH) dos resíduos de selenocisteína (Sec) 
são ainda mais propensos a serem atacados por compostos electrófilicos e por isso as 
selenoenzimas são um alvo potencial dos compostos de mercúrio. O selénio é também 
considerado importante para a destoxificação do mercúrio, essencialmente pela formação de 
seleneto de mercúrio (HgSe) que é insolúvel e não-reativo.  
 
Recentemente, foi demonstrado in vitro com enzimas purificadas e em linhas celulares que o 
MeHg e o Hg
2+
 inibem a atividade das enzimas do sistema da tiorredoxina (Trx), ligando-se ao 
seu centro ativo. O sistema da tiorredoxina é composto pela tiorredoxina (Trx), uma enzima 
com um ditiol no centro activo, pela selenoenzima tiorredoxina redutase (TrxR) e pelo NADPH. 
Este sistema enzimático tem um posicionamento hierarquicamente superior e determina 
inúmeros processos vitais para as células (e.g. replicação de DNA; regulação da apoptose; 
reparação de proteínas). A enzima TrxR é particularmente suscetível à inibição por compostos 
de mercúrio in vitro, dada a presença de um selenol-tiol no centro activo e à sua acessibilidade 
na região C-terminal da enzima. Quando ocorre inibição por Hg
2+
, o tratamento com selenito de 
sódio consegue recuperar a actividade da enzima, indicando por isso um efeito protetor do 
selénio. No entanto, não existem estudos relativos à interação entre o mercúrio e o sistema da 
tiorredoxina in vivo. Assim, neste trabalho de Doutoramento procuraram-se colmatar algumas 
das lacunas de conhecimento do mecanismo de ação tóxica do mercúrio, nomeadamente:    
 
 Estudar a interacção entre o mercúrio e o sistema da tiorredoxina in vivo utilizando uma 
espécie de peixe (Diplodus cervinus; sargo-veado) como organismo-modelo, de modo a 
elucidar como é que a exposição a diferentes compostos de mercúrio interfere com as 
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actividades da tiorredoxina e tiorredoxina redutase nos órgãos-alvo (cérebro e rim) e no 
órgão de metabolização (fígado); 
 Examinar a relação entre a inibição da selenoenzima tiorredoxina redutase e a extensão 
dos danos histopatológicos no fígado e rim dos peixes expostos a compostos de 
mercúrio; 
 Avaliar os efeitos da coexposição a selénio na interação entre os compostos de mercúrio 
e as enzimas do sistema da tiorredoxina; 
 Avaliar a possibilidade de usar a tiorredoxina redutase e a tiorredoxina como 
biomarcadores da toxicidade do mercúrio, comparando com outros biomarcadores 
proteicos; 
 Examinar em detalhe, o mecanismo molecular subjacente à interação entre os 
compostos de mercúrio e o sistema da tiorredoxina numa linha celular, de modo a 
avaliar de que modo é que a expressão e atividade da tiorredoxina redutase e 
tiorredoxina são afetadas pelos compostos de mercúrio e pela coexposição a selénio; 
 
Os primeiros resultados (ver capítulo 3) mostraram que as atividades das enzimas do sistema da 
tiorredoxina são afetadas in vivo em peixes expostos durante 28 dias ao MeHg, tendo sido a 
TrxR particularmente afetada. No fígado, a atividade de ambas as enzimas estava diminuída no 
fim da exposição (TrxR – 40%; Trx – 70% do valor controlo), mas ambas recuperaram 
completamente no final da depuração. No cérebro, a inibição máxima ocorreu já no final da 
depuração (TrxR – 75%; Trx – 70%). Para além disso, a atividade da enzima glutationa redutase 
(que é homóloga à TrxR mas sem o resíduo Sec no centro activo) não foi afetada, ocorrendo 
inclusive um ligeiro aumento de atividade (>120% do controlo) em oposição à inibição 
registada pela TrxR. Este resultado realça a importância do resíduo Sec da TrxR como um alvo 
molecular do MeHg. Para além disso, foi possível observar que enquanto no fígado a inibição 
da TrxR ocorre ainda durante o tempo de exposição (é visível ao fim de 21 dias), no caso do 
cérebro essa inibição é tardia, atingindo o seu máximo, 14 dias após o final da exposição, o que 
demonstra a importância dos processos toxicocinéticos para o desenvolvimento da toxicidade.  
 
A exposição de peixes a MeHg e Hg
2+
 revelou que o Hg
2+
 embora acumule menos que o MeHg 
é um inibidor mais potente do sistema da tiorredoxina. Foi também observado que o decréscimo 
de atividade da TrxR se correlaciona com a severidade dos danos histopatológicos observados 
no fígado e rim (Capítulo 4) tendo o Hg
2+
 produzido igualmente os danos mais extensos. Por 
isso a atividade da TrxR é um potencial marcador de efeitos tóxicos do Hg.  
 
A coexposição a selenito de sódio teve consequências diferentes na toxicocinética do MeHg e 
Hg
2+
 e na interação destes com o sistema da tiorredoxina (Capítulo 4). A exposição simultânea a 
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selénio decresceu para metade a acumulação de MeHg em todos os órgãos, mas não teve 
qualquer efeito relativamente à inibição do sistema da tiorredoxina por este composto, havendo 
inclusive antecipação do efeito inibidor no cérebro. No caso do Hg
2+
 a coexposição a selénio 
preveniu totalmente a inibição de ambas as enzimas do sistema da tiorredoxina no fígado, mas 
este efeito protetor não foi observado em mais nenhum órgão. Nesta parte do trabalho foi 
também demonstrada a importância da estrutura do centro ativo da TrxR uma vez que esta 
enzima se revelou um alvo preferencial para os compostos de mercúrio, em comparação com 
outras selenoenzimas como a glutationa peroxidase, cujo selenol do centro ativo está menos 
acessível. 
 
Com vista a estudar com maior detalhe o modo como o MeHg e o Hg
2+
 afetam o sistema da 
tiorredoxina nas frações citosólica e mitocondrial, foram realizados ensaios toxicológicos com 
uma linha celular de hepatoma humano (HepG2). No geral, of MeHg revelou-se mais citotóxico 
para as células provocando uma redução do crescimento celular em cerca de 50% a uma 
concentração de 2.1 µM ao fim de 72 horas de exposição, por oposição aos 16.2 µM do Hg
2+
. 
Para além disso, a exposição a concentrações crescentes de MeHg induziram um aumento na 
atividade da enzima caspase-3 (115%) enquanto a exposição a Hg
2+
 teve um efeito inibitório 
desta atividade. A exposição a Hg
2+
 inibiu de igual modo a atividade da Trx e da TrxR (62 e 
54% de inibição, respetivamente, enquanto o MeHg inibiu preferencialmente a atividade da Trx 
(49% vs. 29% para TrxR). Os resultados também mostraram que os dois compostos de mercúrio 
estudados se comportam de maneira diferente quanto à interação com o sistema da tiorredoxina 
em diferentes compartimentos celulares. Enquanto o MeHg afeta igualmente o sistema da 
tiorredoxina na fracção citosólica (TrxR1 e Trx1) e na fracção mitocondrial (TrxR2 e Trx2), o 
Hg
2+
 afeta sobretudo os sistema da tiorredoxina na fração mitocondrial, a uma concentração de 
apenas 0.5 µM.  
 
Para definir a gama de concentrações em que o selénio tem efeito protetor foi também analisado 
o efeito da coexposição a este elemento na interação dos compostos de mercúrio com o sistema 
da tiorredoxina. A coexposição a selénio preveniu a inibição de ambas as enzimas pelo Hg
2+
, 
havendo inclusive um aumento significativo (>140%) da atividade das mesmas. No caso do 
MeHg, contrariamente ao observado in vivo, a coexposição ao selénio preveniu a inibição da 
TrxR. A inibição da Trx manteve-se independentemente da concentração de Se no meio.   
 
Foi também avaliado qual o efeito da exposição a selénio e aos compostos de mercúrio nos 
níveis de mRNA da TrxR1 e TrxR2, para se perceber se o efeito protector do Se sobre a 
atividade desta enzima se relacionava com um aumento da sua expressão. A expressão do 
mRNA da TrxR1 aumentou proporcionalmente ao nível de selénio até aproximadamente 3vezes 
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o nível do controlo. A exposição aos compostos de mercúrio também induziu a síntese de 
mRNA da TrxR1, em especial no caso da exposição a Hg
2+
. Os níveis de mRNA da TrxR1 
foram ainda maiores no caso da coexposição a Hg
2+
 e ao nível mais baixo de selénio (2 µM), 
perdendo-se esse efeito a concentrações mais altas (4 µM). Estes resultados parecem indicar que 
o efeito protetor do selénio face à inibição da TrxR1 por compostos de mercúrio resulta em 
parte de um aumento da expressão da enzima. Não foi observado aumento significativo do 
mRNA da TrxR2 em qualquer dos tratamentos. 
 
 
No seu conjunto, os resultados obtidos neste trabalho mostram que o sistema da tiorredoxina é 
efetivamente um alvo dos compostos de mercúrio in vivo e que a sua inibição se relaciona com a 
severidade das lesões histopatológicas. Ficaram também patentes as diferenças entre o Hg
2+
 e o 
MeHg, não só em termos toxicocinéticos, mas também quanto à sua interação com as enzimas 
do sistema da tiorredoxina, nomeadamente no que respeita à interacção com este sistema nas 
frações mitocondrial e citosólica. Os resultados obtidos ajudam a definir os mecanismos 
moleculares da toxicidade do Hg e também contribuem para elucidar a sua interação com o Se, 
ficando patente a coexposição a selénio não é totalmente eficaz na proteção da TrxR da inibição 
por mercúrio, sendo aparentemente órgão-específica e estando em parte dependente da 
capacidade deste em aumentar a expressão da enzima. Para além disso, o efeito benéfico da 
coexposição ao Se verifica-se principalmente a concentrações mais baixas, sendo que a níveis 
mais elevados foi possível observar alguns efeitos pro-oxidantes. 
 
 
PALAVRAS-CHAVE: mercúrio; tiorredoxina; tiorredoxina redutase; selénio; biomarcadores; 
metilmercúrio 
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- AIMS OF THIS THESIS 
 
The specific goals of this PhD thesis are: 
 
1) To study the interaction between mercury and the thioredoxin system in an animal 
model, specifically how exposure to mercurials interferes with the activities of 
thioredoxin and thioredoxin reductase at the target organs (brain and kidney) and at the 
metabolization organ (liver); 
 
2) To examine the relation between the inhibition of thioredoxin reductase by 
mercurials and the severity of histopathological damage in the liver and kidney of 
exposed animals; 
 
3) To study the effect of selenium on the interaction between mercury compounds and 
the enzymes of the thioredoxin system evaluating protective or deleterious effects; 
 
4) To evaluate the possibility of using TrxR and/or Trx as biomarkers of mercury 
toxicity and establish the relative importance of these enzymes in comparison to other 
proteic biomarkers; 
 
5) To give insight on the molecular mechanism involved in the interaction between 
mercury compounds and the thioredoxin system in a cell model, to understand how the 
expression and activity of thioredoxin reductase and thioredoxin are affected by 
mercurials and selenium; 
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- OUTLINE OF THE THESIS 
 
Chapter 1 is divided into two parts. Part A gives an overview on the main aspects of 
mercury toxicology, namely: human exposure pathways; toxicokinetics of mercury 
compounds; health effects of mercury compounds; biomarkers of exposure, effect and 
susceptibility; interaction between mercury and selenium. Part B gives an overview on 
the thioredoxin system, its structure and biological functions, interaction with metallic 
compounds and mercury in particular. The gaps of knowledge leading to this thesis are 
mentioned. 
 
Chapter 2 provides details on the methods used throughout this work.  
 
Chapter 3 reports the results of the interaction between methylmercury and the 
enzymes of the thioredoxin system during an in vivo experiment using an  animal model 
(zeabra-seabreams, Diplodus cervinus).  
 
Chapter 4 relates the inhibition of the thioredoxin system by mercury compounds with 
the severity of histopathological lesions in the liver and kidney of exposed fishes. The 
effects of co-exposure to selenium, on the toxicokinetics of mercury compounds (MeHg 
and Hg
2+
), on the histopathological lesions and on the inhibition of the thioredoxin 
system, are also studied. The differences in the inhibition of thioredoxin reductase and 
glutathione peroxidase by mercurials are also addressed. 
 
Chapter 5 details the molecular studies carried out in human hepatoma cells (HepG2), 
in order to understand how methylmercury and mercury (II) target differently the 
thioredoxin system in the cytosolic and mitochondrial fractions. The influence of 
selenium on the changes in the activity and expression of the thioredoxin system are 
also investigated.  
 
Chapter 6 (Conclusions) provides a final overview of the main results obtained in the 
previous chapters, their implications concerning mercury toxicology and gives 
perspectives for future work. 
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1. GENERAL FACTS ABOUT MERCURY 
 
The element mercury (Hg) has some unique physical and chemical properties that have 
made it useful for several purposes throughout the history of mankind (Clarkson and 
Magos, 2006). Mercury can exist in three oxidation states – elemental mercury (Hg0), 
mercurous ion (Hg2
2+
) and the mercuric ion (Hg
2+
) – and can be found in both organic 
and inorganic compounds and complexes (Eisler, 2006). Although quite inert at room 
temperature, Hg
0
 can form amalgams with metals such as gold and silver. Given its high 
vapor pressure (36.4 Pa at 25 °C) it passes easily to the gaseous phase, originating 
mercury vapor (hereafter Hgv
0
). Both the mercurous and mercuric ions form chlorine 
salts, commonly known as calomel (Hg2Cl2) and corrosive sublimate (HgCl2), 
respectively (Eisler, 2006).  
 
The use of mercury compounds in anthropogenic activities has been wide through the 
ages, from the mining industry, to chlorine production, as antifungals in agriculture, in 
clothing (or garment) and thermometers production (Clarkson and Magos, 2006) and 
more recently as a component of energy-efficient compact fluorescent lamps. Its use in 
medical practices was common and thus several mercury compounds where included in 
some of the world’s pharmacopoeias (Magos, 1997; Wheeler, 1947). Mercury was 
already known in ancient Egypt, and although it was not used in medical treatments it 
was found in tombs of higher class individuals (Abramowitz, 1934). In classic Greece 
and Rome, mercury was viewed as highly poisonous and its use in medical practice was 
quite limited. On the contrary, in Asia mercury compounds (oxides and halides) were 
widely used in medical treatments, a practice that was brought to Europe during the 
middle-age. The first large-scale occupational mercury exposure is thought to have 
occurred in Japan during the 8
th
 century (Satoh, 2000). The therapeutic application of 
mercury for the treatment of syphilis, which began in the late 15
th
century (Abramowitz, 
1934) showed also mercury’s toxic nature (Clarkson and Magos, 2006) and although its 
use for the treatment of this disease declined during the 19
th
 and early 20
th
 centuries, 
mercury remained as a common treatment for a vast myriad of other pathologies (e.g. 
Chisholme, 1813, Clarke, 1912; Kollock, 1896). Nowadays, the use of mercury in 
medicine is limited and is related to the anti-septic properties of mercury compounds, 
such as phenylmercury and ethylmercury thiosalacylate (Thimerosal), that make them 
useful in preserving medical solutions and vaccines (Magos, 1997; Clarkson and 
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Magos, 2006). Moreover, the use of mercury amalgams in dentistry – a practice that 
began in the mid-19
th
 century and reached the 21
st
 century – is the main exposure route 
of the general population to Hgv
0
(Clarkson, 2002). Mercury vapor is oxidized in cells to 
Hg
2+
 which is the form directly responsible for toxic interactions (see section 3.1.2). On 
the other hand, methylmercury (CH3Hg
+
, hereafter MeHg), which is regarded as the 
most toxic mercury form, is also the most common form of mercury present in the 
human diet, particularly in fish (Clarkson, 2002). Thus, this work will focus on MeHg 
and Hg
2+
. 
 
2. BIOGEOCHEMICAL CYCLING OF MERCURY 
 
Mercury (Hg) is considered a global pollutant, meaning that even remote regions, 
without local sources, present traceable amounts of this contaminant (Morel et al., 
1998). Mercury’s environmental ubiquity arises from the importance of atmospheric 
transport in its biogeochemical cycle, known as the mercury global cycle (Figure 1.1).  
 
In the earth’s crust mercury may exist as elemental mercury (Hg0) (Buckell et al.,1946) 
but it is mostly contained in mineral ores of HgS, known a cinnabar (AMAP/UNEP, 
2008). According to the most recent estimates (Pirrone et al., 2009), natural sources 
such as volcanism, geothermal activity and biomass burning are responsible for the 
release of 5,207 tons of mercury to the atmosphere, each year. Anthropogenic emissions 
of mercury still continue, although those resulting from mercury mining, fossil-fuel 
extraction and industrial activities, show a decreasing trend since 1990 (AMAP/UNEP, 
2008), and are currently estimated to be around 2,909 tons per year (Pirrone et al., 
2009).  
 
In the atmosphere, more than 95% of Hg is in the form of Hgv
0
 (Mason, 2009). The long 
residence time of Hgv
0
 in the atmosphere (0.5-1 year) enables its long-range transport to 
remote areas such as the Arctic and Antarctic polar circles (Morel et al., 1998; Mason, 
2009). Atmospheric Hg
0
 can be oxidized to Hg
2+
 under the action of ozone or halogens. 
Mercury (II) may be adsorbed to solid atmospheric particles and deposited on the 
surface (dry deposition). Mercury (II) can also be dissolved by atmospheric moisture 
and then deposited on the surface by rain, snow or aerosols (wet deposition) (Ariya et 
al., 2009).  
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In the water masses, Hg
2+
 can either be abiotically and biotically reduced to Hg
0 
and re-
emitted to the atmosphere or adsorbed onto suspended particles and organic matter and 
then be deposited on the bottom sediments, or transformed by microbiological action 
into alkylated forms of mercury (Morel et al., 1998).  
 
 
Figure 1.1: Mercury Global Cycle showing the inter-conversion of different mercury species 
(adapted from Barkay and Wagner-Döbler, 2005). 
 
The main alkylated forms of mercury resulting from microbial action are 
monomethylmercury (MeHg) and dimethylmercury (CH3HgCH3; DMeHg) (Barkey and 
Wagner-Döbler, 2005). In spite its liposolubility and toxicity, DMeHg is not very 
reactive and given its volatility it diffuses into the atmosphere instead of being retained 
by the aquatic organisms (Barkay and Wagner-Döbler, 2005). Once in the atmosphere, 
DMeHg is reduced by UV radiation to Hg
2+
 (Morel et al., 1998). On the other hand, 
MeHg is the main form of Hg in aquatic organisms (Bloom, 1992; Branco et al., 2007) 
and the one that causes the major concerns in terms of exposure for the human 
population (Clarkson et al., 2003). 
 
2.1. Mercury methylation, biomagnification and bioaccumulation  
 
Mercury methylation occurs mainly by microbiological action - biomethylation (Baldi, 
1997). Sulphate-reducing bacteria are thought to be the main, but not the only, 
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responsible for MeHg formation in the anoxic layer of sediments and in the water 
column (Barkay and Wagner- Döbler, 2005; Barton and Fauque, 2009; Morel et al., 
1998). The biomethylathion mechanism is not totally clear yet and there are several 
possible pathways through which bacteria can methylate Hg
2+
 (Barkay and Wagner-
Döbler, 2005). Up to date, the only shown existing mechanism of mercury methylation 
is the acetylcoenzyme A (acetyl-CoA) pathway in which, the methyl radical (CH3-) is 
transferred though the action of methyl- transferases to Hg
2+
, coupled with the synthesis 
of acetyl-CoA (Barkay and Wagner-Döbler, 2005; Barton and Fauque, 2009).  
 
Once methylated, MeHg becomes available to be absorbed by the microalgae of 
phytoplankton and/or the phytobenthos. Methylmercury enters the phytoplanktonic cell 
and binds cytosolic proteins becoming available for the next trophic level (zooplankton) 
following ingestion of the microalgae cell (Morel et al., 1998) (Figure 1.2). MeHg 
suffers a 10
9
 magnification in concentration from the water column, where it exists at 
concentrations of few picograms per liter (ppq) until the apex predators where its 
concentration may reach several micrograms per gram (ppm); mercury is the only metal 
that presents such a remarkable biomagnification process in the food chain (Monteiro 
and Furness, 1995). 
 
Additionally, the elimination of MeHg by organisms (e.g. fishes) is a rather slow 
process (half-life about 70 days) and the exposure level is more or less constant, leading 
to accumulation in tissues throughout the life-span of the fish (bioaccumulation) 
(Jackson, 1998; Szefer et al., 2003). Thus, species which have high longevity and are at 
the top of the food chain, such as sharks, tunas and sea mammals, tend to accumulate 
higher MeHg levels than smaller planktonivorous fishes (Branco et al., 2007; Mahafey, 
2004). Since humans stand at the very top of the food pyramid, populations with a diet 
containing high amounts of predatory marine fishes are exposed to high levels of MeHg 
(Carvalho et al., 2008a).  
 
 
 
 
 
Chapter 1, Part A: Overview on the Toxicology of Mercury           7 
 
Figure 1.2: Trophic transfer of MeHg at the base of the food web (adapted from Morel et al., 
1998).  MeHg penetrates the phytoplanktonic cell and is transferred through the food-chain. 
Hg
2+
 is not easily absorbed by phyto and zooplankton and thus does not accumulate throughout 
the food-chain. 
 
3. EXPOSURE AND TOXICOKYNETICS OF MERCURY COMPOUNDS 
 
3.1.  Elemental Mercury 
 
3.1.1. Pathway of exposure 
 
Occupational exposure to elemental mercury has long been recognized as an important 
public health problem (Neal, 1938). The liquid metallic mercury itself is not very toxic, 
since upon ingestion gastrointestinal absorption is extremely low (WHO, 2003; Rooney, 
2007). Toxicity of Hg
0
 results primarily from the inhalation of mercury vapor (Hgv
0
) by 
workers in industries where mercury enters the manufacturing process (e.g. chloro-
alkaly plants) or in mines where it is released from the rock bed (Buckell et al., 1946; 
Clarkson and Magos, 2006). Currently, industrial health guidelines set the limit of 
occupational exposure to Hgv
0
 at a time weighed average (TWA) of 0.02 mg 
mercury/m
3
 for an 8h work-journey (SCOEL, 2007). For the general population, 
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mercury vapor in ambient air poses no threat since its concentrations are in the range of 
2 to 20 ng/m
3 
(WHO, 2003). The main route of exposure to Hgv
0 
for the general 
population exposure is the release of Hg
0
 from dental amalgam surfaces (Clarkson, 
2002; Rooney, 2007). Dental amalgams contain 50% of elemental mercury in their 
composition with the remaining 50% composed of other metal(s) like silver, copper or 
tin (Dye et al., 2005) and given their resistance and durability their usage is still 
common in dental practice (De Rouen et al., 2006; Ritchie et al., 2004). The release of 
Hg can happen in the form of Hg
2+
 (Figure 1.3) which is swallowed and mostly excreted 
given its low absorption in the intestines (Clarkson and Magos, 2006). However, some 
Hgv
0
 is also released from the amalgam surface (Figure 1.3) and eventually inhaled 
entering systemic circulation. Several studies (Marcket and Berglund, 1997; De Rouen 
et al., 2006; Dye et al., 2005) have shown a positive correlation between the number of 
amalgam fillings in the oral cavity and the mercury body burden, measured in urine. 
Nevertheless, these increased levels are frequently within the normal range (0-4 µg L
-1
). 
being estimated that it would be necessary to have 10 amalgam restorations to display 
an increase of 1µg L
-1
 Hg in urine (Kingman et al., 1998). There has been no substantial 
evidence to prove that toxic effects of mercury are related to mercury amalgams fillings 
(De Rouen et al., 2006), but its contribution for the total body burden has to be taken 
into account in total exposure estimates and the associated risk for the general 
population cannot be disregarded (Richardson et al., 2011).  
 
 
Figure 1.3: Release of mercury from dental amalgams (adapted from Clarkson et al., 2007). 
 
 
3.1.2. Toxicokinetics 
 
Inhaled air is the main route by which Hg
0
 in the form of vapor enters the body 
(Clarkson et al., 2007). In the lungs, about 80% of Hgv
0
 diffuses from the alveoli into 
Lungs
Saliva
GI Tract
Hg0
Hg2+
H2O2
External Air
Amalgams
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the blood stream (Magos, 1997). As first described by Halbach and Clarkson (1978), in 
red blood cells (RBCs), Hg
0
 can be oxidized to Hg
2+
 by catalase: 
 
 
  
This is a rather slow process, which allows the distribution of Hgv
0
 throughout the body 
(Magos, 1997). Given Hgv
0
 is an uncharged monoatomic gas, it can diffuse through cell 
membranes and gain access to cell interior in all organs (WHO, 2003; Clarkson and 
Magos, 2006). It is also possible that Hgv
0
 is in part transported across cell membranes 
through a specific transporter of uncharged gaseous molecules (Clarkson et al., 2007) as 
previously shown for ammonia (Khademi et al., 2004). Thus, mercury vapor can easily 
cross the blood-brain barrier (BBB), reaching the central nervous system (CNS), and the 
placental barrier reaching the developing fetus (Lettmeier et al., 2010).  
 
Mercury vapor itself is not reactive and does not interact directly with cellular 
components (Clarkson and Magos, 2006). However, once inside cells Hgv
0
 may be 
oxidized (Figure 1.4) (Clarkson et al, 2007). Thus, the mercuric ion (Hg
2+
) is the direct 
responsible for Hgv
0
 toxicity (Clarkson and Magos, 2006) and since it cannot cross 
easily the BBB, it is retained in the CNS for long periods (Mottet et al, 1997; Rooney, 
2007; WHO, 2003). 
 
The liver is a major organ for metabolization of Hgv
0
 and there H2O2 is not a limiting 
factor for oxidation of mercury vapor an thus Hg
2+
 formation is substantial (Magos, 
1997). The mercuric ion can then be conjugated with Se forming mercuric selenide 
(HgSe) precipitates which have been observed in the liver of several species and are 
thought to be a detoxification mechanism for mercury (Groth et al., 1976; Parizek et al., 
1971) (Section 6.2.1). 
 
 
CatOH + H2O2 CatOOH + H2O
CatOOH + Hg0 CatOH + HgO
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Figure 1.4: Mercury vapor distribution through the body and oxidation to Hg
2+
 (adapted from 
Clarkson et al., 2007). 
 
The mercuric ion can also be conjugated with glutathione (GSH) by binding the thiol 
group (SH-) of the cysteine residue (Cys), forming a complex similar to oxidized 
glutathione (Figure 1.5) (Clarkson and Magos, 2006). A fraction of this complex may 
be secreted into the bile followed by Hg
2+
 elimination in the feces (Ballatori and 
Clarkson, 1985). This complex can also enter systemic circulation and eventually reach 
the kidney where, due to its small size, is not retained by glomerular filtration (Zalups, 
2000). In fact, in the long-term, the kidney is the major organ for mercury accumulation 
following exposure to Hgv
0
 similarly to what is observed for exposure to Hg
2+
 (Magos, 
1997). 
 
 
Figure 1.5: Similarities between oxidized glutathione (GSSG) and the complex formed between 
GSH and Hg
2+
 (Adapted from Clarkson and Magos, 2006). 
 
Gly
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Chapter 1, Part A: Overview on the Toxicology of Mercury           11 
According to Lash et al., (2005) several conjugates of mercury with thiol containing 
peptides and proteins, such as albumin, L-cysteine (Cys), N-acetyl-L-cysteine 
(NAcCys) and glutathione (GSH), are biologically relevant forms of Hg
2+
 that can be 
present in the kidney following glomerular filtration. Several mechanisms have been 
proposed for the uptake of Hg
2+
 by proximal tubular epithelial cells involving mediation 
by transport proteins present in plasma membranes (Zalups, 2000). At the luminal 
membrane of proximal tubule cells, the mechanisms include (Figure 1.6): 
 
a) Cleavage of the glutamylcysteine bond releasing the mercury conjugate with 
cysteinylglycine, which then enters the cell trough sodium dependent membrane 
channels;  
b) Sequential action of the enzymes γ- glutamyltransferase and cysteinylglycinase 
(cleaves the Gly-Cys bond) that cleave the GS-Hg-GS complex releasing 
dicysteinylmercury (Cys-Hg-Cys). This compound can enter the epithelial cell 
by molecular mimicry with cystine (Cys-Cys); 
 
 
Figure 1.6: Proposed mechanisms for Hg
2+
 uptake at the luminal membrane of tubular epithelial 
cells (from Zalups, 2000). 
 
Other transport mechanisms regarding uptake at the basolateral membrane of tubular 
cells involve transport of the mercuric-thiol conjugates through membrane carriers 
(Lash et al., 2005). 
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3.2. Methylmercury 
 
3.2.1. Pathway of exposure 
 
During the first half of the 20
th
 century concerns about exposure to organomercurials 
and, in particular to MeHg, were mostly related to its use in some industrial processes 
and in agriculture as a fungicide (e.g. Ahlmark, 1948) although the presence of trace 
amounts of mercury in food was known (Neal, 1938). However, it was only after the 
massive mercury poison outbreak in Minamata (Japan) that the scientific community 
and the general public realized that fish consumption is the major route by which 
humans are exposed to MeHg. Values of MeHg in the seafood of Minamata were 
exceptionally high (>20 µg g
-1
) due to the direct discharge of industrial effluents loaded 
with MeHg to the Minamata bay water (Clarkson and Magos, 2006). From 1956 up to 
1998, more than 2200 cases of chronic mercury poisoning were confirmed and the 
clinical manifestations of such poisoning became known as the Minamata disease 
(Futatsuka et al., 2001) (see section 4.1). Since then, fish was identified as being the 
main vector of MeHg to humans and regulatory agencies worldwide have established 
food safety guidelines for mercury intake by human populations (Table 1.1).  
 
Currently, EU legislation regulates the maximum amount of mercury that can exist in 
fish for human consumption, setting the value at 0.5 mg/Kg for non-predatory fish, 
crustaceans and mollusks and at 1 mg/kg for predatory species (e.g. tuna, swordfish, 
shark) (CEC, 2006). Other food sources have little contribution for the total body 
burden in MeHg, albeit in some particular polluted areas, cereals such as rice can 
accumulate considerable amounts of mercury in the edible part (Feng et al., 2008). 
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Table 1.1: Food safety guidelines proposed by international regulatory agencies, regarding Hg 
intake by humans.  
Agency Guideline type Value Source 
EPA  (RfD) 0.1 µg Hg/Kg bw/day EPA, 2001 
 
WHO 
 
 
PTWI*
 
 
1.6 µg Hg/Kg bw 
(pregnant women, women of childbearing 
age and young children) 
 
WHO, 2004 
3.3 µg Hg/Kg bw/day 
(general population) 
Canada  pTDI 
0.2 µg Hg/Kg bw 
(pregnant women, women of childbearing 
age and young children) 
Feeley et al, 1998 
RfD - Reference Dose; PTWI – Provisional Tolerable Weekly Intake; pTDI - Provisional Tolerable Daily Intake;  bw 
– body weight; *Dividing the PTWI by 7 gives a Tolerable Daily Intake (TDI) of 0.23 µg Hg/Kg bw/day for pregnant 
women, women of childbearing age and young children and of 0.47 µg Hg/Kg bw/day for the general population;   
 
In Portugal, fish consumption is the highest of the EU, with 57 kg of fish intake/per 
capita/per year (EU average 22 kg/per capita/year) (Failler, 2007) hence, the potential 
risk for MeHg chronic toxicity is high (Carvalho et al., 2008a). This is especially true in 
fishing communities, where fish intake is above the national average with frequent 
consumption of predatory fish (e.g. swordfish, shark, black-scabbard fish). In these 
communities, the risk index is high and justifies a more profound assessment of 
exposure to MeHg as well as of the associated nutritional factors existing in fish and 
their importance for the population health (Carvalho et al., 2008a; Ström et al., 2011).  
 
Fishes are rich in high quality protein, vitamins and long-chain-3 polyunsaturated fatty 
acids (PUFA), such as decosohexanoic (22:6) acid (DHA) and eicosapentanoic (20:5) 
acid (EPA) (Budtz-Jørgensen et al., 2007; Dorea, 2003; Ström et al., 2011). Also, fish 
muscle is rich in several micronutrients, namely selenium in the form of 
selenomethionine (SeMet), selenocyteine (Sec) (El-Sayed et al., 2006) and also as the 
strong antioxidant form selenoneine (Anan et al., 2011). Therefore, the risk-benefit 
relationship related to fish consumption as to be weighed in risk communication to the 
populations (Budtz-Jørgensen et al., 2007).  
 
Some authors (e.g. Dorea, 2003) suggest that nutritional benefits of fish consumption 
outweigh the negative effect of MeHg exposure, especially in populations where fish is 
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the most valuable nutritional resource. Dorea (2003) cites several examples of the 
absence of clear Minamata disease cases in indigenous population settlements along the 
Amazon River basin, where hair mercury can be higher than 30 µg g
-1
. On the other 
hand, in gold-mining communities that use mercury amalgamation and where the 
nutritional value of the diet is low (no fish consumption), mercury poisoning symptoms 
are common (Dorea, 2003).  
 
Three large-scale cohort epidemiological studies in the Seychelles Islands, Faroe 
Islands, and New Zealand - where the populations’ diet includes frequent fish-meals 
(low mercury), occasional whale meat (high mercury) and occasional shark meat (high 
mercury), respectively - combined the assessment throughout the years of cognitive and 
motor skills (Clarkson and Magos, 2006). Both the Faroe Islands and New Zealand 
studies pointed that the regular consumption of high mercury food, such as whale and 
shark meat, by pregnant women translated in lower performance results by their 
children when tested for several neurodevelopmental endpoints in the years following 
birth (Grandjean et al., 1992, 1997, 2004; Kjellsrom, 1989). On the other hand, children 
(aged 19 months) from the Seychelles study showed no significant differences from the 
control group regarding the endpoints measured (Davidson et al., 1995; Myers et al., 
1997). The high nutritional value of components on a fish-based diet appears to help 
prevent some of the chronic effects of mercury exposure in human populations. 
However, this interpretation is not straightforward since many confounding factors are 
involved in these epidemiological assessments (Budtz-Jørgensen et al., 2007). Also, 
neurodevelopmental results from the Seychelles study, obtained later (9 years after 
birth) revealed lower performances of children in psychomotor tests when the mothers’ 
exposure to mercury during pregnancy was higher (Myers et al., 2003). Likewise, some 
studies with indigenous populations of the Amazon showed decreased performance in 
neurobehavioral outcomes by adults and children with high hair mercury (Cordier et al., 
2002; Lebel et al., 1998; Yokoo et al., 2003).  
 
Overall, the current state of knowledge of MeHg toxicology allows us to define the in 
utero development and early childhood as the stages in which humans are more 
susceptible to serious toxic effects resulting from exposure to MeHg, and that fish is an 
excellent nutritional source and its absence from the diet is negative (Clarkson and 
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Magos, 2006). Thus, the “Joint FAO/WHO Expert Committee on Food Additives” 
recommends that: 
 
“… the setting of guideline levels for methylmercury in fish may not be an effective way 
of reducing exposure for the general population. The Committee noted that advice 
targeted at population subgroups that may be at risk from methylmercury exposure may 
provide an effective method for lowering the number of individuals with exposures 
greater than the PTWI.” (JEFCA, 2006). 
 
Thus, it is better to advice consumers not to exclude fish and seafood from their diet but 
to consume preferably species low in MeHg, which are also the ones that normally 
contain higher content of important nutrients such as DHA and EPA (Mahaffey, 2004). 
 
3.2.2. Toxicokinetics 
 
Methylmercury constitutes more than 90% (Bloom et al., 1992; Branco et al., 2007) of 
mercury in fish muscle where it is bound to thiol groups in cysteine (Cys) residues of 
proteins (Harris et al., 2003). Once ingested, fish protein is hydrolyzed and the MeHg-
Cys complex is absorbed in the intestinal wall (Clarkson and Magos, 2006). This is an 
highly effective process, with more than 95% of MeHg being absorbed in the GI tract 
(Magos, 1997). This happens because the MeHg-Cys complex has a similar structure to 
the amino acid methionine (Met) (Figure 1.7), which enables it, by molecular 
homology, to use the neutral amino acid carrier (LAT) (Clarkson and Magos, 2006; 
Roos et al., 2010; Simmons-Willis et al., 2002). 
 
 
Figure 1.7: Molecular mimicry between the MeHg-Cys complex and the amino acid methionine 
(from Clarkson et al., 2006). 
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The systemic distribution of MeHg is fast and only about 5% of the absorbed amount 
stays in the blood-stream after 30 to 40 hours, mostly bound to hemoglobin in red-blood 
cells (Berglund et al., 2005; Clarkson and Magos, 2006; Satoh, 2000) and to a smaller 
extent in the plasma bound to albumin (Yasutake et al., 1989). From the blood 
compartment, MeHg is distributed virtually to all protein-rich tissues, such as the brain, 
kidney, liver, muscle, hair and nails (Clarkson et al., 2007; Mottet et al., 1997). 
 
When the MeHg-Cys complexes reach the BBB they can easily cross it by the same 
molecular mimicry mechanism described above (Figure 1.7) and thus, gain access to 
endothelial cells of the BBB, and enter the CNS (Clarkson and Magos, 2006; NRC, 
2000).  
 
The liver is the main organ of MeHg metabolization (Mottet et al., 1997). In the liver, 
MeHg may be conjugated with reduced glutathione (GSH) followed by its secretion 
through the bile into the intestinal lumen (Mottet et al., 1997; Clarkson, 2002). 
However, in the intestine most of these conjugates are hydrolyzed and MeHg is re-
absorbed into the intestinal wall. This entero-hepatic recirculation makes the 
conjugation of MeHg and GSH a rather ineffective process of elimination with only 1% 
of the MeHg being excreted in feces (Clarkson, 2002; Touchonow et al., 2003). 
Although inefficient, fecal excretion is still the major route of MeHg elimination, which 
occurs in the form of Hg
2+
 after cleavage of the Hg-C bond by intestinal microflora 
(Clarkson et al., 2007).  
 
The increase in Hg
2+
 concentration in the liver following exposure to MeHg indicates 
that demethylation is one of the possible metabolization pathways of MeHg (Mottet et 
al., 1997; Watanabe, 2002). Nevertheless, the mechanism by which this conversion 
takes place is not yet known (Yang et al., 2008). Mercury (II) released from 
demethylation may then conjugate with 2 molecules of GSH forming a complex with a 
similar structure to GSSG (Figure 1.5) which is then excreted through the bile (Clarkson 
and Magos, 2006) . Also, these complexes may enter systemic circulation and be 
delivered to the kidney to be excreted (Zalups, 2000). As mentioned previously (see 
section 3.1.2), Hg
2+
 can also conjugate with Se forming mercuric selenide (HgSe) 
(Groth et al., 1976; Parizek et al., 1971). 
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Shortly after exposure to MeHg it has been observed an increase in the mercury burden 
in the kidney (Yasutake et al., 1989; Zalups, 2000; Roos et al., 2010). Methylmercury 
reaches the kidney mostly bound to albumin (Yasutake et al., 1989; Zalups, 2000). 
These complexes can be filtered at the glomerulus, thus gaining access to tubular 
epithelial cells (Zalups, 2000). However, urinary excretion of MeHg is slow, leading to 
its accumulation in the kidney (Yasutake et al., 1989; Zalups et al., 1992).  
 
4. HEALTH EFFECTS OF MERCURY COMPOUNDS 
 
Mercury is a global pollutant that has no known essential biological function. Adverse 
health effects of mercury include neurotoxicity, teratogenicity, nephrotoxicity, 
immunotoxicity and cardiotoxicity. The magnitude of effects may vary considerably 
depending on the dose and duration of exposure (Clarkson and Magos, 2006) and 
symptoms may intensify, become irreversible and eventually lead to death (WHO, 
2003). In this section we will focus on the health effects of chronic exposure because it 
reflects the type of exposure of the general population (Clarkson et al., 2003).  
 
4.1. Neurotoxicity 
 
Neurotoxic symptoms are the most visible consequence of mercury poison (Clarkson 
and Magos, 2006). Both Hgv
0
 and MeHg are able to cross the BBB and accumulate in 
the CNS (Clarkson and Magos, 2006). Although both forms of mercury can be 
considered primarily as neurotoxic, the manifestations of toxic disease are different 
(Magos, 1997). 
 
In the case of chronic exposure to mercury vapor clinical manifestations include, tremor 
and several behavioral alterations (Magos, 1997). Psychological disturbances such as 
extreme shyness, loss of memory, irritability and persistent insomnia are typical 
manifestations of Hgv
0
 poisoning and became known as mercurial erethism (Magos, 
1997). It has been shown that workers occupationally exposed to mercury vapor still 
show mild symptoms several years after cessation of exposure (Ellingsen et al., 1993a; 
Kishi et al., 1994). Studies in animals have shown that following exposure to Hgv
0
 
mercury is mostly accumulated in the cerebral cortex (Warfvinge, 1995). Also, studies 
in rats exposed to Hgv
0
 (Gage, 1961) showed that the elimination rate is much slower 
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for the brain than for the remaining organs, probably due to the oxidation of mercury 
vapor to Hg
2+
 (see section 3.1.2) and its retention for longer periods in the brain (Mottet 
et al, 1997; Rooney, 2007; WHO, 2003).  
 
Neurotoxic symptoms resulting from chronic MeHg exposure usually begin by a 
sensation of numbness in limb extremities (paraesthesia) (Ahlmark, 1948, Clarkson and 
Magos, 2006). This first symptom is then followed by the appearance of slurred speech 
and loss of coordination (ataxia). Losses of balance, hearing and visual capacity are the 
next symptoms and eventually, dementia and death will follow (Ahlmark, 1948; Magos, 
1997). The examination of samples of hair and blood from victims of the Minamata and 
Niigata outbreaks concluded that the NOAEL for MeHg in adults was 50 mg kg
-1
 of Hg 
in hair which corresponded to 200 µg L
-1
 in blood (Clarkson and Magos, 2006). Later, 
the data from the poisoning outbreak in Iraq confirmed this value and allowed to set the 
adult threshold value (LOEL) for the first symptom (paraesthesia) between 50 and  
100 mg kg
-1
 of Hg in hair (Magos, 1997; Clarkson and Magos, 2006). 
 
In vitro studies showed that MeHg inhibits microtubule formation and protein synthesis 
(Mottet et al., 1997; Tchounwou et al., 2003) and that the granular cells of the 
cerebellum are particularly sensitive to increased levels of this compound (Fonfría et al., 
2005). Autopsies of victims of MeHg poisoning also confirmed that the cerebellum is 
particularly affected by this compound (Magos, 1997). Another characteristic of MeHg 
neurotoxicity that became evident with the Japanese and Iraqi outbreaks was that the 
appearance of toxic symptoms is delayed relatively to the peak of exposure to mercury 
(Figure 1.8) (Clarkson and Magos, 2006). 
 
One of the proposed mechanisms for MeHg neurotoxicity is related with the disruption 
of glutamate transport. In the mammalian CNS glutamate is the main excitatory 
neurotransmitter (Fonfria et al., 2005). When released into the synaptic cleft it 
stimulates Ca
2+
 influx through NMDA receptors in the post-synaptic terminal. In a 
normal physiological scenario, the glutamate in the synaptic cleft is taken up by 
astrocytes through Na
+
/K
+
 transporters, allowing for the signal transmission to terminate 
(Fonfria et al., 2005). Both MeHg and Hg
2+
 (Aschner et al., 1993, 1994; Fonfria et al., 
2005) affect glutamate mediated excitatory signaling by simultaneously enhancing its 
release from the pre-synaptic terminal and by hindering their uptake by astrocytes 
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(Figure 1.9). Increased levels of glutamate in the synaptic cleft promote an increased 
calcium influx to the post synaptic terminal. Once there, the excessive calcium will 
affect the mitochondrias by increasing nitric oxide synthase (nNOS) activity and 
consequently NO production. Moreover, mercury increases ROS production and targets 
anti-oxidant enzymes and glutathione. 
 
Figure 1.8: Delayed time between exposure to MeHg and onset of neurotoxic symptoms in the 
Iraqi outbreak in 1971/1972 (from Weiss et al, 2002). 
 
 
Figure 1.9: Disruption of neuronal glutamate transport by MeHg. (from Farina et al., 2011). 
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4.2. Teratogenicity 
 
In exposed pregnant women, MeHg and Hgv
0
 are capable of crossing the placental 
barrier and reach the fetus (Magos, 1997; Clarkson and Magos, 2006) although Hgv
0
 is 
less effective in targeting the fetal brain than MeHg since it is first oxidized to Hg
2+
 in 
the fetal liver (Clarkson et al., 2007). As a consequence, Hg levels following exposure 
to mercury vapor are lower in the brain of the fetus that in the brain of the mother 
(Clarkson et al., 2007).  
 
The developing brain is quite sensitive to MeHg and the fetus presents symptoms when 
the mother has no manifestation of mercury poisoning (Moriyama and Takizawa, 2001; 
Mottet et al., 1997). Also, the lack of maturity of the BBB of the fetus makes it even 
more vulnerable to mercury (Clarkson and Magos, 2006). Data from the poisoning 
outbreak in Iraq and from some major epidemiological studies conducted after, (see 
section 3.2.1) pointed out that the fetal brain could be affected at concentrations as low 
as 10 mg kg
-1
 of Hg in the maternal hair which is 5 to 10 times lower than the toxicity 
threshold previously reported for adults (Magos, 1997; Clarkson and Magos, 2006) 
(section 4.1). The Minamata and Iraq outbreaks revealed that upon exposure to high 
levels of MeHg in utero there is a severe distortion of the fetal brain architecture which 
is caused by hindrance of neuronal migration (Mottet et al., 1997). Consequences 
include microcephaly, cerebral palsy, blindness and ataxia with most severe cases 
ending in fetal death before or shortly after birth (Mottet et al., 1997; O’Hara et al., 
2002). In milder cases, although children may appear physically normal, they show 
delayed neurodevelopment and serious retardation (Clarkson and Magos, 2006).   
 
Since both MeHg and Hgv
0
 are also secreted in breast milk (Bose O’Reilley et al., 
2008), children of breast feeding age might be exposed to dangerous amounts of MeHg 
(depending on the mother’s diet) or Hgv
0
 (if the mother lives in a mining area or has a 
high number of amalgam fillings) (Bose O’Reilley et al., 2008; Richardson et al, 2011). 
Overall, early childhood together with the in utero developing fetus, are considered the 
most vulnerable life stages concerning exposure to mercurials (Clarkson and Magos, 
2006).  
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4.3. Nephrotoxicity 
 
All mercury compounds are nephrotoxic to some degree (Zalups, 2000). Exposure to 
mercury vapor yields Hg
2+
 by catalase mediated oxidation (see section 3.1.2), which is 
considered the direct responsible for mercury vapor toxicity (Clarkson and Magos, 
2006). The main target of Hg
2+
 is the kidney and thus during chronic exposure to 
mercury vapor, besides the CNS, the kidney may become also affected (Ohno et al., 
2007). Workers occupationally exposed to Hgv
0
 have been reported to present 
proteinuria and damaged renal tubules (Cárdenas et al., 1993; Ellingsen et al., 1993b). 
Tubular dysfunction is the most common consequence of a high mercury burden in the 
kidney (Magos, 1997). Nephrotoxicity is usually recognized as a consequence of Hg
2+
 
exposure, although kidney damage may also result from MeHg exposure (Zalups, 
2000). 
 
4.4. Cardiotoxicity 
 
Cardiac effects of mercury compounds comprise increased risk of myocardial 
infarction, ischemic heart, increased blood-pressure, vascular disease and increased 
heart rate variability (Stern, 2005). Exposure to Hg has been associated to increased risk 
of cardiovascular mortality, especially due to hypertension and stroke (Fillion et al., 
2006; Gárcia-Gomez et al., 2007; Yorifuji et al., 2010). In fish eating populations, 
MeHg accumulates in the heart at levels comparable to those found in the brain (Matsuo 
et al, 1989).  
 
In the heart, mercury disrupts sodium transport and is associated with increased 
susceptibility to viral infections and risk of myocarditis (Chan and Egeland, 2004). A 
study by Bartolome et al. (1982) in rats suggested that MeHg might also interfere with 
heart maturation in utero, however no clear evidence exists in humans (Chan and 
Egeland, 2004). In spite the fact that fish is a valuable food source for many nutrients 
considered important for cardio-vascular health, such as PUFA and essential minerals 
like selenium (see section 3.2.1) there is growing concern that high mercury content in 
fish nullifies the cardio-protective effects of fish intake (Budtz-Jørgensen et al., 2008). 
Also, mercurials bind to Se forming Se-Hg complexes, which decreases Se availability 
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in the heart (Houston, 2011) and thus, some of the cardiovascular effects of MeHg may 
result from mercury induced Se deficiency (Venardos et al., 2004; Wu et al., 2003). 
 
4.5. Immunotoxicity 
 
Immunotoxic effects arise at mercury concentrations that are below those reported to 
damage the CNS and the kidneys and have been pointed out as the critical effect for the 
development of toxicity (Vas and Monestier, 2008).  
 
The mercuric ion has a general stimulatory effect over the immune system, 
(Havarinasab and Hultman, 2005). Studies in rodents (Pollard and Hultman, 1997; 
Fournie et al., 2001; Nielsen and Hultman, 2002) have shown the ability of Hg
2+
 to 
promote autoimmunity. Recently, Gardner et al. (2010) showed that occupational 
exposure to mercury vapor increases both antinuclear (ANA) and antinucleolar (ANoA) 
antibodies in serum as well as cytokines levels.  
 
In mice, MeHg acts initially as an immunosuppressor, but as exposure continues and it 
is converted to Hg
2+
, it has a stimulator effect over the immune system inducing the 
production of autoantibodies and increasing serum cytokine levels (Havarinasab and 
Hultman, 2005). 
 
In sensitized individuals, exposure to low levels of mercury vapor or MeHg from fish 
deregulate the immune response, altering serum levels of pro-inflammatory cytokines 
(e.g. IL-1β and TNF-α) and anti-inflammatory cytokines such as IL-4 and IL-17 
(Nyland et al., 2011). 
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5. BIOMARKERS OF MERCURY TOXICITY 
 
Biomarkers can be defined as, xenobiotically induced alterations in cellular or 
biochemical components or processes, structures, or functions (including 
neurobehavioral) that can be measured in a biological system and that can be related to 
exposure, effect or susceptibility to a xenobiotic (Gil and Pla, 2001; Kendal et al., 2001; 
Paustenbach, 2001; Silbergeld and Davis, 1994;). These alterations can occur at any 
stage along the causal pathway from exposure to the toxic compound until the 
establishment of overt toxicity (Figure 1.10) (Bendford et al., 2000). Ideally, biomarkers 
should be, simple to obtain and measure, non-invasive, and be sensitive and specific for 
the xenobiotic being assessed (Grandjean et al., 1994; Paustenbach, 2001). 
 
Biomarkers can be classified as biomarkers of exposure, effect or susceptibility, 
although the distinction between the different types is not always straight forward 
(WHO, 1993; Grandjean et al., 1994).  The link between exposure and effect 
biomarkers is important to establish dose-response relationships, while biomarkers of 
susceptibility concern the different degrees of individual response to exposure (WHO, 
1993).  
 
Exposure biomarkers reflect the internal dose of a xenobiotic, either by direct 
measurement of the compound, its metabolites or conjugates in a biological sample 
(urine, blood, hair.), or may be markers of biologically effective dose (BED) when they 
evaluate the interaction between xenobiotics and critical molecular targets such as 
proteins or DNA (WHO, 1993) depending upon how closely related they are to the 
pathological occurrence (Paustenbach, 2001). Exposure biomarkers are important tools 
in predicting changes in the risk of developing a disease associated with exposure to a 
given xenobiotic (Bendford et al., 2000).   
 
Effect biomarkers are measurable alterations (biochemical, physiological, behavioral) in 
an organism that result from exposure to a xenobiotic. Ideally these biomarkers should 
be predictive of effect, i.e. they should allow identifying initial alterations or adverse 
effects before they become irreversible or a sign of pathology (Bendford et al., 2000; 
Gil and Pla, 2001; WHO, 1993).  
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Biomarkers of susceptibility reflect characteristics that increase individual sensitivity to 
a given compound by either increasing its internal dose or by decreasing the value of the 
effective biological dose, for example as a result of genetic polymorphisms or non-
genetic factors such as age, diet or pre-existing diseases (Schmidt, 2006). 
 
In this section the main biomarkers used for mercurials will be addressed. 
 
 
Figure 1.10: Pathway leading from exposure to a xenobiotic to toxic manifestations and the 
relative position of exposure and effect biomarkers (adapted from Bendford et al., 2000). 
 
5.1. Biomarkers of Mercury Exposure 
 
5.1.1. Biomarkers of Exposure: Internal Dose 
 
Mercury is a ubiquitous environmental pollutant and humans are exposed to varying 
amounts of this xenobiotic (Clarkson and Magos, 2006). Thus, it is important to monitor 
exposure levels in the general population and in particular in groups at risk such as 
pregnant women, newborns and children and occupationally highly exposed workers.  
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Mercury can enter the human body in various forms and each of these has its own 
distinctive toxicological properties. Thus, not all biological indicators have the same 
reliability as biomarkers of exposure for all mercury compounds. Consequently, it is 
important that the biological indicator to be used as a biomarker of exposure translates 
the Hg burden of the organism and if possible at the target organ (Figure 1.11). Also, 
the appropriate biomarker of exposure will depend on the type of exposure (acute vs. 
chronic) (Clarkson et al., 2007).  
 
The most common biomarkers of exposure to mercurials are internal dose markers and 
encompass measurement of Hg levels in hair, urine and blood (Berglund et al., 2005). 
Other biomarkers like the levels of Hg in placental cord-blood, feces, breast-milk or 
nails are seldom used, although in particular situations have proven to be useful (e.g. 
Bose-O’Reilly et al., 2010a; Ohono et al., 2000;). 
 
a) Mercury Levels in the Hair 
 
The level of Hg in the hair is an appropriate biomarker to address exposure to MeHg in 
a non-invasive way (Satoh, 2000; Berglund et al., 2005). Another advantage of 
measuring Hg levels in hair is that it allows retrospective studies by measuring mercury 
in different sections of the hair strand (Mottet et al., 1997). Methylmercury binds the 
SH- groups of keratin and thus is integrated in the hair (Mottet et al., 1997) constituting 
more than 80% of the mercury burden (Berglund et al., 2005). Hair follicles are thought 
to accumulate the same transportable species that reach the brain (Clarkson et al., 2007). 
In fact, hair mercury levels correlate very well with levels in the brain and whole blood 
in the proportion 250:5:1, respectively (Clarkson and Magos, 2006) (Figure 1.12). 
However, the ratio of mercury levels between blood and brain and blood and hair may 
vary to some extent according to individual characteristics such as age, sex and genetics 
(Doi and Tagawa, 1983; Bartell et al, 2000). Levels of mercury in maternal hair 
correlate well with the blood levels of the fetus, which makes it a useful biomarker of 
pre-natal exposure for risk assessment purposes.  
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Figure 1.11: Relation between environmental sources, pathway of exposure and exposure 
assessment of mercury (from Bose-O’ Reilli et al., 2010b). 
 
Hair mercury levels are normally not considered an appropriate biomarker of exposure 
to Hgv
0
 (Mottet et al., 1997). The work of Berglund et al. (2005) showed that in the 
general population, the small amount of Hg
2+
 found in the hair is likely the result of 
MeHg demethylation in hair follicles. Nevertheless, it has recently proven a useful 
indicator of exposure to mercury vapor in gold-mining areas where MeHg intake is 
very-low (Bose-O’ Reilli et al., 2008). Given the possibility of mixed sources of 
exposure (diet vs. occupational) to different Hg compounds (MeHg vs. mercury vapor) 
the measurement of mercury stable isotopic signatures in hair, might be useful to 
distinguish the different inputs of mercury into the organism (Laffont et al., 2011).  
 
Hair treatments may alter mercury in hair and bias the interpretation of results to some 
extent (Ohono et al 2007; Yasutake et al., 2003). Standard procedures include hair 
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washing to discard external contamination but metals can penetrate into the hair strand 
and alter the exposure results (Bose-O’ Reilli et al., 2010b). 
 
 
Figure 1.12: Relative concentrations of MeHg in hair, brain and blood (adapted from Clarkson 
et al., 2007). 
 
b) Mercury Levels in Urine 
 
The concentration of mercury in urine is the most common biomarker of exposure to 
mercury vapor both in occupational exposures as well as in exposure to dental 
amalgams (Magos, 1997). Its use in monitoring workers exposed to mercury dates back 
to the first half of the 20
th
 century (e.g. Buckell et al., 1946; Neal, 1938). Mercury in 
urine derives from mercury accumulating in the renal cells (Cherian et al., 1978) and 
consequently in the mid- to long- term, reflects the body burden in Hg
2+
 that 
accumulates primarily in the kidney after exposure to Hgv
0
 (Clarkson and Magos, 2006; 
Zalups, 2000). Also it can be used to monitor acute exposures to Hgv
0
 (Bose-O’ Reilly 
et al., 2010b). Mercury values are normally reported as a function of creatinine present 
in urine to account for the urine dilution factor (Clarkson and Magos, 2006).  
 
In humans, MeHg is mostly eliminated through feces (Clarkson and Magos, 2006). 
However, a MeHg-Cys conjugate is slowly excreted in urine, originating a considerable 
lag time between exposure and excretion (Yasutake et al., 1989).  Experiments with rats 
showed that even in chronic exposures the urinary excretion of MeHg is very low 
(Zalups et al., 1992) and thus, urine Hg levels are a not considered a useful biomarker 
for assessing MeHg exposure (Berglund et al., 2005). 
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c) Mercury Levels in Blood 
 
The blood is responsible for the distribution of all forms of mercury to the target organs 
(Clarkson et al., 2007). In the blood, about 90% of MeHg is found in RBC bound to 
hemoglobin (Figure 1.12; Clarkson, 2007) over a widespread range of MeHg 
concentrations and length of exposure (Berglund et al., 2005). On the other hand, 
inorganic mercury (Hg
0
 and Hg
2+
) is evenly distributed between RBCs and plasma. 
Mercury levels in whole blood are interpreted as reflecting exposure to MeHg 
(Berglund et al, 2005; Bose-O’ Reilli et al., 2010b). Overall, the analysis of the mercury 
species in the different blood compartments improves exposure assessment (Berglund et 
al., 2005).  
 
Since mercury kinetics in blood is relatively fast, this biomarker has the limitation of 
being only useful in acute exposure scenarios if the time gap between exposure and 
measurement is short or in the case of continuous (chronic) exposure (Satoh, 2000). 
 
Internal-dose biomarkers have been widely used in risk assessment of mercury 
compounds. However, due to the inter-individual human variability to mercurials and 
given its delayed effects (section 4.1), the levels in hair, blood or urine do not 
necessarily translate into the presence or absence of toxicity (Bose O’Reilly et al., 
2010b). 
 
5.1.2.  Biomarkers of exposure: biologically effective dose 
 
For risk assessment purposes it is important to understand the interactions of mercurials 
in the organism and the biological reactions to their presence. However, xenobiotics 
may lead to initial biological alterations that may be significant or not for the 
development of endpoints of toxicity. In this section, the biomarkers of exposure to Hg 
that are classified as biomarkers of biologically effective dose (BED), are assumed to 
reflect a biological reaction to the xenobiotic presence that does not translate per si in 
toxic effects or at least, has not been proven to originate the most important adverse 
effects of mercury. 
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a) Impairment of Heme- Biosynthesis and Coproporphyrin Accumulation  
 
Porphyrin metabolism has been proposed as an indicator of metal exposure and toxicity. 
The synthesis of the prosthetic group Heme- is an important physiological process that 
occurs in all tissues (Woods et al., 2009). The Heme- biosynthetic pathway (Figure 
1.13) involves several product intermediates and enzymatic processes from the initial 
substrate (Succinil CoA) to the final Heme group (Woods, 2009). In the normal 
unfolding of the heme biosynthesis process, excessive production of intermediate 
coproporphyrinogens is accompanied by renal excretion (Woods et al., 1993).  
 
Several metals, including mercury (MeHg and Hg
2+
), lead and arsenic (Fowler and 
Mahafey, 1978; Pingree et al., 2001; Woods and Fowler, 1977, 1978), interfere in a 
dose-dependent manner with the normal course of this pathway by inhibiting the 
activity of some of the specific enzymes and promoting porphyrin oxidation (Woods et 
al., 2009).  
 
Mercury targets specifically the enzyme uroporphyrinogen decarboxylase leading to the 
accumulation of penta-carboxyporphyrinogen (Figure 1.14) that competes with 
coproporphyrinogen 4-CP for the active site of coproporphyrinogen oxidase (CPOX). 
The oxidation of 5-CP by CPOX results in the appearance of keto-isocoproporphyrin 
(KICP) (Woods et al., 2005) (Figure 1.14). This atypical “precoproporphyrin”can be 
detected by HPLC where it elutes prior to coproporphyrin (Woods et al., 1991). 
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Figure 1.13: The Heme Biosynthetic pathway. The enzymes involved in heme biosynthesis 
include: 1- -aminolevulinic acid (ALA) synthetase; 2- ALA dehydratase; 3- uroporphyrinogen 
I synthetase; 4- uroporphyrinogen III cosynthetase; 5- uroporphyrinogen decarboxylase; 6- 
coproporphyrinogen oxidase; 7- protoporphyrinogen oxidase; 8- ferrochelatase. (from Pingree et 
al., 2001). 
 
The change in the porphyrin excretion pattern (i.e. KICP appearance) has been 
described as a biomarker of exposure for both MeHg and Hgv
0
 (Marks, 1985; Woods, 
1995). Moreover, such alterations seem to occur prior to the onset of target tissue injury, 
which raises the possibility of porphyrines being used biomarkers predictive of early 
toxic effects (Woods et al., 1995, 2009). Animal studies (Lund et al., 1991, 1993) have 
provided evidence supporting the usefulness of coproporphyrines in predicting 
nephrotoxic effects. Also it was suggested (Echeverria et al., 1994) a relationship 
between urinary porphyrin changes and alterations in neurobehavioral function, 
resulting from prolonged mercury exposure. However, alterations in porphyrin 
excretion do not necessarily represent a step in the casual pathway between exposure 
and effect (Figure 1.10) and thus its value as a biomarker predictive of neurotoxic 
effects is questionable. Moreover, unlike the measurement of total coproporphyrin 
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accumulation, it is difficult to determine levels of KICP with the desired sensibility to 
make it a useful biomarker in risk assessment (Santos et al., 2007).   
  
 
 
Figure 1.14: Hg mediated inhibition of uroporphyrinogen decarboxylase (UROD) leads to the 
accumulation of penta-carboxy porphyrinogen (5-CP) that competes with coproporphyrinogen 
4-CP for the active site of coproporphyrinogen oxidase (CPOX). The oxidation of 5-CP by 
CPOX results in the appearance of keto-isocoproporphyrin (KICP) (from Woods et al., 2005). 
 
b) Depletion of Intracellular Glutathione (GSH) 
 
GSH is the most abundant cellular thiol, especially in hepatocytes where it reaches 
millimolar concentrations (Meister, 1988). GSH is a tripeptide consisting of glutamate, 
cysteine and glycine. It is involved in many cellular processes (for instance, in the 
regeneration of oxidized proteins and as a radical scavenger) and together with its 
coupled enzyme systems (S-transferases and glutathione peroxidases), constitutes one 
of the most important antioxidant defense lines (Meister, 1988). Conjugation with GSH 
is an important step in the metabolization and systemic transport of mercurials (see 
section 3). However, an excessive mercury burden may lead to the depletion of reduced 
glutathione, with serious consequences in the cell antioxidant response (Farina et al., 
2011). Several in vitro and in vivo studies (Bo et al., 1993; Franco et al., 2007; Fujiyama 
et al., 1994; Piccoli et al., 2012) have demonstrated that GSH may become depleted 
following exposure to MeHg and Hg
2+
. In the liver, such a decrease may not be 
dramatic due to higher GSH re-synthesis ability (Santos et al., 2007; Sura et al., 2011). 
 
Although GSH depletion is correlated with mercury exposure, many other compounds 
such as paraquat (e.g. Djukic et al., 2012), arsenic (e.g. Jain et al., 2012), 
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benzo(a)pyrene (Romero et al., 1997) and acetaminophen (McMurtry et al., 1978) 
produce a similar effect. As a consequence, in a multi-contaminant or therapeutic 
context this end-point does not allow to distinguish mercury related toxicity from other 
compounds. 
 
c) Induction of Metallothionines 
 
Metallothionines (MTs) are low-molecular weight proteins (6-7 kDa) rich in Cys 
residues (30% of amino acid residues of MT are cysteines) and without aromatic amino 
acids (Eroglu et al., 2005). Therefore, the MTs have a large number of sulfhydryl 
groups, which can be coordinated by heavy metal ions (up to 7 molecules). These 
proteins are important for maintenance of Cu
2+
 and Zn
2+
 homeostasis (Eroglu et al., 
2005). Inorganic mercury (Hg
2+
) is known to induce and bind MTs especially in the 
kidney and liver (Gerson and Shaik, 1982; Piotrowski et al., 1974; Yasutake and 
Nakamura, 2011) and concurrently enhancing urinary excretion of Cu
2+
 and Zn
2+
 
(Chmielnicka et al. 1986, Liu et al. 1992). Mercury vapor and MeHg also induce MT 
synthesis after conversion to Hg
2+
 in tissues (Yasutake and Nakamura, 2011).  
 
The mercuric cation replaces Zn
2+
 in recombinant mammalian MTs with the 
concomitant unfolding of MTs (Leiva-Presa et al., 2004). Besides Hg
2+
, other elements 
both essential (Zn
2+
 and Cu
2+
) and non-essential (Ag
2+
; Cd
2+
) induce MT synthesis 
(Zalups, 2000) and thus it becomes difficult to discern between mercury induced 
alterations in the presence of other metals with this biomarker. 
 
d) Changes in the levels of Oxidative Stress markers 
 
Mercurials are known to enhance the production of reactive oxygen/nitrogen species 
(ROS/RNS), such as hydrogen peroxide (H2O2), the superoxide anion (O
-
2), and nitrous 
oxide (NO
-
) (Farina et al., 2011). Increased ROS production may lead to increased lipid 
peroxidation (LPO) which has been widely used as an indicator of mercury induced 
oxidative stress (Huang et al 2011; Kong et al. 2012; Mahboob et al., 2001; Suda and 
Takabashi, 1992). However, many compounds in the environment increase ROS 
production (e.g. pesticides; cadmium; PAHs). Thus, like the case of GSH these 
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biochemical changes are not good markers of mercury toxicity in a multi-contaminant 
scenario due to the lack of specificity.   
 
5.2. Biomarkers of Effect 
 
5.2.1. Neurobehavioral alterations 
 
In order to relate exposure to mercurials with the development of neurotoxic effects, 
many studies have relied on clinical observations of subtle alterations in neuromotor 
endpoints and behavior (Bose O’Reilly et al., 2010b). 
 
These include assessment of language milestones, attention deficit, memory outcomes, 
hand–eye coordination evaluation, reaction time and IQ tests (Bose O’Reilly et al., 
2010b; Dahl et al., 1996; Grandjean et al., 1997, 1999; Myers et al., 1997). In children it 
is also frequently assessed the age of achievement of several developmental milestones 
such as sitting, standing up, walking and talking (Grandjean et al., 1995; Myers et al., 
1997). In occupational exposed workers, motor skills assessment frequently includes 
writing tests and coordination tests that allow identifying hand tremor onset (Bose O’ 
Reilly 2010a). 
 
One of the problems with this type of endpoints is the occurrence of confounding 
factors that make the interpretation of results difficult (Grandjean et al., 1995). Also, 
these alterations may represent either reversible effects or already established 
manifestations of toxicity and thus, it would be important for risk prevention, to identify 
biomarkers predictive of early toxic effects (Santos et al., 2007). 
 
5.2.2. Changes in the activity of antioxidant enzymes 
  
Some enzymes involved in the degradation of ROS can see their activity changed by 
mercurials. Glutathione peroxidase 1 (GPx1), which is one of the main scavengers of 
H2O2 has been (Agarwal and Behari, 2007; Bulato et al., 2007; Chang and Suber, 1982; 
Nath et al., 1996; Watanabe et al., 1999) shown to decrease its activity following 
exposure to mercurials. This can be the result of several factors, such as GSH depletion 
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(see section 6.2), Se depletion or direct interaction between mercurials and its active site 
(see section 6.2.2). 
 
Changes in the activities of other enzymes participating involved in ROS scavenging 
enzymatic systems such as catalase (CAT) and superoxide dismutase (SOD) are also 
frequently used as markers of mercury induced oxidative stress. However, the results in 
the literature are not consistent regarding the effect of mercurials over the activity of 
these enzymes. In workers exposed to Hgv
0
, Perrin-Nadif et al. (1996) observed an 
increase in CAT activity in the plasma, while in rats Nath et al. (1996) saw no 
significant changes and Kong et al. (2012) reported a decrease in activity levels during 
the embryonic development of a fish-model. The same pattern is observed in the 
literature reporting SOD levels following exposure to mercury (e.g. Hussain et al., 
1997; Perrin-Nadif et al.; 1996). 
 
Recently Carvalho et al., (2008b) showed that in vitro mercurials target the enzymes of 
the thioredoxin system - thioredoxin reductase (TrxR) and thioredoxin (Trx) - binding 
their active site and decreasing activity. The thioredoxin system is found in all tissues of 
the body and is involved in several functions which are key for cell maintenance and 
survival (e.g. protein repair; regulation of the cell cycle, cell signaling). Since the 
thioredoxin system is upstream of several biochemical pathways, it can be anticipated 
that its inhibition by mercurials is a key step in the development of mercury toxicity 
(Carvalho et al., 2008b). Further detail on the thioredoxin system and its interaction 
with mercury are given in Part B of this chapter. 
 
5.3. Biomarkers of susceptibility to mercury  
 
Susceptibility to mercurials is mostly related to the life stage. As previously mentioned 
the in utero developing fetus and first infancy are the most sensitive life-stages to 
mercurials and thus these population groups constitute the core target of mercury risk 
assessment (e.g. Grandjean et al., 1992, 1997, 2004; Myers et al., 2003).  
 
Interestingly, a few recent studies in humans point to a relation between exposure 
biomarker levels with polymorphisms in genes related to glutathione synthesis and 
metabolism (Custodio et al., 2004, 2005; Gundacker et al., 2009; Schläwicke-Engström 
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et al., 2008) and with metallothionein synthesis (Gundacker et al., 2009; Wang et al., 
2012). Nevertheless, despite the promising results of these studies, some 
methodological constrains make interpretation difficult and false-positive findings 
cannot be totally ruled out (Schläwicke-Engström et al., 2008).  
 
 
6. INTERACTION BETWEEN MERCURY COMPOUNDS AND SELENIUM 
 
6.1.  Biological Importance of Selenium 
 
Selenium is an essential micronutrient that was discovered by Jöns Jakob Berzelius 
(Berzelius, 1818) and is located in the periodic table in group VI between tellurium and 
sulphur. Its most abundant stable isotopes are isotopes with the mass numbers 80 and 78 
and 76. The range of the essential concentrations of Se is narrow and health problems 
will arise from both an insufficient (e.g. Keshan Disease) as well an excessive intake 
(e.g. selenosis) (Reilly, 2006). Several important biological functions have been 
attributed to Se including prevention of cardiovascular disease, regulation of immune 
response, endocrine function and spermatogenesis as well as cancer preventing 
properties (Rayman, 2000). Selenium is a component of the antioxidant enzymes 
glutathione peroxidase and thioredoxin reductase. It is also found in three deiodinase 
enzymes, which convert thyroid hormones (Lillig and Holmgren, 2007; Papp et al., 
2007).  
 
Recommend values for Se intake vary between 55 and 75 µg/day, but the claimed 
anticancer properties of this element are only apparent at intakes above 200 µg/day 
(Beckett and Arthur, 2005). Several studies have reported decreased incidence of cancer 
and decreased mortality due to cancer in subjects on a selenium-rich diet (e.g. Clark et 
al., 1996; Combs and Gray, 1998; Yu et al., 1997) Notwithstanding, results from a long-
term and large scale study targeted at understanding if Se supplementation reduced the 
incidence of prostate cancer in U.S. men (SELECT study) gave no indication of a 
beneficial role of Se supplementation (Dunn et al., 2010).  
 
Selenium can work as a co-factor of some proteins, but its most important biological 
role arises from the integration of proteins in the form of selenocysteine (Sec) (Papp et 
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al., 2007). Sec (Figure 1.15) is now recognized as the 21
st
 genetically encoded amino 
acid and proteins containing it are known as selenoproteins (Papp et al., 2007). 
Selenium can also exist in proteins in the form of selenomethionine (SeMet; Figure 
1.15) which, unlike Sec, is not genetically encoded and its integration into proteins is 
the result of the non-specific replacement of the sulfur atom in methionine (Suzuki and 
Ogra, 2001). 
 
 
Figure 1.15: Structure of the amino acids containing selenium: selenocysteine and 
selenomethionine (from Suzuki and Ogra, 2001).  
 
Upon entering the cells, and regardless of being in the form of inorganic (selenite or 
selenate) or organic compounds (Sec and SeMet), selenium compounds have to be 
reduced to selenide (Se
2-
) before they can take part in selenoprotein synthesis (Suzuki 
and Ogra, 2001) (Figure 1.16). GSH is responsible for reducing selenite to Se
2-
 while 
Sec is reduced by β-lyase. Selenide may be methylated and excreted or enter the Sec 
and selenoprotein synthesis (Suzuki and Ogra, 2001) (Figure 1.16). 
 
 Figure 1.16: Metabolic pathway of selenium (from Ralston et al., 2008) 
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Sec is integrated in proteins according to its corresponding codon, UGA (Papp et al., 
2007). UGA is normally a stop codon of the translation process, thus selenoprotein 
synthesis also requires the presence of the selenocysteine insertion sequence (SECIS), 
its specific selenocysteinyl-tRNA (Low and Berry, 1996) and several other protein 
factors (e.g. SBP2) (Papp et al., 2007). Unlike other amino acids, Sec has to be 
degraded into selenide for de novo synthesis of Sec and integration into selenoproteins 
(Hatfield et al., 2006).   
 
Many selenoproteins require the presence of the Sec residue at the active site for 
catalytic activity. The first mammalian enzyme to be identified as being a selenoprotein 
was glutathione peroxidase 1 (GPx1) (Mills, 1957, 1959; Oh et al., 1974) which is 
involved in degradation of H2O2. Since then, at least 40 selenoproteins were found to be 
part of the mammalian proteome (Reilly, 2006). The function of some of these enzymes 
is still unknown, but others have been well characterized and have important roles at the 
cellular level and determine organisms’ physiology (Table 1.2).  
 
Some well-characterized families of selenoenzymes are:  the glutathione peroxidases 
(GPxs; involved in peroxides degradation), the iodothyronine deiodinase (DIOs; 
responsible for regulating the activity of thyroidal hormones) and thioredoxin reductase 
(TrxRs; involved in several key cellular processes; further discussed in Section B). The 
selenol (-SeH) group in the Sec residue has a much lower pKa than the thiol (-SH) in 
Cys (5.2 vs 8.5, respectively) and at physiological pH is ionized to selenolate (-Se
-
) 
which increases greatly the catalytic efficiency of selenoenzymes (Stadtman, 1996).  
 
Table 1.2 - Selenoproteins and some of their functions (Adapted from Papp et al., 2007) 
Function Selenoproteins 
Antioxidant  enzymes 
Glutathione peroxidases (GPx1, GPx2, GPx3, GPx4, 
GPx6); SelK; SelR; SelW. 
Redox Signaling Thioredoxin reductases (TrxR1, TrxR2, TGR) 
Thyroid Hormone Metabolism Iodothyronine deiodinases (DIO1, DIO2, DIO3) 
Selenocysteine Synthesis SPS 2 
Transport and Storage of Selenium SelP 
Protein Folding Sep15, SelN, SelM, SelS 
Unknown Function SelH, SelI, SelO, SelT, SelV 
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Selenoenzymes are not equally ranked in synthesis priority. There is a hierarchy of 
synthesis depending on the cellular status of selenium, with DIOs and TrxRs near the 
top and GPx1 at the bottom (Flohé and Brigelius-Flohe, 2006). In fact, GPx1 is 
frequently used as an indicator of selenium deficiency in organisms as it is normally the 
first to be affected by its deficit (Ralston and Raymond, 2010). 
 
Additionally, the brain is a priority organ for selenium distribution and it was shown 
that during periods of insufficient intake, the selenium stored in visceral organs (e.g. 
kidneys) is re-distributed to the brain (Behen et al., 2000) 
 
Another important protein containing Sec is Selenoprotein P (SelP). SelP differs from 
the other selenoproteins as it contains multiple Sec residues (9 in mammals) in its 
structure (Burk and Hill, 2009; Ralston and Raymond. 2010). This protein is secreted 
from the liver into the plasma and is thought to be the main responsible for distributing 
Se throughout the body (Burk and Hill, 2009; Papp et al., 2007). During Se deprivation, 
serum levels of Sel P decrease dramatically (less than 5%) making it a good indicator of 
the Se status of the body (Burk and Hill, 2009). The liver does not retain significant 
amounts of Sel P (Anan et al., 2011). The role of SelP in antioxidant defense and as a 
ROS scavenger has also been demonstrated in animal experiments (Burk et al., 2003; 
Burk and Hill, 2005; Papp et al., 2007).  
 
6.2. Mercury-Selenium Interaction 
 
The protective role of Se against mercury toxicity was first observed by Parizek and 
Ostadalova (1967) in rats injected with HgCl2 and Na2SeO3. Later, Ganther et al. (1972) 
showed that in rats co-exposure to Se was able to alleviate the lethal effects of MeHg. 
Starting from then, several authors have showed the same type of phenomenon in 
various species (Chen et al., 2001; Cuvin-Aralar and Furness, 1988; Koeman et al., 
1975) including humans (Kosta et al., 1975). Nevertheless, other works (Magos and 
Webb, 1977; Ralston et al., 2008) showed that mercury selenium interaction is not 
always beneficial, as it may lead to Se depletion making it unavailable to participate in 
metabolism. As observed by Khan and Wang (2009) the overall net effect of Se over Hg 
toxicity will depend on the relative concentrations of Hg and Se (Figure 1.17) and their 
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bioavailability. Other variables to be taken into account are the organism species and/or 
the target organ. In this section this relation will be examined. 
 
 
Figure 1.17: Importance of the Hg:Se ratio for development of toxicity (from Khan and Wang, 
2009). 
 
6.2.1. Effects of Co-exposure to Selenium and Mercury Compounds 
 
In the work of Parizek and Ostadalova (1967) co-exposure to Na2SeO3 reduced the renal 
toxicity of injected HgCl2. Subsequently, it was observed that both elements formed a 
complex at equimolar ratio that was found bonded to a protein in the plasma (Burk et 
al., 1974). The protein was identified to be SelP (Yoneda and Suzuki, 1997) and binding 
occurred through ionic interaction with cationic (imidazole groups of histidinyl 
residues) and anionic centers in SelP (Suzuki et al., 1998). Figure 1.18 represents the 
interaction of Hg
2+
 with Se
2-
 as proposed by Suzuki and Ogra (2001). Intravenously 
administered selenite is reduced by GSH in red-blood cells to selenide (Se
2-
) and in the 
plasma binds Hg
2+ 
forming a complex (HgSe)n, that binds to SelP excreted from the 
liver (Suzuki and Ogra, 2001). Additionally, observations of insoluble granules of HgSe 
have been reported in the organs of several species (e.g. Eley, 1990; Arai et al., 2004). 
Recently, Carvalho et al. (2011) proposed a mechanism for the reactivation of purified 
mammalian TrxR inhibited by Hg
2+
 by Na2SeO3, which could be another possibly 
pathway of HgSe formation (see Section B for further discussion). 
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Figure 1.18: Toxicokinetics and toxicodynamic processes involved in the interaction between 
Hg
2+
 and Se
2-
 in a co-exposure situation. See text for detailed description (from Suzuki and 
Ogra, 2001). 
 
 
The benefit of Se supplementation is also dependent on the chronology of exposure 
treatments, and is frequently reported that only is only observable when both 
compounds (HgCl2 and Na2SeO3) are provided simultaneously. Delaying the 
administration of sodium selenite is reported as having no protective effect (Nagamuna 
et al., 1984). Agarwal and Behari (2007) noted that post-treatment with sodium selenite 
of rats previously exposed to HgCl2 resulted in greater accumulation of mercury in the 
brain and kidney with increased LPO and decreased GPx activity and did not decrease 
toxicity of Hg
2+
. 
 
Co-exposure to Se compounds has also been indicated to alleviate MeHg toxicity by 
several authors (Beyrouty and Chan, 2006; Ganther et al., 1972; Hoffman and Heinz, 
1998; Ralston et al., 2008; Satoh et al., 1985). Dietary selenium was recently shown to 
diminish the neurotoxic effects caused by MeHg in rats (Ralston et al., 2008). It has 
been proposed that MeHg (mostly bound to thiols), due to its higher affinity to selenols 
(-SeH), could exchange ligands forming MeHg-Se-R compounds that are less reactive, 
more stable and so less bioavailable (Canty et al., 1983). Such compounds include 
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CH3Hg–Se–HgCH3
reduction
SeO3
2- Se2-
Se2- + 2CH3Hg
+ HgSe + CH3HgCH3
MeHg–Sec and bis(methylmercuric)selenide (CH3HgSeHgCH3, hereafter referred as 
(MeHg)2Se). The latter compound is thought to be rapidly eliminated from tissues 
(Watanabe, 2002).  
 
Selenium has been also reported to have a role in MeHg demethylation, which is known 
to occur in vivo, especially in the liver, but also in the brain (Mottet et al., 1997). The 
mechanism by which the C-Hg bond is cleaved remains unknown but, several 
hypotheses concerning the involvement of Se in this process have been suggested (Yang 
et al., 2008): 
 
a) Selenium has a direct role in demethylation: 
 
 (2) 
 
 
b) R-SeH compounds generate superoxide radicals that will promote 
demethylation: 
 
 
 
             (3) 
 
       
c) Diffusion of (MeHg)2 Se into the mitochondria where demethylation occurs by 
radical attack. 
 
 
However, the beneficial effects of selenium co-exposure over MeHg toxicity are still 
controversial. In some studies (e.g. Magos and Webb, 1977; Masukawa et al., 1982), 
(MeHg)2Se was shown to form in the blood, modifying MeHg distribution and 
increasing concentrations in the brain, which could increase MeHg toxicity. A study by 
Newland and co-workers (2006) also showed that a Se rich diet increased levels of 
MeHg in the brain of female rats and their pups. This increase of MeHg levels in the 
brain, can potential enhance its interference with the activity of selenoenzymes (see 
following section). 
H2Se   
GSH       GSSG O2 •O2
-
•O2
-
CH3Hg
+ Hg2+
R-SeH Se0
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6.2.2. Interaction between mercury compounds and selenoenzymes 
 
Mercury is known to have a greater affinity to bind SeH than SH groups (Carvalho et 
al., 2008b). Therefore, selenoproteins are prone to be targeted by mercurials leading to 
loss of activity (Ralston and Raymond, 2010). Since, selenium exists primarily in 
selenoproteins many of which are enzymes with important roles in cellular and tissue 
homeostasis (Papp et al., 2007), impairment of their functions by mercurials is probably 
a determinant factor in the development of toxicity and therefore Se-Hg interaction 
studies must address this issue. Toxic effects of selenoenzyme inhibition may be 
aggravated further, given that the formation of unreactive compounds, such as HgSe and 
(MeHg)2Se, thought to function as detoxifying mechanisms, can in fact, render Se 
unavailable to take part of de novo selenoenzyme synthesis (Figure 1.19) (Ralston and 
Raymond 2010). Harmful effects may be reduced if the selenium status becomes 
replenished by an exogenous source (e.g. diet) (Ralston and Raymond, 2010). 
 
 
Figure 1.19: Schematic view of how formation of mercury-selenium compounds disrupts the 
synthesis process of selenoproteins. See text for explanation (from Ralston and Raymond, 
2010). 
 
There are several reports in the literature concerning interaction of mercurials with 
selenoproteins. In neuroblastoma cells exposed to MeHg, Franco et al. (2009), showed a 
concentration dependent decrease (up to 40%) in GPx activity. Bulato et al., (2007) 
showed that activity loss of GPx in LNCaP cells during exposure to Hg
2+
 resulted from 
Se depletion and not from interaction between the mercurial and the Sec residue in the 
active site (Bulato et al., 2007). Also, given that GPx1 ranks low in the selenoenzyme 
synthesis hierarchy, it is likely the first to be affected upon Se depletion induced by 
mercurials. Several animal studies (Chang and Suber, 1982; Franco et al., 2009; 
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Fredriksson et al., 1993;Nishikido et al., 1987; Watanabe et al., 1999) also reported 
decreased GPx activity in rodents after exposure to MeHg (up to 50%) followed by 
recovery when Se was provided.  
 
The levels of selenoprotein W (SelW) - a 10 kDa protein with GSH-dependent 
antioxidant activity – have been shown in tissue cultures of muscle and brain cells to be 
influenced by Se levels (Whanger, 2000). However, the negative effects of mercurials 
over the activity of Se W were not always found to be related to Se depletion. For 
example, the activity and expression of Sel W- in SH-SY5Y was shown to be affected 
by MeHg as a result of GSH depletion (Kim et al., 2005). Selenium depletion had no 
effect on the expression and activity of SelW in these cells.  
 
Recently (Carvalho et al., 2008b), it was shown that mammalian TrxR activity was 
affected by both Hg
2+
 and MeHg in HeLa and HEK 234 cells, indicating that mercurials 
targeted the active site SeH (Carvalho et al., 2008b). Given its role upstream several 
cellular pathways, inhibition of TrxR by mercury might be a key step in the 
development of toxicity. The implications of TrxR inhibition in the molecular 
mechanism of mercury toxicity will be further addressed in Part B of this Chapter
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1. STRUCTURE AND FUNCTIONS OF THE THIOREDOXIN SYSTEM 
 
The thioredoxin system is of critical importance for the maintenance of several 
important functions in the cell (e.g. protein repair; cell cycle regulation). It comprises 
thioredoxin (Trx), thioredoxin reductase (TrxR) and NADPH (Holmgren, 1989).  
 
 
                          (4) 
 
 
It is one of the major antioxidants systems used by cells to maintain the reduced state in 
intracellular environment as well as to defend against oxidative and nitrosative stress 
(Holmgren, 1985; Nakamura et al., 1997).Additionally, the thioredoxin system is 
implicated in a large number of biological functions such as DNA synthesis and cell 
proliferation, angiogenesis, control and activity of numerous transcription factors, 
protection of cells against apoptosis and cell signaling pathways (Lillig and Holmgren, 
2007). 
  
This section intends to be a review on the structure, functions and health implications of 
the thioredoxin system. Special focus will be given to the interaction of electrophilic 
compounds with Trx and TrxR and their effects on the overall functioning of the system 
and cell.    
 
1.1. The Enzymes of the Trx System: Structure and Catalytic Mechanism 
 
1.1.1. Thioredoxin (Trx) 
 
The thioredoxin superfamily of proteins includes such varied proteins like thioredoxins, 
glutaredoxines, glutathione transferases or glutathione peroxidases (Lillig and 
Holmgren, 2007). In common they share the same structural feature, known as the 
thioredoxin-fold with four β-sheets and three α-helices (with additional strands varying 
according to the specific protein) and the same conserved active site motif (-Cys-X-X-
Cys-) (Lillig and Holmgren, 2007). In Trxs and Grxs, the dithiol in the active site is 
used to catalyze the reversible reduction of disulphides. 
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Thioredoxin (Figure 1.20) is a small (≈12 kDa) ubiquitous protein with a dithiol active 
site (Holmgren, 1985) and in its reduced form is also a general protein disulfide 
reductase (Arnér and Holmgren, 2000). The catalytic motif of the active site, -Trp-Cys-
Gly-Pro-Cys-Lys, is conserved in all phylogenetic groups from Archea to the most 
complex eukaryotic organisms (Arnér and Holmgren, 2000). Both active site thiols (Cys 
32 and Cys 35) are necessary for the catalytic activity of Trx (Lillig and Holmgren, 
2007) (Figure 1.21). Briefly, the N-terminal cysteine thiolate in Trx forms an 
intermediate with the target disulfide (1) which is subsequently reduced by the C-
terminal thiol (2), resulting in a reduced dithiol in the substrate and a disulfide in the 
active site o Trx (3). The disulfide in Trx is afterwards reduced by the action of TrxR 
(see reaction (4) above and section 1.2 ). 
 
 
Figure 1.20: The structure of human Trx1 showing the relative position of the active site and the 
three structural Cys residues (Cys62, Cys 69, Cys73) (from Lillig and Holmgren, 2007).  
 
 
 
Figure 1.21: Catalytic mechanism of disulfide reduction by Trx. See text for details (from Lillig 
and Holmgren, 2007). 
 
 
Chapter 1, Part B: Overview on the Thioredoxin System           49 
Two isoforms of Trx have been described for mammals: Trx1, encoded by gene TXN1 
exists predominantly in the cytosol but also in the nucleus and in the mitochondrial 
inter-membrane space. Trx1 can be imported to the nucleus from the cytoplasm during 
periods of increased cellular stress (Hansen et al., 2006a); Trx2, encoded by gene TXN2 
found in the mitochondria (Lillig and Holmgren, 2007). In mammals, Trx1 contains 
three additional structural Cys residues (Cys62, Cys69, Cys73; Figure 1.20), which can 
be oxidized and are important in regulating its activity (Lillig and Holmgren, 2007). 
Trx2 lacks these structural Cys residues but contains an N-terminal elongation involved 
in mitochondrial uptake (Smeets et al., 2005). 
 
Besides the two Trx isoforms, there are several tissue/organelle specific proteins such as 
spermatocyte specific thioredoxins (SpTrxs), Trx-like 1 and nucleoredoxin (Nrx) that 
contain the Trx active site motif C-X-X-C, albeit not all have oxireductase activity. In 
plasma there is also a truncated form of Trx, containing the first 80 N-terminal residues 
of Trx but without oxireductase activity, named Trx80. This protein is a substrate of full 
length Trx (Lillig and Holmgren, 2007).   
 
 
1.1.2. Thioredoxin reductase (TrxR) 
 
Thioredoxin reductases are flavoproteins that belong to the family of pyridine 
nucleotide-disulfide oxido-reductases. Besides TrxR, this family includes enzymes like 
lipoamide dehydrogenase, glutathione reductase (GR), mercuric ion reductase and 
trypanothione reductase (Zhong et al., 1998).  
 
TrxR is a homodimeric protein with a molecular mass of 112 kDa that also contains a 
FAD prosthetic group, a NADPH binding location and an N-terminal redox-active 
disulfide/dithiol at the active site (Mustacich and Powis, 2000, Sandalova et al., 2001). 
The motif of the N-terminal active site of mammalian TrxR (Cys-Val-Asn-Val-Gly-
Cys) is the same found in GR, but mammalian TrxR is unique in having a C-terminal 
elongation containing a Cys residue adjacent to a penultimate selenocysteine (Sec) 
residue, with the conserved sequence Gly-Cys-Sec-Gly-COOH (Zhong et al., 1998) 
(Figure 1.22). This elongation exposes the electron transport chain to the enzyme 
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surface, and blocks the redox-active disulfide preventing GR-like activity (Sandalova et 
al., 2001).  
 
The spatial arrangement of the two monomers is such that in the homodimer, the N-
terminal portion disulfide/dithiol of one of the monomers is adjacent to the 
selenenylsulfide/selenolthiol (Cys497-Sec498) in the C-terminal elongation of the other 
(Figure 1.23) (Zhong et al., 2000). 
 
 
Figure 1.22:- Structure of the reduced active site of TrxR1, showing the selenolthiol (C497 + 
U498) at the C-terminus and the N-Terminal dithiol (C59 + C64) (adapted from Cheng et al. 
2009) 
 
 
The presence of this selenolthiol (in the reduced enzyme) was found to be essential to 
TrxR activity, and given its accessibility and reactivity it is responsible for the wide 
substrate specificity of mammalian TrxR (Zhong et al., 1998). Moreover, under 
physiological conditions the SeH group in reduced TrxR is present as a highly reactive 
selenolate anion (Se
-
) (Stadtman, 1996) (see previous introduction; section A.6.1). 
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Figure 1.23: Schematic view of the homodimer of mammalian TrxR. The black dots on the 
FAD domain represent the disulfide/dithiol of the N-terminal region and the black dots on the 
interface domain, the selenenylsulfide/selenolthiol of the C-terminal elongation (from Zhong et 
al., 2000). 
 
 
Thioredoxin reductase is the only enzyme known to reduce oxidized Trx (Mustacich 
and Powis, 2000) and is normally found in cells at levels that exceed the required for 
Trx reduction (Cheng et al., 2010). As proposed by Zhong et al. (2000), the reduction of 
Trx involves electron transfer from NADPH via FAD and the N-terminal dithiol into the 
C-terminal region selenenylsulfide forming a thiol and a selenolate (Figure 1.24). The 
selenolate reacts with the disulfide in oxidized Trx forming an intermediate 
selenenylsulfide with Trx. Electron transfer from the Cys497 releases reduced Trx and 
regenerates the selenenylsulfide (Figure1.24). 
 
TrxR can also reduce other substrates such as lipid hydroperoxides, hydrogen peroxide, 
selenite, lipoic acid, dehydroascorbate, S-nitrosoglutathione, seleno-diglutathione, 
selenocysteine, Vitamin K and ubiquinone or protein disulphide isomerase (Arnér, 
2009; Lillig and Holmgren, 2007; Xia et al., 2003; Zhong et al., 2000). Also, the 
reduction of selenium compounds to the active form (Se
2-
) by TrxR is a key step for the 
synthesis of all selenoproteins including TrxR (Xia et al., 2003). 
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Figure 1.24 – Proposed mechanism for the reduction of Trx by mammalian TrxR. NADPH 
transfers electrons via FAD an the N-terminal dithiol to the C-terminal forming a thiol and 
selenolate which reacts with oxidized TrxR reducing the active site dithiol  (from Zhong et al., 
2000). 
 
In humans there are three isoforms of TrxR: TrxR1, TrxR2 and TGR (thioredoxin 
glutathione reductase). TrxR1 is the main form found in the cytosol of most tissues (for 
a matter of simplicity, during this work the TrxR1 nomenclature will be used when 
referring to the main cytosolic form of TrxR). TrxR1 encoding gene, TXNRD1, can 
originate TrxR1 variants with specific functions and locations by splicing (Arnér, 2009). 
TrxR2, which is encoded by gene TXNRD2, is the main form found in mitochondria 
(along this work TrxR2 will be used when referring to the mitochondrial isoform of 
TrxR). It is similar to TrxR1 but has a 33 amino acid N-terminal extension 
corresponding to the mitochondrial targeting sequence (Miranda-Vizuete et al., 1999). 
The TXNRD2 gene can also generate some splicing variants of TrxR2 which in some 
cases are found in the cytosol (Arnér, 2009). TGR (gene TXNRD3) is a particular type 
of TrxR found in the testis and differs from other isoforms in having an N-terminal 
elongation with a monothiol glutaredoxin motif (Cys-Pro-His-Ser) (Arnér, 2009). TGR 
can reduce both oxidized Trx and GSSG, having low activity over Grx and is implicated 
in disulphide bound formation and sperm maturation (Su et al., 2005). 
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Recently (Lu et al., 2009), it was shown that in a situation of Se depletion, TrxR variant 
forms with the Sec498 residue replaced by Cys may be formed. These Sec-to-Cys forms 
of TrxR are less effective in reducing Trx but, still, are important in maintaining 
reduced Trx levels during Se starvation (Lu et al., 2009). However, they have no 
capacity to degrade H2O2 (Cheng et al., 2010). 
 
TrxR1 and TrxR2 have some interesting differences regarding their substrate 
specificities, which could be related to the numerous key residues around the redox-
active centers that differ between the two isoforms (Biterova et al., 2005). TrxR1 has 
broader substrate specificity and can equally reduce both Trx1 and Trx2 (Rackham et 
al., 2011). On the other hand, TrxR2 has a lower Km (Michaelis constant) value for 
Trx2 than for Trx1 and shows a higher affinity for other mitochondria-related substrates 
such as Grx2 and cytochrome c especially at mitochondrial pH value (8.0) (Rackham et 
al., 2011). 
 
1.2. Biological Functions of the Thioredoxin System 
 
The Trx system is upstream of several metabolic pathways including DNA replication, 
protein repair, redox signaling and transcription regulation, which eventually determine 
the health status of the cell and organism (Figure 1.25) (Holmgren and Lu, 2010). 
 
Because the activity of Trx is dependent on the ability of TrxR to reduce it, factors 
affecting the performance of TrxR (e.g. Se depletion; electrophilic inhibitors) will 
compromise the metabolic pathways dependent on Trx activity (Arnér, 2009). This fact 
is the basis of the treatment strategies for some pathologies related to an overexpression 
(e.g. cancer) or deficit (e.g. hemolytic anemia) in TrxR activity (Arnér, 2009). On the 
other hand, due to its wide substrate specificity, TrxR has also important functions 
besides reducing Trx (e.g. ascorbate recycling) (Arnér, 2009).  
 
Although, some functions  performed by the thioredoxin system may be considered 
unique, some of them are also accomplished by other enzymes, mainly those of the 
glutathione system, which to some degree may compensate for a transient loss in the 
functioning of the Trx system (Lu et al., 2007) (Figure 1.26). In fact, very recent results 
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showed that cell proliferation can be enabled either by the Trx system or the glutathione 
system (through Grx) (Peng et al., 2012; Prigge et al., 2012). 
 
A description of some of the main cellular functions of the Trx system will follow in 
this section and Trx and TrxR enzymes will be addressed, as well as the consequences 
for cell metabolism and organism health. 
 
 
 
Figure 1.25: Metabolic pathways downstream of the Trx system and related cellular processes 
and diseases (from Holmgren and Lu, 2010). 
 
1.2.1. DNA replication 
 
The first Trx enzyme isolated form Escherichia coli was found to be the main hydrogen 
donor of ribonucleotide reductase (RNR), a function later found to be also performed  
by mammalian Trx (Holmgren, 1989). The enzyme RNR is responsible for reducing 
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ribonucleotides to their matching deoxyribonucleotides and its activity is essential for 
DNA replication and progress of the cell cycle (Holmgren, 1989). Ribonucleotide 
reduction is accomplished by a dithiol motif in one of the subunits in RNR, which is 
kept in the reduced state by Trx. Glutaredoxins (Grxs) can also reduce RNR and thus 
Trx inhibition will not result in an immediate arrest of a cell cycle but will hamper cell 
growth substantially (Lillig and Holmgren, 2007).  
 
 
 
Figure 1.26: Complementarity of function between the glutathione (GR; GSH/GSSG; Grx; 
GST; GPx) and the thioredoxin system (TrxR; Trx) (adapted from Lu et al., 2007).  
 
On the other hand, in tumor cells where cell division is fast and the demand for 
deoxyribonucleotides is great, the Trx system is normally overexpressed (Berggren et 
al., 1996). This fact constitutes the basis of some cancer therapeutically agents that 
target the Trx system in order to arrest tumor cell progression (Chew et al., 2008; Lu et 
al., 2007; Witte et al., 2005). TrxR, due to its particular active center and wide substrate 
specificity (see section 1.1.2) is regarded as a potential key molecular target for some 
pharmaceuticals (ex: quinolones; arsenic trioxide) used in the treatment of some types 
of cancer (Witte et al., 2005).   
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1.2.2. Antioxidant Defense  
 
Oxidative stress as a result of an excessive ROS production is associated with the onset 
of several diseases, including cardiac and neurodegenerative disorders (Andersen, 2004; 
Vernardos et al., 2004). Oxidative stress leads to the damaging of intracellular 
macromolecules such as lipids, proteins and DNA (Pacifici and Davies, 1991). The 
thioredoxin system has an important role in ROS scavenging. This task could be 
accomplished by direct degradation of hydrogen peroxide and other organic peroxides 
by TrxR (Zhong et al., 2000) and is physiologically important at high peroxide levels 
(Zhong et al., 2000) as by doing that TrxR possibly prevents the formation of HO• that 
could damage the enzyme (Zhong and Holmgren, 2000). Nevertheless, modulation of 
peroxiredoxins activity constitutes the main pathway for ROS scavenging by the Trx 
system. 
 
Peroxiredoxins (Prxs) - of which at least six isoforms exist - are enzymes involved in 
H2O2 scavenging (Rhee et al., 2005). Prxs are homodimers containing a Cys residue in 
the N-terminal region that is the location of oxidation by H2O2 (Rhee et al., 2005). The 
oxidized Cys in one subunit (Cys–SOH) reacts with the Cys residue in the other subunit 
forming a disulfide. Trx2 activity is then a key for reducing this disulphide (Hansen et 
al., 2006a; Rhee et al., 2005).  During periods of increased stress Prxs may form homo-
oligomers which help in further protecting cells from ROS toxicity (Miki and Funato 
2012). 
 
In addition to ROS scavenging, TrxR can reduce directly small molecules with 
antioxidant function such as ascorbate and lipoic acid which may be important in 
maintaining redox balance in the cell (Arnér, 2009). 
 
1.2.3. Protein Repair 
 
One of the consequences of free radicals is the damaging of macromolecules such as 
proteins. As previously stated, many enzymes rely on the presence of reactive thiol 
groups in their active center for their catalytic activity and the Trx system is the key in 
this process. Also, the methionine amino acid in proteins can become oxidized forming 
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methionine sulfoxide, which is thought to be a first line of defense in protecting proteins 
from oxidative damage (Levine et al., 2000). Methionine sulfoxides are reduced back by 
the enzyme methionine sulfoxide reductase (Msr), and this turnover cycle can also 
regulate the activity of certain proteins. Msr is kept in the reduced state trough the 
action of Trx (Levine et al., 2000). Interestingly, the protein disulphide isomerase (PDI) 
responsible for protein folding is a direct target of TrxR, most likely due to its Trx-like 
motifs that enable its reduction by TrxR (Lundström-Ljung et al., 1995). 
 
 
1.2.4. Apoptosis regulation 
 
Programmed cell death, i.e. apoptosis, is a key process to preserve the physiological 
integrity of multicellular organisms. The execution of apoptosis is critical for several 
processes (e.g. embryogenesis) and its deregulation is associated with hyperproliferative 
disorders including cancer and autoimmune response (Galluzi et al., 2009).  
 
Reduced Trx binds the apoptosis signal-regulating kinase 1 (ASK1) suppressing its 
activity and promoting its degradation (Lillig and Holmgren, 2007). Oxidation of Trx 
and the subsequent release of ASK1 (Figure 1.27) lead to the development of an 
enzymatic cascade trough the p38 and c-Jun N-terminal (JNK) mitogen-activated 
protein kinases (MAPK) pathways (Saitoh et al., 1998).Thus, Trx is a negative regulator 
of apoptosis trough the ASK1 pathway and functions as a redox probe for signaling 
cytokine and stress-induced apoptosis (Saitoh et al., 1998). Also, Trx2 is known to 
regulate the release of cytochrome c from mitochondria, which is an early step in 
apoptosis signaling (Ueda et al., 2002). Likewise, inhibition of TrxR2 was shown to 
cause apoptosis via the opening of the mitochondrial (Bax/Bak) pore (Rackham et al., 
2011). 
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Figure 1.27: Role of Trx in the signaling of apoptosis trough the ASK1 pathway (from Miki and 
Funato, 2012) 
 
 
1.2.5. Cell Signaling 
 
Besides its role in apoptosis signaling discussed above, the Trx system is also involved 
in the transduction of exogenous signals and in the regulation of several transcription 
factors involved in the cellular response to stress (e.g. infections) (Lillig and Holmgren, 
2007). Many transcription factors contain Cys motifs vital for binding to DNA and 
which can be reduced by Trx. The transcription factors activated by Trx include among 
others the nuclear factor-kB (NFkB), and the tumor suppressor p53 (Ueno et al., 1999). 
Upon stress, Trx1 is translocated to the nucleus and promotes p53 phosphorylation 
resulting in its activation and subsequent transcription of cell cycle regulatory genes 
(Lillig and Holmgren, 2007). The activation of NFkB by Trx is a complex mechanism 
where high values of oxidized Trx are essential for cleavage of the IkB from NFkB 
(Figure 1.28), but reduced Trx is needed in the nucleus for reducing its Cys residue and 
enable DNA binding (Li et al., 2005).    
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However, Trx is not only involved in the endogenous translation of molecular signals. 
Several cells secrete Trx through a leaderless pathway, independent from the ER-Golgi 
apparatus, similar to what is observed with IL-1β (Rubartelli et al., 1992). This secretion 
is thought to be a cellular response to oxidative stress and extracellular Trx was shown 
to suppress TNF-α induced apoptosis and protect endothelial cells from H2O2 damage 
(Nakamura et al., 2006). In plasma, Trx triggers anti-inflammatory response by 
suppressing the activation of neutrophils and preventing their migration to the 
inflammatory site. Since extracellular Trx is quickly oxidized, these functions cannot be 
explained by the thiol reduction ability of Trx (Nakamura et al., 2006). The truncated 
form of Trx, Trx80 which is present in plasma is also associated to monocyte 
differentiation.  
 
 
 
Figure 1.28: Regulation of the activity of the NFkB (subunits p50+p65) translocation factor by 
Trx and related enzyme Grx. Oxidation of cytoplasmic Trx1 allows the cleavage of NFkB from 
IkB its subsequent transfer to the nucleus; in the nucleus, Trx enables NFkB binding to DNA 
trough the reduction of its Cys residue  (from Lillig and Holmgren, 2007). 
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Liver cells were shown to actively secret Trx into extracellular medium, which 
correlated with growth inhibition. Interestingly, human hepatoma cells (HepG2) despite 
producing large quantities of Trx do not secret it. However, if Trx is provided to culture 
media their growth is impaired like with normal hepatocytes when they secrete Trx 
(Rubartelli et al., 1995).   
 
 
2. INTERACTION BETWEEN THE TRX SYSTEM AND ELECTROPHILIC 
COMPOUNDS 
 
Several compounds are known to cause inhibition of both enzymes of the Trx system. 
TrxR is particularly prone to interaction with electrophilic agents. As previously 
mentioned, the selenol (selenolate at physiological pH) in the open C-terminus of its 
active site account for the broad substrate specificity of TrxR, but also makes it 
susceptible to inhibition by other electrophilic agents (Arnér, 2009). This property has 
proven to be useful in the treatment of diseases associated with an overexpression of 
TrxR. There are several studies showing that certain anti-tumor drugs target the Sec 
residue in the active site of TrxR (Chew et al., 2008). However, the effects of targeting 
the selenol in the active site can be more complex than the simple loss of TrxR activity 
(Arnér, 2009). It was shown (Anestäl et al., 2008) that when an electrophilic agent 
targets the Sec in the C-terminus region of TrxR but not the dithiol at the N-terminus, it 
forms a selenium compromised form of TrxR without capacity to reduce Trx, but still 
maintaining NADPH oxidase activity. This modified TrxR lacks peroxidase activity 
(Cheng et al., 2010) and is pro-oxidant increasing greatly the cytotoxicity of inhibitory 
agents inducing cell death and thus became known as SecTRAPS (Selenium 
compromised thioredoxin reductase-derived apoptotic proteins) (Figure 1.29) (Anestäl 
et al., 2008). Possibly the same may happen when Se depletion leads to the formation of 
Se compromised forms of TrxR in cells (Anestäl et al., 2008).  
 
Interestingly, many of the compounds known to target TrxR, contain metals such has 
gold and platinum (e.g. aurofin and cisplatin) (Rigobello et al., 2004). For instance, 
organic gold compounds are known to inhibit TrxR activity and have been used to treat 
some autoimmune diseases (Mustacich and Powis, 2000) and platinum compounds have 
been tested as anti-cancer drugs (Witte et al., 2005). Also, other metals and metalloids 
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such as cadmium, arsenic and mercury were shown (e.g. Carvalho et al., 2008b; 
Hansen, 2006b; Lu et al., 2007) to interfere with the enzymes of the thioredoxin system. 
In this section (Part B, section 2) the effects of metal containing compounds on the 
enzymes of the thioredoxin system are reviewed, with special emphasis on the 
interaction of mercury compounds with Trx and TrxR. 
 
 
 
 
Figure 1.29: Formation of SecTRAPS upon targeting of the Sec residue at the C-terminal region 
of TrxR. When electrophilic agents target only the Sec residue in the active site of TrxR leaving 
the N-terminal dithiol functional, TrxR loses the ability to reduce Trx but gains a pro-oxidant 
function capable of inducing cell death   (from Arnér, 2009). 
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2.1. Effects of Metals on the Activities of purified Trx and TrxR    
 
Both Trx (Carvalho et al., 2008b; Hansen et al., 2006b; Lemaire et al., 1999) and TrxR 
(Carvalho et al., 2008b; Lu et al., 2007; Rigobello et al., 2004; Witte et al., 2005)  have 
been shown to be inhibited by metallic compounds. 
 
The concentration that inhibits the activity of purified TrxR by 50% (IC50) for several 
different metallic compounds are shown in Table 1.3. All the compounds shown, 
inhibited the activity of TrxR to some degree presumably trough the interaction with the 
Sec residue in the active site.  
 
Moreover, the inhibitory capacity of mercury compounds and especially Hg
2+ 
over 
purified TrxR is remarkable among metallic compounds (Table 1.3). Additionally, the 
inhibitory effect of mercurials was particularly fast with full inhibition of TrxR activity 
after only 5 minutes of incubation (Carvalho et al., 2008b). These results clearly show 
that TrxR is highly susceptible to inhibition by mercurials. Also the fact that Hg
2+
 is a 
stronger inhibitor of TrxR has toxicological significance since it could indicate that 
MeHg upon demethylation can produce an even more toxic outcome (Carvalho et al., 
2008b).  
 
 
Subsequent structural studies (Carvalho et al., 2011) revealed that mercurials form 
adducts with the active site of TrxR causing the loss of catalytic function. Once again, 
Hg
2+
 was shown to bind the active site of TrxR with higher efficiency and at a lower 
molar ratio than MeHg (Carvalho et al., 2011). Treatment of TrxR inhibited by Hg
2+
 
with selenite proved successful in recovering TrxR activity, with higher efficiency than 
British Anti-Lewisite (BAL) (Carvalho et al., 2011), which is one of the compounds 
that as long been used as a chelating agent in cases of mercury poisoning (e.g. 
Longcope et al., 1946). However, such a recovery by selenite was not observed with 
MeHg. The mechanism for the recovery of activity of Hg
2+
- inhibited TrxR by selenite 
as proposed by Carvalho et al (2011) is shown in Figure 1.30. Briefly, Hg
2+
 binds the 
selenolthiol in the C-terminal region of reduced TrxR inhibiting its activity; selenite, 
after reduction to selenide (HSe
-
) displaces Hg
2+
 from the active site leading to the 
formation of HgSe which is non-reactive (see section A.6.2.1). 
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Table 1.3: IC50 values for the inhibition of purified TrxR by metallic compounds. 
Compound 
[TrxR] 
(nM) 
IC50 (µM) 
incubation 
time (min) 
Reference 
Mercury 
HgCl2 50 0.0072 5 
Carvalho et 
al., 2008b 
MeHgCl 50 0.0197 5 
Gold (I) 
Aurofin 2 0.020 10 
Rigobello et 
al., 2004 
TEPAu 2 0.065 10 
Aurothiomalate 2 0.280 10 
Gold (III) 
Aupy 2 1.42 10 
Audien 2 0.42 10 
Aubipy 2 0.28 10 
Aubipyxil 2 0.21 10 
Tin Tributyltin 2 76.1 10 
Rigobello et 
al., 2004 
Cadmium 
Cadmium 
acetate 
2 23.5 10 
Zinc 
Zinc Acetate 2 19.5 10 
Zinc pyrithione 2 11.8 10 
Platinum 
Cisplatin 300 
200              
(approx. value) 
20 
Witte et al., 
2005 
Oxaliplatin 300 
100             
(approx. values) 
20 
Silver Ag2SO4 25 
0.025/5 
(approx..values) 
5 
Srivastava et 
al., 2012 
Arsenic As2O3 50 0.25/30 30 
Lu et al., 
2007 
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Figure 1.30: Proposed Mechanism for the reactivation by selenite of TrxR inhibited by Hg
2+
 
(from Carvalho et al., 2011). 
 
Thioredoxin has also been reported to present a decrease in activity following exposure 
to metals in vitro. Lemaire et al. (1999) observed that in vitro Hg
2+
, Cd
2+
 completely 
inhibited the activity of DTT-reduced Trx-h (Trx isoform found in the cytosol of 
plants). Recently, Carvalho et al. (2008b) showed that both Hg
2+
 and MeHg targeted the 
dithiol at the active site of Trx1 leading to loss of activity, albeit with higher IC50 than 
the observed for TrxR. However, like with TrxR, Hg
2+
 was the stronger inhibitor of Trx 
activity. Moreover, it was shown through mass spectra analysis that a 2.5 molar ratio of 
Hg
2+
 fully inhibits Trx1 and leads to dimer formation, while for MeHg a 5.0 molar ratio 
to Trx1 was needed and dimer formation did not occur. As previously mentioned, Trx1 
has three structural Cys residues (Cys62, Cys69 and Cys73) (see section B.1.1.1). 
Carvalho et al. (2008b) proposed that, Hg
2+
 besides binding the dithiol (Cys32 and 
Cys35) at the active site of Trx1 with the subsequent loss of activity, also binds Cys62 
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and Cys69, forming a disulfide, and binds Cys73 in two adjacent molecules forming a 
~24 kDa dimer (Figure 1.31). MeHg (CH3Hg
+
) only binds one thiol at a time and thus 
does not induce enzyme dimerization. 
 
 
 
Figure 1.31: Interaction of mercurials with Cys residues in Trx1. A – Hg2+; B – MeHg. See text 
for detailed description (from Carvalho et al., 2008b). 
 
 
2.2. Effects of metals on the Activities of TrxR and Trx in cells and animal models   
 
In vitro experiments clearly showed that both TrxR and Trx become inhibited in the 
presence of metallic compounds (see section B.2.1). However, the effects of metals can 
differ significantly in living systems, such as cell models, but especially in animals or 
humans where toxicokinetics plays an important role in the distribution of the 
compound to tissues. Moreover, besides the compound interacting directly with the 
active site of the enzymes, one has to consider that changes in the expression of the 
enzyme may also occur. 
 
Arsenic trioxide (ATO) was shown to decrease significantly in a time and concentration 
dependent manner the activity of TrxR in MCF-7 cell (Lu et al., 2007). Also, ATO and 
aurofin were reported to decrease TrxR activity in A549 cells (lung) (Talbot et al., 
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2008). Interestingly, Talbot and co-workers (2008) mentioned that although mRNA 
transcription was not altered upon exposure to both these compounds, radio labeling 
with 
75
Se revealed a decrease in Se incorporation into proteins. Jung et al. (2004), 
reported that AlCl3 (0.5 mM), ZnCl2 (0.5 mM), CuCl2 (0.2 mM) and CdCl2 (0.1mM) 
enhanced TrxR activity in Chang and HepG2 cells. Furthermore, CdCl2 was shown to 
enhance TrxR1 expression trough the activation of the NF-E2-related factor 2 (Nrf2) 
transcription factor (Sakurai et al., 2005). On the contrary, results in rats exposed to 
CdCl2 revealed a decrease in TrxR activity in the liver (Newairy et al., 2007) and kidney 
(El-Sharaky et al., 2007) that could be counteracted by co-exposure to sodium selenite. 
Exposure to Pb
2+
 was reported to increase TrxR activity in the kidney of exposed rats 
(Conterato et al., 2007). However, when blood levels of TrxR activity were monitored 
in workers exposed to Cd
2+
 and Pb
2+
, no correlation was found with blood levels of 
these two metals (Conterato et al., 2011). 
 
Mercurials were also shown to affect TrxR in HeLa and HEK 293 cells in a time and 
concentration dependent manner (Carvalho et al., 2008b). Inhibition of TrxR was seen 
after only 7 hours of exposure (Carvalho et al., 2008b), which correlates well with 
observations in vitro showing a fast inhibition of TrxR by mercurials (see section 2.1). 
Interestingly, the activity of GR was not affected by mercurials in HeLa cells, which 
reinforced that the Sec residue in the C-terminus of TrxR is a target for mercurials 
(Carvalho et al., 2008b). Like in vitro (with purified enzymes), selenite could recover 
TrxR activity in HEK293 cells previously exposed to 5 µM of Hg
2+
 (Carvalho et al., 
2011). Higher concentrations of Hg
2+
 or a larger time interval between mercury 
exposure and treatment with selenite, failed to recover TrxR activity (Carvalho et al., 
2011). Results in human THP1 monocytic cells exposed to Hg
2+
 suggested that mercury 
could induce transcription of the enzymes of the Trx system, via the increase of Nrf-2 
levels (Wataha et al., 2008). Recently, Wagner et al. (2010) showed that MeHg reduced 
the activity of TrxR in the liver and kidney of exposed rats, however, the authors failed 
to see any inhibition of TrxR in the brain (Wagner et al., 2010), which might be related 
to the fact that their observation on TrxR activity was made only after 24 hours of 
exposure. As mentioned previously, toxicokinetic processes cause a delay between 
exposure to mercurials and neurotoxic effects, thus more time may be needed between 
to observe effects in the brain (see section A.4.1). 
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Thioredoxin has also been reported to be affected by mercurials in cells. Hansen et al. 
(2006b) reported that the mercury, arsenic and cadmium led to the oxidation of Trx1 
and in particular of Trx2. Also in HeLa cells, both MeHg and Hg
2+
 decreased 
significantly Trx activity after only 7h of exposure albeit at concentrations not as low as 
seen for TrxR (Carvalho et al. 2008b). Notwithstanding,  in the unicellular green algae, 
Chlamydomonas reinhardtii, Lemaire et al. (1999), observed an increase in mRNA 
levels of cytosolic Trx following exposure to Hg
2+
 (6-fold increase) and Cd
2+
 (4-fold 
increase). The increase in protein levels was not so remarkable, but still 2.5-fold for 
Hg
2+
 and 1.7-fold for Cd
2+
, which agrees with the results of Wataha et al. (2008) that 
suggested increased transcription following exposure to Hg
2+
. 
 
Overall, the state-of-the-art indicates that both TrxR and Trx are important targets for 
mercurials. Given that the Trx system is upstream a network of metabolic pathways, the 
interaction of mercurials with both TrxR and Trx may be a key step in the development 
of toxicity. Surprisingly, there were no animal studies concerning variations in 
TrxR/Trx activity upon exposure to mercurials, especially at the target organs and that 
constitutes the core of the present thesis. Changes in gene transcription and protein 
expression may also play a role in the final balance of mercury inhibition of the 
thioredoxin system and that will also be discussed in face of the results obtained. 
Moreover, given the fact that Se supplementation was shown to recover the activity of 
TrxR in vitro, it would be another important objective of this research to look at co-
exposure to mercurials and selenium to investigate how it affects the thioredoxin system 
in living organisms.    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 – MATERIALS AND METHODS
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1. TOTAL MERCURY, METHYLMERCURY AND SELENIUM ANALYSIS  
 
Fresh fish samples collected during the in vivo experiments (see Chapters 3 and 4) were 
analyzed for total mercury (HgT), methylmercury (MeHg) and selenium (Se). All 
reagents used in these analyses were analytical grade. 
 
1.1. Total mercury determination 
 
Total mercury was determined by atomic absorption spectrometry, after pyrolysis of 
each sample in a combustion chamber at 750º C under an oxygen atmosphere, pre-
concentration onto a gold amalgamator and quantification by atomic absorption 
spectrometry, using a LECO AMA-254 advanced mercury analyzer (Costley et al, 
2000). Detection limit (LOD) measured as 3 times de standard deviation of the blanks 
(3) was 2 ng/g.  Precision error was determined by analyzing the minimum of three 
replicates and was less than 4%. 
 
1.2. Methylmercury quantification 
 
Methylmercury was quantified using the methodology proposed by Armstrong et al. 
(1999) with some modifications. Briefly, 2 mL of Milli-Q water and 3 mL of a 6 M 
KOH solution were added to 10-20 mg of samples. The mixture was shaken for 2 hours 
after which 3 mL of 6 M HCl and 4 mL of a KBr/CuSO4 mixture (3:1) were added. 
Vials were then manually shaken and left to rest for 20 minutes previously to the 
addition of 5 mL of dichloromethane (DCM). After overnight shaking, extracts were 
centrifuged and finally the organic phase was separated. A thiosulphate solution 
(Na2S2O3, 0.01 M) was used to extract MeHg from the organic phase and then MeHg 
was back-extracted to DCM. MeHg was then quantified by GC-AFS in an Agilent 
chromatograph coupled with a pyroliser unit and a PSA Hg fluorescence detector. The 
spiking of several samples with Hg(II) and MeHg standard solutions (Sigma) in 
different concentrations led to recoveries varying from 92 to 103% without any artifact 
MeHg formation. Detection limit (LOD) was 0.1 ng/g and precision error was less than 
7%. 
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1.3. Selenium quantification 
 
Selenium analysis followed the procedure described in Branco et al. (2007). Briefly, 
samples were digested at 60 °C overnight in Teflon vessels containing 2 mL of HNO3 
(65%, v/v) followed by 1 h at 100 °C, after which 1 mL of H2O2 (30%, v/v) was added 
and the digestion completed at 80 °C for 1 h. Quantification was done by ICP-MS 
(Thermo Elemental – X Series). LOD was 1.0 ng g-1 and precision was less than 9%.  
 
1.4. Analytical quality control 
 
International certified standards (NRC Canada) DORM-2 (dogfish muscle), DOLT-2 
(dogfish liver) and DOLT-4 (dogfish liver) were used to ensure the accuracy of the 
procedure (Table 2.1). 
 
Table 2.1: Certified and Observed values of Hg, MeHg and Se (µg g
-1
) in CRMs DORM-2 and 
DOLT-4 and DOLT-2. 
CRM  Hg (µg g
-1
) MeHg (µg g-1) Se (µg g-1) 
DORM-2 
Certified 4.64 ± 0.26 4.47 ± 0.32 1.40 ± 0.09 
Observed 4.47 ± 0.07 (n=9) 4.60 ± 0.16(n=9) 1.33 ± 0.13 (n=4) 
DOLT-2 
Certified 1.99 ± 0.10 0.693 ± 0.053 - 
Observed 2.09 ± 0.04 (n=8) 0.647 ± 0.016 (n=6) - 
DOLT-4 
Certified 2.58 ± 0.22 1.33 ± 0.12 8.3 ± 1.3 
Observed 2.41 ± 0.05 (n=8) 1.43 ± 0.17 (n=5) 7.7± 0.6(n=5) 
 
Additionally, the HgT and MeHg analytical methodologies were used in an inter-
calibration exercise held in 2009 by the International Atomic Energy Agency for the 
CRM IAEA-45L (Trace Element and MeHg in scallop). Results (blinded to the 
reference values) obtained were within the range of expected values for Hg and MeHg 
(Table 2.2). 
 
Table 2.2: Values of Hg and MeHg (µg g
-1
) obtained for the reference material IAEA-1452 and 
respective Z-score. 
 Obtained value  Certified value Z-Score 
Hg (µg g 
-1
) 0.146 ± 0.003 0.150 ± 0.02 -0.21 
MeHg (µg g
-1
) 0.0216 ± 0.0016 0.0217 ± 0.0027 0.64 
Chapter 2: Materials and Methods           73 
 
A z-score value of |2| is considered good. Further details on the inter-calibration 
exercise can be found on are provided in (Vasileva et al., 2010) 
 
2. HISTOPATHOLOGICAL ANALYSIS 
 
2.1. Histopathological observations 
 
Samples of liver and kidney from zeabra-seabreams collected for histopathological 
observations were immediately fixed after collection in 10% neutral buffered formalin 
(diluted in 10% salt water). Following fixation, samples were washed with distilled 
water and dehydrated in a progressive series of ethanol, embedded in paraffin and then 
cut into 3µm thick sections further stained with Harris haematoxylin (Merck) and 
counterstained with Eosin (Merck) according to the standard protocol described by 
Lillie and Fullmer (1976). Histopathological observations were carried out by using a 
Olympus BX 51light microscope linked to a digital camera (Olympus DP-20). 
 
2.2. Organ Damage Index  (ODI) calculation 
 
Based on the histopathological observations, the Organ Damage Index (ODI) was 
calculated for an exposure groups according to the formula:  
 
 
 
where Pi is the pathological importance factor (Table 2.3) following the proposal of 
Bernet et al. (1999) for a given organ lesion (OL) observed in the number of fishes (N) 
tested at each time-point.  
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Table 2.3: Pathological importance factor (Pi) of lesions observed in the liver and kidney of 
zeabra-seabreams, according to Bernet et al., (1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. CELL CULTURE 
 
3.1. Culture conditions 
 
HepG2 cells were a kind gift from Dr. Elsa Dias (National Health Institute Dr. Ricardo 
Jorge, INSA). Cells were grown in medium consisting of a 1:1 mixture of DMEM and 
F-12 (Gibco), supplemented with 10% of fetal bovine serum (Gibco), 5% of a Pen-Strep 
mixture (Gibco) and 2.5% HEPES (1 M), in a humidified incubator at 37º C and 5% 
CO2. For lysates, HepG2 cells were plated in 100 mm dishes (1x10
6
 cells), in the same 
medium and allowed to reach 80% confluence. Fresh medium was then supplied to the 
cells and afterwards different concentrations of Na2SeO3 (Sigma), MeHgCl (Sigma) or 
HgCl2 (Sigma) were added, depending on the exposure conditions. Co-exposure 
conditions were obtained by adding Na2SeO3 immediately after the mercurial 
compound under study. Incubation for a period of 24 h followed, after which cells were 
harvested from plates.  
 
 
 
                      Organ Lesion Pi 
L
IV
E
R
 
Architectural pattern lost 1 
Vacuolar degeneration. 1 
Hydropic degeneration 1 
Hypertrophy of Hepatocytes 2 
Extensive focal necrosis 3 
Focal necrosis 2 
Parenchymal congestion 1 
Pigment deposition 1 
K
ID
N
E
Y
 Vacuolar degeneration 1 
Hydropic degeneration 1 
Pigment deposition 1 
Parenchymal necrosis 3 
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3.2. Cell lysis 
 
For measuring the activities of TrxR, Trx, GPx and GR cells were disrupted in lysis 
buffer (25 mM Tris.Cl, pH 7.5; 100 mM NaCl; 2.5 mM EDTA; 2.5 mM EGTA; 20 mM 
NaF, 1 mM sodium orthovanadate, 20 mM sodium pyrophosphate; 20 mM of sodium β-
glycerophosphate; 0.5% Triton X-100 and protease inhibitor (1 pellet per 10 mL; 
Roche). After lysis, samples were centrifuged at 12 000 rpm for 7 minutes and the pellet 
discarded and enzymatic activities determined as described in section 5. 
 
Sub-cellular fractioning of HepG2 cells was based on the protocol by Zhang et al. 
(2011) with some modifications. After exposure to different concentrations of 
mercurials, cells were washed and suspended in mitochondrial isolation buffer (210 mM 
mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM Hepes–NaOH, pH 7.5) containing 
protease inhibitor cocktail (Roche). Cells were disrupted by douncing (20–25 strokes) 
followed by centrifugation at 600 g for 15 min. The nuclear pellets were discarded and 
the supernatants were centrifuged at 13,000 g for 15 min to yield the mitochondrial 
pellets and the supernatant cytosolic fraction. Mitochondrial pellets were lysed in cell 
lysis buffer as described above. Enzymatic activities (TrxR and Trx) were analyzed in 
each fraction as described in section 5.2. 
 
Fish organ samples (see chapters 3 and 4) were homogenized, at 4º C, in TE buffer - a 
mixture of Tris·HCl buffer (50 mM, with 200 mM of EDTA, pH 7.8) and protease 
inhibitor (Roche, 1 tablet per 10mL of buffer) - using a glass homogenizer and a Teflon 
mortar. Homogenized samples were then centrifuged at 12000 rpm for 7 min, at 4ºC. 
The soluble fraction was transferred to Eppendorf vials and kept at -20ºC until analysis.  
 
3.3. Viability Assay 
 
Cells (4x10
3
 cells/well) were plated in 96-well plates (Nunc)  and allowed to attach for 
24 h before adding different concentrations of HgCl2 (0, 1, 5, 10, 25, 50 µM), MeHgCl 
(0, 0.1, 0.5, 1, 5, 10 µM) or Na2SeO3 (0, 0.1, 0.5, 1, 2, 4, 8, 10, 15, 25, 40 µM). Cell 
viability was determined at the time of addition (0h) and after 24, 48 and 72 hours of 
exposure to each compound by the MTT assay. MTT ((3-4,5-dimethylthiazol-2-yl)-2,5-
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diphenyltetrazolium bromide; Sigma) was added to plates at a final concentration of 400 
µg/mL per well followed by incubation a 37º C for 4 h. After incubation the medium 
was removed and the formazan crystals formed dissolved in a 4:1 DMSO/Glycine 
buffer (pH 10.5). After shaking for 15 min, viability was then assessed by measuring 
formazan absorption at 550 nm. 
 
4. IN VIVO ASSAYS – FISH HUSBANDRY CONDITIONS 
 
Prior to the assays, juvenile zeabra-seabreams were kept in a rearing tank filled with 
treated seawater (600 L) in a closed circuit, with biological filters. Food was given 
once-a-day and physical-chemical parameters (O2, ammonia, pH, temperature and 
salinity) were monitored daily. At the beginning of each experiment, fishes were 
randomly selected and transferred to the test tanks. Specific conditions for each in vivo 
assay are given in chapters 3 and 4.  
 
 
5. ENZYMATIC ACTIVITY DETERMINATIONS 
 
5.1. Protein Determination  
 
Total protein was quantified in all samples by the Bradford method (Bradford, 1976). 
Briefly, 1 µL of each sample was incubated with Coomassie dye (BioRad; diluted 5 
times) in 96 well plates and read at 595 nm in a microplate reader. Protein concentration 
was then calculated from a calibration curve prepared using BSA as standard to the 
following concentrations (0, 1, 2, 4 , 8, 10, 12 µg/µL). 
 
5.2. Determination of thioredoxin reductase and thioredoxin activities 
 
Trx and TrxR activities were determined according to the insulin end-point assay 
described by Arnér and Holmgren (1999) for complex biological samples. Samples 
(organ homogenates or cellular lysates) are incubated together with insulin and 
NADPH. The Trx system in samples reduces the oxidized thiols in insulin yielding 
NADP
+
. The reaction is stopped after guanidine addition and the number of thiols 
reduced in insulin is determined with DTNB, yielding TNB:  
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For TrxR activity determination, samples (50 µg for liver; 30 µg for brain and kidney; 
40 µg for cell lysates; 15 µg for sub-cellular fractions of HepG2 cells) of soluble protein 
samples were incubated in 96 well plates with 0.3 mM of insulin, 720 µM of NADPH, 
2.5 mM of EDTA and 3 µM of fully reduced human Trx (IMCO Corp., Sweden) in 
85mM HEPES buffer (pH 7.6), for 20 min at room temperature. Control wells 
containing the same reagents excluding Trx addition, were prepared in parallel. After 
the incubation period, 250 µL of a 1 mM DTNB solution in 6 M guanidine 
hydrochloride (pH 8.0) was added to each well and absorbance was measured in a 
microplate reader (Zenyth 3100, Anthos Labtec Instruments) at 412 nm. TrxR activity 
was quantified as the difference in absorbance between the Trx containing well and the 
control well. The determinations of Trx activity followed the same procedure used for 
TrxR, being samples incubated with 100 nM of recombinant rat TrxR (Arnér and 
Holmgren, 1999). In the case of HepG2 cells, the amount of Trx and TrxR in controls 
was determined from a calibration curve preformed using purified Trx and TrxR. 
Results report enzymatic activities as percentage of control. 
 
5.3. Glutathione reductase activity 
 
Glutathione reductase activity was measured in samples according to Mannervik (1999). 
Samples (25 µg for organs and 40µg for cell lysates) were mixed in 96-well plates with 
phosphate buffer (100 mM, pH 7.0), NADPH (1mM) and GSSG (200µM). The decay in 
NADPH, resulting from the reduction of GSSG to GSH, was followed at 340 nm for 5 
minutes at 30ºC: 
 
 
  
 
DTNB +  Insulin-(SH)2 2TNB +  Insulin-S2
NADPH + H+ + Insulin-S2 NADP 
+ + Insulin–(SH)2
TrxR+Trx
GR
GSSG + NADPH + H+ 2GSH + NADPH+
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5.4. Glutathione peroxidase activity 
 
The activity of cytosolic seleno-dependent glutathione peroxidase 1 (GPx1) was 
measured according to the method (basic protocol) described by Esworthy et al. (1999). 
Thus, samples (25 µg for organs and 40µg for cell lysates) were mixed in 96-well plates 
with sodium phosphate buffer (50 mM, pH 7.0), GSH (10 mM), NADPH (2 mM), 
sodium azide (1.125 mM), and GR (100 U/mL). A 5 mM solution of H2O2 was used as 
the substrate. The GSSG resulting from H2O2 degradation by GPx is reduced to GSH in 
the presence of GR and NADPH. The decrease in NADPH is monitored at 340 nm for 5 
min and used to calculate GPx activity:  
 
 
 
In order to evaluate the contribution of GPx for the total glutathione peroxidase activity 
(TGPx) in each organ the analyses were repeated using cumene hydroperoxide (30 mM) 
as the substrate (Protocol 1 from Esworthy et al. 1999).  
 
5.5. Superoxide dismutase activity 
 
Total SOD activity was determined as described in McCord (1999). Briefly, samples 
were incubated with a mixture of oxidized cytochrome c (1 mM in phosphate buffer, pH 
7.8) and xanthine (1 mM in phosphate buffer, pH 7.8). After addition of xanthine 
oxidase (0.3 U/mL in phosphate buffer, pH 7.8), the increase in absorbance (550 nm) 
was monitored for 5 min. Oxidized cytochrome c is reduced by superoxide radicals 
generated by the oxidation of xanthine. The activity of SOD enzymes will scavenge the 
superoxide radicals thus leading to a decrease in the rate of cytochrome c reduction, 
which is proportional to enzyme activity. 
 
 
 
 
GPxROOH + 2GSH ROH + GSSG + H2O
GR
GSSG + NADPH + H+ 2GSH + NADPH+
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5.6. Caspase-3 Activity  
 
Cells cultured as described in 3.1, were harvested and cytosolic proteins were extracted 
by douncing (20-25 strokes) cellular pellets in ice cold isolation buffer (10 mM Tris pH 
7.6; 5 mM MgCl2; 1.5 mM potassium acetate, 2mM DTT and protease inhibitor - 
Roche). The assay for detection of general caspase-3-like activity in cell lysates is based 
on the cleavage of N-acetyl-Asp-Glu-Val-Asp-pNA (DEVD-pNA) (Sigma-Aldrich) to 
yield p-nitroanilide (pNA). The reaction was carried out in isolation buffer using 40 µg 
of protein and 50 µM DEVD-pNA. The reaction mixtures were incubated at 37 °C for 1 
h, and the formation of p-nitroanilide was measured at 405 nm using a micro plate 
reader (Amaral et al., 2007). 
 
6. QUANTIFICATION OF mRNA LEVELS BY QPCR  
 
For the measurement of TrxR1 and TrxR2 mRNA levels, HepG2 cells were cultured 
and harvested as described in 3.1. RNA extraction from HepG2 cells was performed 
with the RNeasy Mini kit (QIAGEN, Spain), according to manufacturers' protocol. 
cDNA was synthesized using SuperScriptTM III First-strand Synthesis SuperMix for 
qRT-PCR kit (NZYTech, Portugal) according to manufacturers' protocol. Quantitative 
PCR was achieved using the set of primers in Table 2.4. 
  
Table 2.4: Primers used in the quantification of TrxR1 and TrxR2 mRNAs. GAPDH was used 
as the control gene. 
Gene Primer Sequence 
TrxR1 
Forward 5’-CCAGGCCGACTCAGAGTAG - 3’ 
Reverse 5’- GCCAGCATCACCGTATTATATTCTC - 3' 
TrxR2 
Forward 5’-CGCCCATTATAAACCACTGGAGTT-3’ 
Reverse 5’-CAGGCACACCATCTTTACATAACAC-3’ 
GAPDH 
Forward 5′-GGTGGTCTCCTCTGACTTCAACA - 3′ 
Reverse 5’-GTTGCTGTAGCCAAATTCGTTGT - 3’ 
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Reactions contained 1 x MaximaTM SYBR Green qPCR Master Mix (Fermentas), 300 
nM forward primer, 300 nM reverse primer, and 150 ng of template DNA in a 25 µL 
volume. After initial incubations at 50°C for 2 min and 95°C for 10 min, 40 cycles of 
amplification were carried out at 15 s at 95°C followed by 1 min at 60°C. Reactions 
were performed using the ABI 7300 Real-Time PCR System (Applied Biosystems, 
Foster City, California).  
 
7. STATISTICAL ANALYSIS 
 
All values concerning analyses of fish organs are presented as mean ± standard 
deviation (std). Values concerning experiments with HepG2 cells are given as mean ± 
standard error (SE).  
 
The Shapiro-Wilks test was used to check the normality of data and the Levene test to 
check variance homogeneity. Accordingly to the results of these tests, either the 
parametric independent samples t-test or the non-parametric Mann-Whitney test was 
applied to examine differences between groups. Differences between groups were 
considered very significant at a p level below 0.01, significant at p<0.05 and marginally 
significant at p<0.08. Correlation between enzymatic activities (e.g. TrxR and GR) 
activities was evaluated by calculating the Spearman Rank Correlation (Zar, 1999). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 – INHIBITION OF THE THIOREDOXIN 
SYSTEM IN THE BRAIN AND LIVER OF ZEBRA-
SEABREAMS EXPOSED TO WATERBORNE 
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1. BACKGROUND 
 
TrxR and Trx were both shown to be inhibited by mercury compounds in vitro 
(Carvalho et al., 2008b), however, there are no animal studies regarding the interaction 
between the thioredoxin system and mercurials. Thus, the objective of this chapter is to 
study the in vivo effects of repeated exposure to MeHg (the most toxic form of Hg) on 
the thioredoxin system, in the brain and liver of juvenile zebra-seabreams in order to 
understand the importance of this system in the development of MeHg toxicity in 
vertebrates.  
 
Fishes have been widely used in toxicological studies due to the similarities between 
fish and mammal liver that allow the use of fish-models as alternative to the traditional 
rodent-model (Wolf and Wolfe, 2005). Also most fish species, such as zebra-seabreams 
(Diplodus cervinus, Lowe 1838), are easy to maintain in captivity (Gad, 2007) and 
juveniles have sufficient body and organ mass to ensure the appropriate number of 
replicates for the analysis of the different parameters. Moreover, fish-models are quite 
suitable for mercury toxicity studies since they are the main vertebrate group exposed to 
this compound with more than 90% of Hg stored in the muscle as MeHg (Harris et al., 
2003). Inorganic mercury is known to induce oxidative stress in fishes, causing changes 
in the activity of antioxidant enzymes such as superoxide dismutase (SOD) and 
glutathione reductase (GR) (Elia et al., 2003; Monteiro et al., 2010). Regarding MeHg, 
some studies have pointed some aspects concerning its accumulation and elimination in 
fishes (Almund et al., 2007; Bjerregaard et al., 1999) and the interaction with the 
endocrine (Bleau et al., 1996) and nervous system (Liao et al., 2006), and antioxidant 
enzymes (Berntssen et al., 2003). However, the interaction between mercury 
compounds and the redox active proteins of the thioredoxin system in fish was never 
investigated by other authors. 
 
In order to accomplish the proposed objective an in vivo assay was carried out in zebra-
seabreams with repeated exposure to MeHg for 28 days and toxicokinetics of MeHg 
with speciation analysis was carried out along with TrxR, GR and Trx activity 
monitoring. Post-exposure evaluation of toxicological targets is also reported. 
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2.  EXPERIMENTAL PLAN 
 
Juvenile zebra-seabreams (weight: 16±5g; length. 10±1cm) from the same cohort were 
collected from the aquaculture station of IPIMAR in southern Portugal in November 
2008. A total of 125 individuals were divided into 4 groups (30 each; see Figure 3.1) 
and placed in 60 L fiberglass tanks filled with seawater that was renewed daily. Food 
was given once-a-day, 1-2 hours before complete water renewal, and physical-chemical 
parameters (O2, ammonia, pH, temperature and salinity) were daily monitored. Fishes 
were allowed to acclimatize to experimental conditions for one week. A group of five 
fishes was sacrificed at the beginning of the experiment and used as the initial reference 
group (time zero; d0). In order to assure the correct handling and welfare of fishes, the 
entire experimental procedure was held according to the EC 609/86 Directive for 
laboratory animal welfare and subsequent Portuguese legislation (Law nº 129/92 of July 
6
th
) and supervised by a veterinary doctor at the National Institute for Biological 
Resources (IPIMAR/ INRB).  
 
Methylmercury chloride was added to tanks in an aqueous solution prepared from the 
dilution of a stock solution containing 2 mg mL
-1
 of CH3HgCl in DMSO. Thus, to the 
control tank it was added an amount of DMSO, equal to the largest volume used in the 
dilutions. To the exposure groups, methylmercury chloride was added in order to give 
the following total concentrations of CH3Hg
+
: 0.5, 1 and 2 µg L
-1
. Exposure 
concentrations were established after a 96-hours LC50 experiment (Appendix 1) and 
were lower than those used by other authors in similar studies (Liao et al., 2006), 
indicating high susceptibility of Diplodus cervinus to MeHg. Samples of contaminated 
water were collected immediately before and after recontamination in order to control 
variations in the exposure concentrations. Control water was monitored daily and total 
mercury levels stayed below 1 ng L
-1
.  
 
Exposure of fishes lasted for 28 days and was followed by a 14-day depuration period, 
in a total of 42 days. Every 7 days, five fishes per tank were collected, measured, 
weighed and sampled for muscle, liver, brain, kidney and gills (Figure 3.1). Samples 
were stored at -80 ºC until analysis in the laboratory. 
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Figure 3.1: Experimental plan of the assay designed to study the in vivo effects of repeated 
exposure to MeHg on the thioredoxin system of juvenile zebra-seabreams (Diplodus cervinus). 
 
Analyses of samples include the quantification of HgT and MeHg levels as well as of 
the activities of TrxR, Trx, GR and SOD (see Chapter 2 for details on methodologies).  
 
3. RESULTS 
 
3.1. Mercury Toxicokinetics  
 
 The results for total mercury (HgT) variation in liver, kidney, brain, muscle and gills of 
zebra-seabreams exposed to different concentrations of methylmercury are shown in 
Figure 3.2. For the three exposure groups (0.5, 1, 2 µg L
-1
 MeHg) Hg accumulated 
differently in the various organs and throughout the experimental period. The kidney 
was the organ where the highest Hg concentrations were found (Figure 3.2). This was 
particularly significant in the group exposed to 2 µg L
-1
, where after 28 days of 
exposure HgT levels reached 24.9 ± 5.7 µg g
-1
. At the end of the depuration period, 14 
days after exposure to MeHg ceased, HgT levels decreased to levels similar to those 
found at day 14 of exposure (14.1 ± 2.1 µg g
-1
). Total mercury also accumulated to a 
large extent in the liver though at levels 2 to 5 times lower than in the kidney. 
Accumulation was higher in the first 7 days of exposure; after exposure cessation, 
125 Fishes
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mercury elimination was fast being levels at day 42 similar to those at day (highest 
exposure group: 3.8 ± 1.6 µg g
-1
) (Figure 3.2). 
 
Accumulation of HgT in the brain was lower than in the kidney or liver and the kinetics 
was also quite different. HgT increased during exposure of fish to MeHg and 
throughout the depuration period reaching a level of 4.6 ± 0.7 µg g
-1
 (2 µg L
-1
 group). 
The accumulation pattern in the muscle was quite similar to the brain although levels at 
day 42 were slightly lower (highest exposure group: 3.6 ± 0.4 µg g
-1
) (Figure 3.2). 
 
Total mercury accumulation in the gills also differed from the remaining organs, with a 
very fast accumulation in the first 7 days of exposure and then increasing with a lower 
slope until the end of exposure. During the depuration period HgT levels decreased 
sharply until day 35, reaching at day 42 levels below those of day 7 (Figure 3.2). 
 
In general, the accumulation pattern for MeHg was similar to the observed for HgT 
(Figure 3.3) but with some variations regarding its proportion (%) of total mercury in 
the different organs throughout the experiment (Table 3.1). In the liver, MeHg averaged 
70-80% of HgT at day 14, reaching 90-100% at day 28 and 55-60% at day 42. In the 
kidney, the elimination of MeHg after exposure was only significant in fish exposed to 
the highest concentration (Figure 3.3). Also, in the kidney the percentage of mercury in 
the form of MeHg remained relatively constant (60-70%) (Table 3.1). In the gills, 
MeHg decreased more pronouncedly than HgT suggesting also some degree of 
demethylathion (Figures 3.2 and 3.3). In brain samples, MeHg accounted for almost 
100% of the whole mercury with the exception of the samples analyzed at day 42 when 
MeHg decreased slightly to 80-90% of total mercury (Table 3.1). The trend in the 
muscle was similar to that observed for the brain. 
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Figure 3.2: Variation of HgT levels (µg g
-1
) in the liver, kidney, brain, muscle and gills of 
seabreams during 28 days of exposure (shaded area) to MeHg and 14 days of depuration (light 
area). All data points represent the mean ± std of 5 different fishes being each individual 
subjected to 2-3 independent determinations. 
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Figure 3.3: Variation of MeHg levels (µg g
-1
) in the liver, kidney, brain, muscle and gills of 
seabreams during 28 days of exposure (shaded area) to MeHg and 14 days of depuration (light 
area). MeHg concentrations in controls were below LOD. All data points represent the mean ± 
std of 5 different fishes being each individual subjected to 2-3 independent determinations. 
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Table 3.1: Amount (%) of MeHg relative to total mercury concentration in liver, kidney, muscle, brain and gills of zebra-seabreams at days 14, 28  and 42 of experiment. All 
values mean ± std. 
  Liver Kidney Muscle Brain Gills 
 
Exposure concentration 
(µg L-1) 
0.5 1 2 0.5 1 2 0.5 1 2 0.5 1 2 0.5 1 2 
Day 
14 86 ± 16 73 ± 18 76 ± 19 70 ± 28 67 ± 16 62 ± 16 72 ± 5 95 ± 24 88 ± 4 93 ± 12 92 ± 11 94 ± 8 68 ± 15 86 ± 19 98 ± 41 
28 101 ± 7 92 ± 21 100 ± 14 63 ± 13 50 ± 13 55 ± 20 94 ± 11 102 ± 14 102 ± 8 94 ± 7 93 ± 15 101 ± 18 71 ± 14 71 ± 25 98 ± 23 
42 55 ± 24 62 ± 19 61 ± 31 56 ± 21 61 ± 18 61 ± 12 97 ± 12 97 ± 13 89 ± 11 82 ± 18 86 ± 19 87 ± 30 46 ± 9 64 ± 13 71 ± 14 
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3.2. Enzymatic Activities 
 
The results for the activity of the thioredoxin system  show that in the liver and brain 
both TrxR and Trx were affected by the exposure to MeHg (Figures 3.4 and 3.5). In the 
liver samples collected during the second half of exposure (days 21 and 28), and for all 
exposure concentrations, TrxR showed activity levels that were 40% of control levels 
(p<0.05) (Figure 3.4 A-C). After the exposure period (depuration), activity returned to 
levels similar to those of the control samples (p>0.05). Thioredoxin (Figure 3.4 D-F) 
was affected in a different manner than TrxR. In the early stages of exposure (day 14) 
Trx was not affected (p>0.05) and, especially in the group exposed to the lowest 
concentration of MeHg, its activity was slightly higher than the control group (p<0.05). 
Inhibition was only significant (p<0.05) at day 28 (70% of control activity) lasting until 
day 35 with full recovery at day 42 (p>0.05) (Figure 3.4 D-F).  
 
In the brain, the thioredoxin system was also affected, although to a lesser extent than in 
the liver (Figure 3.5). Inhibition of TrxR was significant (p<0.05) in the group exposed 
to the highest concentration of MeHg, with enzyme activity decreasing to 80% at day 28 
and to 70% at day 42 (Figure 3.5 C). In the lowest exposure group no significant 
(p>0.05) inhibition could be noticed (Figure 3.5 A) and in the 1 µg L
-1
 group there was 
only a significant degree of reduction in activity at day 35 (p<0.05) (Figure 3.5 B). 
Thioredoxin in the brain, also appeared to be more affected (p<0.05), with cumulative 
exposure to mercury with activity decreasing to 60-70% in the groups exposed to 1 and 
2 µg L
-1
 (Figure 3.5 E-F) 
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Figure 3.4: Variation of thioredoxin reductase activity (TrxR; A, B and C) and thioredoxin (Trx; 
D, E, and F) in the liver of zebra-seabreams exposed to different concentrations of MeHg (0.5, 1 
and 2 µg L
-1
). Days 14-28 correspond to the exposure period; days 28-42 correspond to the 
depuration period. ** Significantly different from control (p<0.05); * marginally different from 
control (p<0.08). All data points represent the mean ± std of 5 different fishes being each 
individual subjected to 3-4 independent enzymatic determinations.  
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Figure 3.5: Variation of thioredoxin reductase activity (TrxR; A, B and C) and thioredoxin (Trx; 
D, E, and F) in the brain of zebra-seabreams exposed to different concentrations of MeHg (0.5, 
1 and 2 µg L
-1
). Days 14-28 correspond to the exposure period; days 28-42 correspond to the 
depuration period. ** Significantly different from control (p<0.05); * marginally different from 
control (p<0.08). All data points represent the mean ± std of 5 different fishes being each 
individual subjected to 3-4 independent enzymatic determinations.  
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both enzymes (Liver: R=-0.928, p<0.01, n=6; Brain: R=-0.900, p<0.05, n=5 – Figure 
3.7). The activity of SOD in the liver and brain of seabreams was also not significantly 
affected by exposure to 2 µg L
-1
 of MeHg (Figure 3.6 C and D). 
 
Figure 3.6: Variation of glutathione reductase (GR; A and B) and superoxide dismutase (SOD; 
C and D) activities in liver and brain of zebra-seabreams exposed to 2 µg L
-1
 of MeHg. Days 
14-28 correspond to the exposure period; days 28-42 correspond to the depuration period. ** 
Significantly different from control (p<0.05); * marginally different from control (p<0.08). All 
data points represent the mean ± std of 5 different fishes being each individual subjected to 3-4 
independent enzymatic determinations. 
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Figure 3.7: Relation between TrxR and GR activities in liver and brain of zeabra-seabreams 
during the 42 days of the experiment. R – Spearman Rank Correlation Coefficient 
 
4. DISCUSSION 
 
4.1. Mercury Toxicokinetics  
 
All organs analyzed showed a significant accumulation of Hg following exposure to 
MeHg in water, especially the liver and kidney, which is in agreement with other works 
(Farias et al., 2009; Liao et al., 2006; Mieiro et al., 2009). In this study, it was observed 
a rapid decrease of Hg concentration in both liver and kidney after exposure cessation 
indicating that mercury was excreted. Moreover, the decrease of MeHg percentage 
(Table 3.1) in the liver after exposure, suggests active demethylation, which has been 
reported before (Gonzalez et al., 2005; Suda and Hirayama, 1992). In spite of MeHg 
demethylation being mostly accomplished by intestinal microflora (Clarkson et al., 
2003; Liao et al, 2006; Magos, 1997), there is also evidence of mercury being 
demethylated in various organs (Counter and Buchanan, 2004), especially in liver 
(Branco et al., 2007;  Gonzalez et al., 2005; Tchounwou et al., 2003;). The mechanism 
by which such demethylation occurs is not completely understood, but evidence 
suggests that it may be associated with free radical production (Yasutake and Hirayama, 
2001; Counter and Buchanan, 2004) and that selenium might play a key role in this 
process (Yang et al., 2008; Chapter 1A, section 6.2.1). However, demethylation 
mechanisms have a limited efficiency and may not be completely developed since the 
zebra-seabreams used were juveniles (Branco et al., 2007; Yang et al., 2008) thus 
resulting in the bioaccumulation of MeHg throughout exposure. Accumulation of 
inorganic mercury in the kidney following MeHg exposure is expected as a result of 
demethylation occurring in liver (Zalups, 2000). Nevertheless, our results showed that a 
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significant fraction of Hg in this organ was in the form of MeHg. In fact, some of the 
MeHg metabolized in liver (Gochfeld, 2003) is likely to have reached the kidney as 
Hg
2+
. However, since MeHg entered the fish body through the gills, following the 
course of arterial blood through the different organs, before passing through the liver, it 
is possible that it can also accumulate in the kidney. 
 
Even though HgT decreased rapidly in liver, kidney and gills during depuration, it 
continued on accumulating in muscle and brain, indicating that these organs are a final 
destination of MeHg. A similar observation was previously reported for Atlantic cod 
muscle (Almund et al., 2007) and cited as a reason for MeHg bioaccumulating to a large 
extent in muscle tissue. This finding is quite significant regarding MeHg accumulation 
in the brain because it shows that, despite cessation of exposure, the mercury remaining 
in circulation (for instance conjugated with Cys) is probably entering the central 
nervous system by using the neutral amino acid carrier (Clarkson and Magos 2006). 
Since the threshold concentration of MeHg may be reached long after exposure ended, it 
may explain why there is usually a lag time between MeHg exposure and neurotoxic 
symptoms (Mottet et al., 1997; Chapter 1 A, section 4.1). The inorganic mercury found 
in the brain at the end of the depuration period, may result from in situ demethylation 
(Vahter et al., 1995), rather than from transport of inorganic species from other organs, 
since these cannot cross the blood-brain barrier  (Clarkson and Magos, 2006). However, 
it cannot be exclude the possibility that the transport of high doses of MeHg across the 
blood brain-barrier may have affected its integrity allowing the uptake of some 
inorganic mercury (Mottet et al., 1997). Regardless of how it reached the brain tissue, 
the presence of Hg
2+
 may contribute to increase the interaction of Hg with proteins 
located in the CNS, such as TrxR. 
 
4.2. Mercury interaction with the thioredoxin system  
 
Mercury compounds have been shown to inhibit the activity of TrxR and Trx in vitro, 
both in purified enzymes and in cells (Carvalho et al., 2008b; Hansen et al., 2006b; 
Wataha et al., 2008). The present results show that this inhibition also occurs in vivo in 
vertebrates exposed to MeHg. In the liver, inhibition is faster and was detected after 21 
days of exposure to MeHg. In the brain of zebra-seabreams, inhibition of both enzymes 
was maximal at the end of the depuration period. At the same time, Wagner et al. (2010) 
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reported no inhibition of TrxR in mouse brain. Most likely this was a consequence that 
their observation on TrxR activity was made immediately after a single (acute) exposure 
to MeHg. As the results in Figures 3.2 and 3.3 show, there is a time lag between 
exposure and maximum MeHg concentration in brain and the inhibition of the 
thioredoxin system becomes evident after repeated exposure to MeHg. This is probably 
a consequence of the increasing values of Hg
2+
 by demethylation of MeHg (Table 3.1). 
Mercury (II) was previously shown in vitro to be a stronger inhibitor of Trx as it 
establishes a disulfide bridge between adjacent thiols and promotes dimerization of Trx 
molecules, whereas the CH3Hg
+
 ion can only bind to one thiol at a time (Carvalho et al., 
2008b; Chapter 1B, section 2.1).  
 
In the liver, both TrxR and Trx activities were at their lowest level when the relative 
amount of MeHg was at its maximum (days 21 and 28). At day 35, even though 
mercury concentration was the same as at day 21, TrxR activity recovered to control 
levels. This may be the result of several conjugated effects including: 1) MeHg 
demethylation; 2) formation of stable thiol-mercury conjugates and 3) de novo synthesis 
of TrxR. At day 21, MeHg was the main form of Hg in the liver and synthesis of fresh 
TrxR would not result in increased activity because any new enzyme produced would 
be inhibited by the MeHg arriving to the liver. At day 35, MeHg percentage was 
decreasing and the resulting Hg
2+
 was most likely sequestered and eliminated in the 
form of HgSe compounds (Gonzalez et al., 2005) and/or thiol conjugates (Zalups, 
2000), making it unavailable to interact with de novo expressed TrxR.  
 
No inhibition of GR activity was detected following MeHg exposure, in spite that it is 
structurally homologous to TrxR, albeit it lacks the Sec residue in the active center, 
(Zhong et al., 1998). Similar results were obtained with different cell lines leading to the 
hypothesis that the Sec residue in TrxR is a main target to mercury (Carvalho et al. 
2008b, 2011). Our results support this hypothesis and moreover, suggest that in vivo, the 
observed increase in GR activity, by opposition to the decrease in TrxR activity, may be 
a compensating mechanism. GR is responsible by reducing GSSG to GSH (Meister, 
1998), which in turn participates in several functions operated by other enzymes such 
as, glutathione-S-transferases and glutaredoxin (Lu et al., 2007). GSH is known to form 
conjugates with mercury compounds decreasing their toxicity (Zalups, 2000) and the 
subsequent increase in available GSH, may be a way to compensate for the loss of 
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antioxidant protection provided by the thioredoxin system, as suggested previously by 
Hansen and co-workers (2006b) (Chapter 1B, section 2.1).  
 
The interaction of mercury compounds with the thioredoxin system was previously 
proposed as a molecular mechanism of mercury toxicity (Carvalho et al., 2008b). This 
study demonstrates that the inhibitory effects of MeHg on the thioredoxin system occur 
in vivo, and reports for the first time its inhibition in the brain. TrxR, a selenoenzyme, is 
particularly susceptible to MeHg. This is quite significant, since the thioredoxin system 
is a ubiquitous system upstream of a network of pathways in cell signaling and function, 
and its inhibition, would compromise cell survival and proliferation (Chapter 1B, 
section 1). In the CNS, impairment of these key cellular functions would result in 
neurotoxic effects of significant magnitude, particularly, in the developing brain. This 
together with the delayed transport processes of methylmercury to the brain is 
toxicologically relevant and should be taken into account when studying at-risk human 
populations. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 - MERCURIALS AND THE THIOREDOXIN 
SYSTEM: RELATION WITH ORGAN DAMAGE AND 
THE PROTECTIVE EFFECT OF SELENIUM 
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1. BACKGROUND 
 
In Chapter 3, the in vivo inhibitory effect of MeHg on the thioredoxin system was 
shown in the brain and liver of juvenile seabreams and confirmed the higher 
vulnerability of TrxR to this compound.  
 
In organs that accumulate high amounts of mercury such as the liver and kidney (see 
chapter 3), inhibition of the Trx system might be a key step in the development of 
toxicity, since it is vital for several key cellular functions (Lillig and Holmgren, 2007). 
Therefore, the first goal of this work was to investigate the correlation between the 
incidence of histopathological changes in the liver and kidney of zebra-seabreams and 
its correlation with the decrease in TrxR activity caused by MeHg or Hg
2+
 exposure.  
 
Since TrxR is a selenoprotein, the Se status of the organism should be an important 
factor in determining the toxic outcome resulting from exposure to mercury. Thus, 
another objective of this chapter is to study the effect of Se supplementation on the 
interaction between mercury and the Trx system. Because it was recently shown in vitro 
that selenite can reactivate TrxR inhibited by Hg
2+ 
but not by MeHg (Carvalho et al., 
2011), the interaction between mercurial compounds (MeHg and Hg
2+
), selenium and 
the thioredoxin system was here analyzed in vivo.  
 
Other authors have also reported the interaction between mercury compounds and other 
selenoenzymes such as GPx (Franco et al., 2009; Fredriksson et al., 1993; Watanabe et 
al., 1999), which is frequently regarded as an indicator of the Se status of the organism. 
Therefore, another aim of this chapter is to compare the effects of mercurials and Se 
supplementation over TrxR with the effects on GPx activity in vivo. 
 
In order to achieve these goals, an in vivo assay was carried out with different groups of 
zeabra-seabreams either exposed to mercurials or co-exposed to mercurials and Se. 
Post-exposure supplementation with Se was also tested. The brain, kidney and liver 
were sampled for monitoring the activities of selenoenzymes and other anti-oxidant 
enzymes (TrxR, Trx, GR, and GPx) as well as to analyze total mercury, methylmercury, 
and selenium contents. In the liver and kidney histopathological evaluation of organ 
lesions was also performed.  
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2. EXPERIMENTAL PLAN 
 
Juvenile zeabra-seabreams were collected from the aquaculture station of IPIMAR in 
December 2009. A total of 78 fishes (weight, 29±6 g; length, 9.8±0.6 cm) were placed 
in fiberglass tanks filled with seawater at a density of 2.5 g of fish per liter and 
acclimatized to experimental conditions for 1 week previous to the beginning of the 
assay. Fishes were fed once a day, 1–2 h before complete daily water renewal and 
physical-chemical parameters (O2, ammonia, pH, temperature, and salinity) were also 
monitored.  
 
Six experimental groups were defined (Figure 4.1): control group; exposure to Se; 
exposure to Hg
2+
; co-exposure to Hg
2+
  and Se (Hg_Se); exposure to MeHg; co-
exposure to MeHg and Se (MeHg_Se). Exposure of fishes lasted for 28 days and was 
followed by a 14-day depuration period. Sampling of fishes took place at DAYS 0, 14, 
28, 32, and 42 (hereafter referred to as d0, d14, d28, d32, and d42), as shown in Figure 
4.1. During the depuration phase, fishes that had been exposed to Hg
2+
 and MeHg were 
split into two subgroups, one kept in clean seawater and the other kept in water 
containing Se (hereafter Hg_R_Se and MeHg_R_Se), in order to verify if Se could 
influence the recovery from exposure to mercurials. In these groups an additional 
sampling was done at d32 (to monitor the recovery process carefully). At each sampling 
time, fishes were weighed and measured and brain, kidney, liver, and muscle samples 
were collected, rinsed with a 0.9% NaCl solution, and stored at -80 °C until analysis.  
 
Exposure concentration to mercury compounds was chosen in agreement with previous 
results from Chapter 3. Thus, MeHg was added to tanks as previously described 
(Chapter 3) in order to give a final concentration of 2 μg L-1. Likewise, Hg2+ was added 
to tanks as an aqueous solution to a final concentration of 2 μg L-1. After a 96-h LC50 
experiment, the exposure concentration to sodium selenite (hereafter referred to as Se) 
was established at 10 μg L-1. At this concentration Se was kept in a molar excess over 
mercury (13:1) without reaching a deleterious level during the course of the experiment. 
Samples of control and contaminated water were collected for monitoring of the 
exposure conditions.  
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Figure 4.1: Experimental plan of the assay designed to study in vivo the toxic effects of MeHg 
and Hg
2+
 with and without Se supplementation in zebra-seabreams (Diplodus cervinus).  
 
All organ samples were analyzed for HgT, MeHg and Se levels. In brain, liver and 
kidney samples the activities of TrxR, Trx, total GPx (TGPx), GPx1 and GR were 
measured and additionally, liver and kidney samples were treated for histopathological 
observation. The methodologies used for all the analyses are described in Chapter 2.   
 
3. RESULTS  
 
3.1. Mercury and selenium toxicokinetics  
 
The results for HgT accumulation in the brain, kidney, liver, and muscle of fishes 
exposed to the different treatments are shown in Figure 4.2 and in Table 4.1 (for 
specific data points). Fishes exposed to MeHg presented, in all organs, the highest 
values of HgT by the end of exposure (brain, 4.6±0.8 μg g-1; kidney, 28.7± 8.3 μg g-1; 
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liver, 10.2±4.8 μg g-1; muscle, 3.4±0.2 μg g-1) with the kidney accumulating the highest 
levels of total mercury (Figure 4.2 C). Noteworthy, is the accumulation of mercury in 
the brain (5.6±1.3 μg g-1) and muscle (4.7±0.1 μg g-1) that proceeded until the end of the 
depuration phase (Figures 4.2 A and G), while in kidney (17.7±6.3 μg g-1) and liver 
(6.2±1.4 μg g-1) HgT levels decreased significantly with exposure cessation (p<0.01and 
p<0.05 at d42, respectively) (Figures 4.2 C and E). When fishes were co-exposed to 
MeHg and Se, the levels of HgT accumulated at the end of exposure were lower (brain, 
2.4±0.3 μg g-1; kidney, 15.1± 1.9 μg g-1; liver, 5.8±1.7 μg g-1; muscle, 2.3±0.8 μg g-1) 
than with just MeHg (p<0.01). On the other hand, when selenium was administered 
during the depuration phase the most significant difference was in the kidney (23.6±1.1 
μg g-1) where total mercury elimination was initially slower (p<0.01) (Figure 4.2 C). In 
fishes exposed to Hg
2+
, total mercury levels in all organs were 5 to 10 times lower than 
those found in fishes exposed to MeHg, at the end of the exposure phase (brain, 
0.61±0.10 μg g-1; kidney, 5.8±1.9 μg g-1; liver, 1.4±0.2 μg g-1; muscle, 0.25±0.05  
μg g-1). During the depuration in the Hg2+ group, HgT levels remained reasonably stable 
in the brain (0.88±0.47 μg g-1) and muscle (0.19± 0.020 μg g-1) (Figures 4.2 A and G) 
but increased in kidney (8.3±1.3 μg g-1) and liver (2.8±0.4 μg g-1) (Figures 4.2 C and E). 
In fishes co-exposed to Hg
2+
 and Se, total mercury levels in the kidney at the end of 
exposure (8.6±3.3 μg g-1) were higher than in fishes exposed to Hg2+ alone, but in the 
other organs were similar (brain, 0.58±0.16 μg g-1; liver, 1.5±0.1 μg g-1; muscle, 
0.24±0.04 μg g-1). Selenium supplementation did not change significantly (p>0.05) Hg2+ 
toxicokinetics during the depuration phase (brain: 0.41±0.15 μg g-1; kidney: 8.8±1.7 μg 
g
-1
; liver: 2.4±0.5 μg g-1; muscle: 0.22± 0.08μg g-1).  
 
In the brain of MeHg-exposed fish, while HgT kept increasing, MeHg levels reached a 
plateau (Figure 4.2 B). As a consequence, MeHg percentage in the brain decreased from 
97 at d28 to 83% by the end of depuration (Table 4.2). This decrease was not observed 
when fishes were co-exposed to MeHg and Se. The variation of MeHg levels in the 
kidney and liver of fishes exposed to this compound followed a similar pattern to the 
levels of HgT in the same organs (Figure 4.2 D and F). In the liver, MeHg percentage 
(Table 4.2) reached a maximum (95% of HgT) by the end of exposure decreasing to 
72% at d42 and in the kidney MeHg percentage remained approximately 70% 
throughout the experiment. When fishes were co-exposed to MeHg and Se, the 
toxicokinetics of MeHg in liver and kidney was similar to that reported for fishes 
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exposed merely to MeHg. In the muscle, MeHg accounted for 90–100% of HgT during 
all the experiment, in the case of both exposure only to MeHg and co-exposure to 
MeHg and Se (Table 4.2). Exposure to Se during the depuration period had no effect on 
the possible demethylation rate of MeHg in any of the organs. 
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Figure 4.2: Variation of HgT levels (µg g
-1
) and MeHg levels (µg g
-1
) in the brain (A, B), kidney 
(C, D), liver (E, F) and muscle (G, H) of seabreams during 28 days of exposure (shaded area) to 
different treatments and 14 days of depuration (light area). Due to very similar results Hg, Hg 
Co-exposure Se and Hg Recovery w/ Se series overlap. All data points represent the mean of 3 
different fishes being each individual subjected to 2-3 independent determinations. For clarity, 
error bars were omitted from figures. Mean values and standard deviation are provided in Table 
4.1 for specific data points of interest. 
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Table 4.1. Quantification of total mercury (HgT) and selenium (Se) values (µg g
-1
) in liver and kidney of zeabra-seabreams exposed to different treatments at 
days 28 and 42. MeHg – exposure to Methylmercury; Hg2+ – exposure to Hg2+; MeHg_Se – co-exposure to MeHg and Se; Hg_Se – co-exposure to Hg2+ and 
Se; MeHg_R_Se – Exposure to MeHg followed by exposure to Se during depuration; Hg_R_Se - Exposure to Hg2+ followed by exposure to Se during 
depuration; Se – exposure to selenium; C – control group; 
 
MeHg Hg
2+
 MeHg_Se Hg_Se 
MeHg_R_ 
Se 
Hg_R_Se Se C 
d28 d42 d28 d42 d28 d42 d28 d42 d42 d42 d28 d42 d28 d42 
LIVER 
HgT (µg g
-1
) 10.2 ± 4.8 6.2 ± 1.4 1.4 ± 0.2 2.8 ± 0.4 5.8 ± 1.7 4.8 ± 1.3 1.5 ± 0.1 2.3 ± 0.5 5 .8  ±  1 . 5 2.4 ± 0.5 0.07 ± 0.02 0.09 ± 0.02 0.10 ± 0.06 0.07 ± 0.03 
Se (µg g
-1
) 0.6 ± 0.1 0.9 ± 0.2 0.5 ± 0.2 1.3 ± 0.2 0.9 ± 0.02 1.3 ± 0.3 1.1 ± 0.3 1.6 ± 0.3 1 .3  ±  0 . 2 1.0 ± 0.1 1 .3  ± 0 .2 1 .3  ± 0 .2 1.0 ± 0.14 1.0 ± 0.21 
KIDNEY 
HgT (µg g
-1
) 28.7 ± 8.3 17.3 ± 6.3 5.8 ± 1.9 8.3 ± 4.1 15.1 ± 1.9 11.9 ± 3.9 8.6 ± 3.3 10.0 ± 3.5 23.6 ± 1.1 8.8 ± 1.7 0.11 ± 0.03 0.15 ± 0.02 0.16 ± 0.04 0.14 ± 0.01 
Se (µg g
-1
) 1.6 ± 0.6 3.3 ± 0.6 0.4 ± 0.3 1.3 ± 0.2 2.7 ± 1.2 2.1 ± 1.1 1.0 ± 0.3 2.8 ± 0.8 2 .3  ±  0 . 6 4.5 ± 1.2 1 .7  ± 0 .3 1 .7  ± 0 .5 1 .3  ± 0 .6 1 .0  ± 0 .2 
 
 
 
  
 
 
Table 4.2: Amount (%) of MeHg relative to total mercury concentration in brain, kidney, liver and muscle of zebra-seabreams at days 14, 28 and 42 of 
experiment. All values are the mean ± std. 
  Brain Kidney Liver Muscle 
 
Exposure 
condition MeHg1 MeHg_Se2 MeHg_ R_Se3 MeHg MeHg_Se MeHg_R_ Se MeHg MeHg_Se MeHg_R_ Se MeHg MeHg_Se MeHg_R_Se 
Day 
14 95 ± 9 108 ± 22 95 ± 9 74 ± 4 76 ± 14 74 ± 4 70 ± 10 70 ± 6 70 ± 10 97 ± 14 93 ± 8 97 ± 14 
28 97 ± 12 106 ± 15 97 ± 12 74 ± 7 82 ± 11 74 ± 7 95 ± 14 96 ± 9 95 ± 14 88 ± 7 91 ± 6 88 ± 7 
42 83 ± 10 101 ± 18 79 ± 8 67 ± 6 64 ± 9 77 ± 8 72 ± 18 72 ± 4 68 ± 26 98 ± 17 105 ± 18 95 ± 20 
1MeHg – Exposure to MeHg; 2MeHg_Se – Co-exposure to MeHg and Se; 3MeHg_R_ Se – Exposure to MeHg and depuration with Se 
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Despite the initial increase observed in Se concentrations after 2 weeks of selenite 
supplementation, by the end of exposure, levels of Se in selenite exposed fishes (brain, 
0.259± 0.002 μg g-1; kidney, 1.7±0.3 μg g-1; liver, 1.3±0.2 μg g-1; muscle, 0.35±0.04  
μg g-1) were similar (p>0.05) to those in control fishes (brain, 0.22±0.5 μg g-1; kidney, 
1.3±0.6 μg g-1; liver, 1.0±0.1 μg g-1; muscle, 0.33±0.02 μg g-1) (Figure 4.3). Exposure to 
MeHg led to a decrease (p<0.05) of Se levels in the brain (0.14±0.02 μg g-1; Figure 4.3 
A) and liver (0.61±0.14 μg g-1; Figure 4.3 E) but not in the kidney (p>0.05) (1.6±0.6  
μg g-1; Figure 4.3 C). Co-exposure to MeHg and Se avoided the decrease of Se levels 
observed for the brain and liver of fishes exposed only to MeHg (d28 in Figures 4.3 A 
and E) (p>0.05). In fishes exposed to Hg
2+
, Se levels in the brain were equal or above 
control levels during all the experiment (Figure 4.3 B). Exposure to Hg
2+
 led to a 
decrease (p<0.05) of Se in the kidney and liver by the end of exposure (kidney, 
0.40±0.32 μg g-1; liver, 0.50±0.20 μg g-1: Figures 4.3 D and F), while fishes co-exposed 
to Hg
2+
 and Se showed no significant (p>0.05) variation during exposure (kidney, 
0.96±0.31 μg g-1; liver, 1.1±0.3 μg g-1; Figures 4.3 D and F) in comparison with the 
control group. The depuration period allowed the recovery of Se levels for the 
treatments that affected the kidney and liver (Figures 4.3 C-F). In the brain  
(Figure 4.3 A), there was an exception for MeHg exposure since Se levels remained 
below control levels even when Se was provided during the depuration phase (p<0.05).  
 
In the muscle (Figures 4.3 G-H) Se levels presented no decrease during the exposure 
period (p>0.05), except in the case of fishes exposed to Hg
2+
 alone (p<0.05). However, 
during depuration Se levels decreased in fishes that had been exposed to mercurials 
(p<0.05). In the case of Hg
2+
, supplementation with Se could counteract this decrease 
(p>0.05), but in the case of MeHg, exposure levels stayed below the control (p<0.05).  
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Figure 4.3: Variation of Se levels (µg g
-1
) in the brain (A, B), kidney (C, D), liver (E, F) and 
muscle (G, H) of seabreams exposed to the different treatments as described in the methods 
section. Days 14-28 correspond to the exposure period; day 42 corresponds to the depuration 
period. All data points represent the mean ± std of 3 different fishes being each individual 
subjected to 2-3 independent determinations. 
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3.2. Liver and Kidney Histopathology 
 
Fish dissection showed that the liver of fishes from MeHg and Hg
2+
 groups had softer 
consistency, when compared with the control group. No lesions or alterations were 
observed in the liver of controls (Figure 4.4 A). The liver of fishes exposed for 28 days 
to MeHg and Hg
2+
 showed signs of hepatocyte alterations, namely, degenerative 
cytoplasmatic alterations, architectural pattern changes, loss of typical polygonal cell 
shape and undefined cell limits. Additionally, vacuolar degeneration with lateral 
migration of the nuclei, hydropic degeneration (Figure 4.4 B-C), vacuolization within 
the hepatocytes with lipid-type vacuoles, which can be infiltrated fats, and appearance 
of some typical globular bodies that may result from an increase in the lipid, water 
and/or glycogen content (Liao et al., 2006). Hypertrophied hepatocytes were also 
disseminated at the parenchyma of fishes from both Hg
2+
 and MeHg groups, which is in 
good agreement with alterations described in the literature (Liao et al., 2006, Mela et al., 
2007, Ribeiro et al., 2002). Liver extensive focal necrosis associated to congestion and 
pigments deposition was observed in two fishes exposed to Hg
2+
 (Figure 4.4 B).  
 
The MeHg group displayed three cases of little focal liver necrosis. During exposure to 
both mercurials the type of lesions was the same, but the necrotic lesions observed in 
the liver of fishes exposed to Hg
2+
 were more predominant and severe, leading to higher 
Organ Damage Index (ODI) values (Table 4.3). Despite the fact that, the accumulation 
of Hg
2+
 was lower than MeHg (Figure 4.2; Table 4.1) the ODI was higher. Although 
fishes from Hg_Se and MeHg_Se (Figure 4.4 D) showed at d28 the same kind of 
lesions observed in fish exposed only to mercurials (i.e, focal cellular vacuolization, 
megalocytic hepatocytes focal necrosis and congestion of the hepatic parenchyma), 
these lesions were observed side by side with normal tissue areas. 
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Figure 4.4: Histopathological observations in the liver of Diplodus cervinus after 28 days of 
exposure. A) control (C) group: section of polygonal hepatocytes cords (bar= 50µm); B) 
exposure to Hg
2+
: extensive necrosis with congestion of sinusoids and pigment deposition (pd), 
nuclear hypercromatose (nhc), picnotic nucleus (pn) and cytolysis (cy) (bar= 50µm); C) 
exposure to MeHg: extensive cytoplasmic degenerative vacuolization (cdv) with large, smooth-
edged vacuoles (v) (bar= 50µm); D) co-exposure to MeHg and Se: focal coagulative necrosis 
(cn) associated to blood congestion (arrowhead) (bar= 200µm). 
 
After the depuration phase at d42, fish exposed to mercurials still exhibited extensive 
coagulative necrotic changes. Hypertrophy of the hepatocytes was clear in the 
parenchyma outside necrotic areas. Fishes depurating in water containing Se presented 
the same type of necrotic lesion although liver parenchyma beyond the necrotic zones 
appeared normal, resulting in a lower ODI than the attained by fishes depurating in 
clean water (Table 4.3). 
 
Kidney changes such as vacuolar and  hydropic degeneration of tubular epithelium and 
pigment deposits around the tubules, were observed in fish exposed to both mercurials 
at days 28 and 42 were. Posterior kidney was quite more susceptible to Hg
2+
 than MeHg 
which was evidenced by larger necrotic areas (Figure 4.5 B) and occlusion of the 
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v
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tubular lumen with eosinophilic material (Figure 4.5 C). Co-exposure to MeHg and Se 
seemed to delay the appearance of the more severe lesions in the kidney (Table 4.3). 
Co-exposure to Hg
2+
 and Se decreased the detrimental effects of mercury at the end of 
the depuration period (Table 4.3). This decrease in renal toxicity does not reflect a 
decrease in mercury concentration (Figure 4.2; Table 4.1) but instead it might be related 
to the formation of inorganic inert complexes. 
 
 
 Table 4.3: Values of the Organ Damage Index* (ODI) calculated for the liver and kidney of zeabra-seabreams exposed to the different treatments. No lesions 
were observed in control fishes. MeHg – exposure to Methylmercury; Hg2+ – exposure to Hg2+; MeHg_Se – co-exposure to MeHg and Se; Hg_Se – co-
exposure to Hg
2+
 and Se; MeHg_R_Se – Exposure to MeHg followed by exposure to Se during depuration; Hg_R_Se - Exposure to Hg2+ followed by 
exposure to Se during depuration; Se – exposure to selenium. 
 
 
 
 
 
 
 
 
 
Pi – Pathological index of each lesion according to their importance to organ function (Bernet et al. 1999) 
NOL – number of fishes displaying one type of organ lesion (OL) 
*ODI - sum of lesions observed for each organ taking into account their relative severity and the number of fishes (NOL). 
 
Organ Lesion (OL) Pi 
MeHg Hg
2+
 MeHg_Se Hg_Se MeHg _R _Se Hg_ R_ Se Se 
d28 d42 d28 d42 d28 d42 d28 d42 d42 d42 d28 d42 
  NOL NOL NOL NOL NOL NOL NOL NOL NOL NOL NOL NOL 
LI
V
ER
 
Architectural pattern lost 1 4 3 4 4 3 2 4 0 3 3 2 0 
Vacuolar degeneration. 1 3 1 4 1 2 0 1 2 3 3 2 0 
Hydropic degeneration 1 4 2 3 1 1 2 1 1 0 3 0 0 
Hypertrophy of  hepatocytes 2 2 3 1 4 4 0 4 1 0 0 0 0 
Extensive focal necrosis 3 0 3 2 4 0 2 1 3 0 2 0 0 
Focal necrosis 2 3 0 0 0 1 2 2 0 3 1 0 0 
Parenchymal congestion 1 0 1 2 0 1 0 3 0 0 0 0 0 
Pigment deposition 1 0 0 2 0 0 0 0 0 0 0 0 0 
ODI  21 22 23 26 17 14 24 14 12 17 4 0 
K
ID
N
EY
 
Vacuolar degeneration 1 1 0 1 2 1 1 0 1 1 2 0 0 
Hydropic degeneration 1 3 2 1 0 1 3 0 3 0 2 0 0 
Pigment deposition 1 3 1 1 1 0 2 0 1 1 0 0 0 
Parenchymal necrosis 3 0 0 0 3 0 0 1 0 0 0 0 0 
ODI  7 3 3 12 2 6 3 5 2 4 0 0 
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Figure 4.5: Histopatological observations in the kidney of Diplodus cervinus after 28 days of 
exposure to Hg
2+
. A) control group: posterior kidney section (bar= 50µm); B) exposure to Hg
2+
: 
posterior kidney section showing a massive necrosis area (nec)  and cytolysis (cy) (bar= 
200µm). C) exposure to Hg
2+
: occlusion of the tubular lumen (otl) (bar= 50µm). 
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3.3. Activities of antioxidant enzymes 
 
3.3.1. Thioredoxin reductase 
 
Thioredoxin reductase activity in the brain (Figure 4.6 A) decreased significantly with 
exposure to MeHg (63% inhibition; p<0.01). The concentration of MeHg selected for 
the present study (2 µg L
-1
) was based on the results described in chapter 3 and so there 
is a part of the experiment that replicates the study described in the previous chapter for 
the control and the highest exposure group and although it was a time and space 
independent assay, emphasis should be given to the fact that the results between 
homologous sampling times were statistically similar (p>0.05). Co-exposure to MeHg 
and Se also inhibited TrxR activity (54% inhibition; p<0.01; d28).The inhibitory effect 
remained during the depuration phase after MeHg exposure (55% at d42; p<0.01) and 
Se addition to the water during this phase had also no significant effect (p>0.05) (Figure 
4.6 A). Although Hg
2+
 accumulated 6 to 8 times less than MeHg, it caused a similar 
inhibition (50%; at d28; p<0.01) of TrxR activity that lasted until the end of the 
depuration phase (Figure 4.6 B). No protective effect of Se against Hg
2+
 effect was 
observed in the brain, both during co-exposure and post-exposure supplementation 
(Figure 4.6 B). Exposure of fishes only to Se promoted an initial increase in the TrxR 
activity in the brain that slowly tended to approach control levels as exposure proceeded 
(Figure 4.6 A).  
 
Kidney TrxR was significantly affected (>30% inhibition; p<0.05) by treatments with 
both mercurial compounds throughout the entire experiment (exposure plus depuration) 
(Figures 4.6 C-D) and no protective effect of Se was observed. In the liver, exposure to 
MeHg alone (Figure 4.6 E) led to a significant inhibition (p<0.05) of TrxR activity 
(65% at d28), followed by complete recovery during the depuration phase. Despite that 
co-exposure to Se decreased MeHg accumulation in fish liver (Figure 4.2 E-F), the 
inhibition of TrxR was stronger (88% inhibition at d14; p<0.01) (Figure 4.6 E). 
Exposure to Se during depuration had no significant (p>0.05) effect in the recovery of 
TrxR activity from exposure to MeHg (Figure 4.6 E). Although Hg
2+
 accumulated in the 
liver at lower levels than MeHg (Figure 4.2 E), exposure of fishes to this compound led 
to 52% inhibition of TrxR activity on d14 (p<0.05), continuing during the exposure 
period and with full recovery at the end of depuration (Figure 4.6 F). Co-exposure to Se 
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clearly prevented the inhibition of TrxR by Hg
2+
 with activity levels varying between 
102 and 182% of control activity during exposure (p>0.05). However, when Se was 
administered during the depuration phase the (p>0.05) improvement on TrxR activity 
recovery was not so significant (Figure 4.6 F) and inclusive there was a delay on the 
recovery of TrxR activity.  
 
3.3.2. Thioredoxin 
 
Thioredoxin activity in the brain reacted with an initial increase (up to 40%; d14) to 
MeHg exposure but became significantly inhibited (51% inhibition d42; Figure 4.7 A) 
by the end of the depuration regardless of the administration of Se during this phase. 
The same happened to fishes co-exposed to MeHg and Se (40% inhibition at d42; 
Figure 4.7 A). On the contrary, exposure to Hg
2+
 alone or in co-exposure with Se did 
not inhibit significantly (p>0.05) Trx activity in the brain (Figure 4.7 B). Unlike TrxR, 
exposure to Se alone did not increase significantly (p>0.05) Trx activity (Figure 4.7 A 
and B). In the kidney, Trx was initially affected (p<0.01) by exposure to MeHg alone 
(80% inhibition; d14), but recovered to control levels by the end of the depuration 
(p>0.05) (Figure 4.7 C). Co-exposure to MeHg and Se resulted in a lower inhibition of 
Trx on d14 (30%) and led to a higher activity at d42 (Figure 4.7 C). In the case of 
exposure to Hg
2+
 (Figure 4.7 D), Trx activity decreased to 33% of control at d28 
(p<0.05) but recovered after depuration. Selenium supplementation did not change 
significantly the recovery of Trx activity from exposure to Hg
2+
 (Figure 4.7 D). In the 
case of liver Trx, exposure to MeHg alone led to a significant decrease (p<0.05) of 
activity at the end of exposure (56% inhibition at d28), followed by a slow increase 
towards the end of the depuration phase (Figure 4.7 E). Despite that co-exposure to Se 
decreased MeHg accumulation in fish liver (Figure 4.2 E), the inhibition of Trx took 
place earlier (d14; p<0.01) (Figure 4.7 E). Exposure to Se during depuration had no 
significant (p>0.05) effect in the recovery of Trx activity from exposure to MeHg in the 
liver. Inhibition of Trx in the liver of fishes exposed to Hg
2+
 was much lower (28%; 
d28) than that observed for MeHg (56%; d28). Moreover, co-exposure to Se fully 
prevented inhibition of Trx by Hg
2+
 (p>0.05). When Se was supplied afterwards (during 
depuration) no positive effect was noted on Trx activity (Figure 4.7 F).  
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Figure 4.6: Activity of TrxR in the brain (A, B), kidney (C, D) and liver (E, F) of zebra-
seabreams exposed to the different treatments as described in the experimental plan. Days 14-28 
correspond to the exposure period; days 32-42 correspond to the depuration phase. All data 
points represent the mean ± std of 3 different fishes being each individual subjected to 3-4 
independent enzymatic determinations. Albeit statistical comparisons were made for each 
sampling period and its correspondent control, the average of all controls is represented. 
*Significantly different from control (p<0.05); **very significantly different from control 
(p<0.01);§ - significantly different from MeHg exposure (p<0.05); § § - very significantly 
different from MeHg exposure (p<0.01); # significantly different from Hg exposure (p<0.05); 
## - very significantly different from Hg exposure (p<0.01). 
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Figure 4.7: Activity of Trx in the brain (A, B), kidney (C, D) and liver (E, F) of zebra-
seabreams exposed to the different treatments as described in the experimental plan. Days 14-28 
correspond to the exposure period; days 32-42 correspond to the depuration phase. All data 
points represent the mean ± std of 3 different fishes being each individual subjected to 3-4 
independent enzymatic determinations. Albeit statistical comparisons were made for each 
sampling period and its correspondent control, the average of all controls is represented. 
*Significantly different from control (p<0.05); **very significantly different from control 
(p<0.01);§ - significantly different from MeHg exposure (p<0.05); §§ - very significantly 
different from MeHg exposure (p<0.01); # significantly different from Hg exposure (p<0.05); 
## - very significantly different from Hg exposure (p<0.01). 
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3.3.3. Glutathione reductase 
 
Glutathione reductase activity was not significantly inhibited by any treatment (Figure 
4.8). Moreover, GR activity was increased above the control value when TrxR activity 
was inhibited. In the brain, when TrxR was inhibited (55%) by MeHg at d42 (Figure 4.6 
A), GR activity was 33% above control levels (Figure 4.8 A). The same trend was 
observable in the kidney (Figures 4.8 C and D) and in the liver (Figures 4.8 E and F).  
 
3.3.4. Glutathione peroxidase 
 
GPx activity accounted on average for 74, 41, and 14% of TGPx activity in brain, 
kidney and liver, respectively. TGPx activity presented the same activity variation as 
GPx; therefore, only the data of GPx are presented and discussed. In the brain, GPx 
activity was significantly inhibited (51%; d28; p<0.05) during MeHg exposure (Figure 
4.9 A) but with full recovery by d42. In the case of co-exposure to MeHg and Se, 
inhibition (p<0.05) of GPx activity was less pronounced (25% at d28) and was followed 
by full recovery at d42 (Figure 4.9 A). Exposure only to Se reduced GPx activity in the 
brain to 67% at d28 (p<0.05). Recovery in the presence of Se induced an initial increase 
of activity that lowered to control levels by d42. No significant (p>0.05) inhibition of 
GPx was observed in the case of exposure to Hg
2+
, both with or without Se co-exposure 
(Figure 4.9 B). In the kidney and liver GPx was not significantly affected by any 
treatment during the time course of the experiment (Figures 4.9 C- F).  
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Figure 4.8: Activity of GR in the brain (A, B), kidney (C, D) and liver (E, F) of zebra-seabreams 
exposed to the different treatments as described in the experimental plan. Days 14-28 
correspond to the exposure period; days 32-42 correspond to the depuration phase. All data 
points represent the mean ± std of 3 different fishes being each individual subjected to 3-4 
independent enzymatic determinations. Albeit statistical comparisons were made for each 
sampling period and its correspondent control, the average of all controls is represented. 
*Significantly different from control (p<0.05); **very significantly different from control 
(p<0.01);§ - significantly different from MeHg exposure (p<0.05); §§ - very significantly 
different from MeHg exposure (p<0.01); # significantly different from Hg exposure (p<0.05); 
## - very significantly different from Hg exposure (p<0.01). 
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Figure 4.9: Activity of GPx in the brain (A, B), kidney (C, D) and liver (E, F) of zebra-
seabreams exposed to the different treatments as described in the experimental plan. Days 14-28 
correspond to the exposure period; days 32-42 correspond to the depuration phase. All data 
points represent the mean ± std of 3 different fishes being each individual subjected to 3-4 
independent enzymatic determinations. Albeit statistical comparisons were made for each 
sampling period and its correspondent control, the average of all controls is represented. 
*Significantly different from control (p<0.05); **very significantly different from control 
(p<0.01);§ - significantly different from MeHg exposure (p<0.05); §§ - very significantly 
different from MeHg exposure (p<0.01); # significantly different from Hg exposure (p<0.05); 
## - very significantly different from Hg exposure (p<0.01). 
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4. DISCUSSION 
 
4.1. Mercury and selenium toxicokinetics 
 
Fishes exposed solely to MeHg were the group with higher accumulation of mercury 
(Figure 4.2). The toxicokinetics of MeHg in these fishes showed a fast accumulation 
during exposure followed by elimination during depuration in the liver and kidney. In 
the brain and muscle, accumulation proceeded during the entire experiment confirming 
previous results (see Chapter 3). When fishes were co-exposed to MeHg and Se, 
accumulation was much lower in all organs, which is in agreement with other studies 
(Belzile et al, 2006; Bjerregaard et al., 1999; Glaser et al., 2010). This may result from: 
(1) excess Se inducing an increased production of selenoprotein P, with the Sec residues 
in this protein acting as a trap for MeHg, keeping it in circulation and preventing its 
entry to the different organs (Watanabe, 2002; Papp et al., 2007); (2) selenium 
preventing MeHg interaction with proteins by competing for the binding sites (i.e., SeH 
and SH groups) (Yang et al., 2008); (3) Se binding MeHg during co-exposure 
enhancing its excretion (Yang et al., 2008; Khan and Wang, 2009). Exposure 
exclusively to Hg
2+
 led to a lower accumulation in comparison to MeHg exposed fishes. 
In the brain this could be anticipated since Hg
2+
 does not easily cross the blood–brain 
barrier (Clarkson and Magos, 2006). Despite being a target organ for Hg
2+
 (Goering et 
al., 2000), the kidney accumulated more mercury with MeHg exposure, which can be 
explained by a faster elimination of divalent mercury which is less accumulated 
(Zalups, 2000).  
 
The brain is ranked as a high priority target organ for Se, while the kidney, liver, and 
muscle are low priority (Behne et al., 2000). Exposure to both mercurials led to a drop 
of Se levels in liver (Figure 4.3 E-F) which is consistent with redistribution to the brain. 
However, MeHg exposure also led to a drop in Se levels in the brain while Hg
2+
 did not 
(Figure 4.3 A-B) probably due to its lower accumulation. On the contrary, in the kidney, 
the decrease in Se levels was caused by Hg
2+
, but not by MeHg (Figure 4.3 C-D). 
Possibly, during exposure to Hg
2+
, Se excretion is reduced, as this element gets 
mobilized to the brain (Behne et al., 2000). MeHg may retain more effectively Se in 
circulation, thus reducing mobilization of Se to priority organs, and enhancing its co-
excretion with mercury (Watanabe, 2002; Khan and Wang, 2009).  
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4.2. Interaction between mercury compounds and anti-oxidant enzymes  
 
4.2.1. Thioredoxin reductase  
 
The present results confirm the in vivo inhibition of the thioredoxin system by MeHg in 
the brain and liver (Chapter 3) and show for the first time the inhibition of the 
thioredoxin system in the kidney of seabreams. Evidence that Hg
2+
 affects this system in 
vivo at quite lower concentrations is also given. In previous work with purified TrxR 
and Trx, Carvalho et al. (2008b) showed that the Hg
2+
 IC50 for these enzymes was about 
half that of MeHg. Divalent mercury binds more effectively the active site of TrxR than 
MeHg (Carvalho et al., 2011) and also Hg
2+
 can bind two thiol groups of Trx inducing 
dimerization, while MeHg cannot (Carvalho et al., 2008b). Additionally, these results 
confirm that TrxR is more sensitive to mercury compounds than Trx, most likely due to 
the strong affinity of mercurials to the Sec residue in its active site, as hypothesized by 
Carvalho et al. (2011).  
 
In the brain and liver of fishes co-exposed to MeHg and Se there was an initial (at d14) 
increase of the MeHg inhibitory effect over TrxR activity (Figures 4.6 A and E). 
Although these results contradict the generalized notion that Se alleviates the toxicity 
effects of MeHg (Yoneda and Suzuky, 1997; Tchounwou et al., 2003), they agree with 
the results of Carvalho et al. (2011) which showed beneficial effects of selenium 
occurring over TrxR inhibited by Hg
2+
, but not by MeHg, whose toxic effects were 
exacerbated by Se.  
 
Co-exposure of fishes to Hg
2+
 and Se prevented TrxR inhibition in the liver  
(Figure 4.6 F). As proposed by Carvalho et al. (2011), treatment with Se can reactivate 
TrxR by displacing Hg
2+
 bound to the active site selenolthiol with the subsequent 
formation of HgSe. In addition, the liver was reported by Gan et al. (Gan et al., 2002) to 
have the highest expression levels of selenoproteins, which might contribute to the 
maintenance of enzyme activity levels in co-exposed fishes. The present results also 
show a protective effect of Se supplementation on Trx activity in the liver (Figure 4.7 
F). Since Trx is not a selenoenzyme, such a protective effect should result from a priori 
binding of Se to Hg
2+
 forming HgSe, and decreasing the available Hg
2+
 that otherwise 
could induce Trx dimerization (Carvalho et al., 2008b). In fact, the molar ratio Se:Hg 
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was higher in the liver (Table 4.4) which favors the binding between Hg
2+
 and Se, as 
opposed to the kidney where the Se:Hg ratio was lower than 1 (Table 4.4). The 
protective effects of Se over TrxR and Trx activity were not observed in the brain and 
kidney (Figures 4.6 B and D and 4.7 B and D). Although in the brain the Se:Hg molar 
ratio was also higher than 1 (Table 4.4), it may not be enough since, as previously 
observed with purified TrxR (Carvalho et al., 2011), a recovery to 80% of activity took 
place only at Se:Hg molar ratios above 2.5. Additionally, the free available Se which is 
essential for the proposed reactivation mechanism to occur might be lower in brain than 
in liver. Co-exposure was necessary for Se to produce beneficial effects over Hg
2+
-
inhibited TrxR, since supplementation of Se during the depuration phase had no 
beneficial effect on the recovery of TrxR activity. 
 
4.2.2. Glutathione reductase  
 
Glutathione reductase activity, which is structurally homologous to TrxR, was not 
significantly inhibited by the presence of mercury compounds in any organ (Figure 4.8). 
This was also previously observed in cells (Carvalho et al., 2008b) and in vivo (Chapter 
3) and may be a consequence of the lack of a Sec residue by GR. Moreover, the increase 
of GR activity functions as a mechanism to compensate the loss of antioxidant 
protection resulting from the decrease in TrxR activity by increasing the turnover of 
GSSG to GSH (see Chapter 3).This increase in GR activity was also observed in vivo in 
fishes living in mercury-contaminated sites (Mieiro et al., 2011).  
 
 
  
  
 
 
Table 4.4: Selenium: Mercury molar ratios in brain, kidney liver and muscle of seabreams exposed for 28 days to different treatments and 14 days of 
depuration. All data points represent the calculation of molar ratios based on the quantification of each element in 3 different fishes being each individual 
subjected to 2-3 independent determinations. MeHg – exposure to Methylmercury; Hg2+ – exposure to Hg2+; MeHg_Se – co-exposure to MeHg and Se; Hg_Se 
– co-exposure to Hg2+ and Se; MeHg_R_Se – Exposure to MeHg followed by exposure to Se during depuration; Hg_R_Se - Exposure to Hg2+ followed by 
exposure to Se during depuration; Se – exposure to selenium. 
 
 Brain Kidney Liver Muscle 
Exposure Condition T14 T28 T42 T14 T28 T42 T14 T28 T42 T14 T28 T42 
Control 11 ± 2 8.3 ± 0.3 10 ± 1 44 ± 9 19 ± 14 18 ± 2 40 ± 16 26 ± 16 47 ± 25 4.8 ± 0.2 3.0 ± 2.6 5.3 ± 1.5 
Se 13 ± 4 13 ± 1. 7.9 ± 1.3 37 ± 1 40 ± 12 33 ± 14 42 ± 1 43 ± 8 28 ± 7 5.1 ± 0.3 5.3 ± 1.0 2.5 ± 0.3 
Hg2+ 1.8 ± 0.4 0.44 ± 0.29 0.67 ± 0.38 0.58 ± 0.35 0.17 ± 0.11 0.33 ± 0.07 4.4 ± 1.6 1.1 ± 0.1 1.3 ± 0.2 3.5 ± 0.1 3.1 ± 0.35 1.1 ± 0.5 
Hg_ Se 2.4 ± 0.8 1.0 ± 0.3 1.1 ± 0.657 0.23 ± 0.10 0.40 ± 0.26 1.0 ± 0.3 6.8 ± 1.8 1.8 ± 0.6 1.6 ± 0.6 4.9 ± 1.1 3.1 ± 0.35 1.5 ± 0.2 
Hg_R_Se 1.8 ± 0.4 0.44 ± 0.29 1.5 ± 0.9 0.58 ± 0.35 0.17 ± 0.11 0.81 ± 0.34 4.4 ± 1.6 1.1 ± 0.1 1.2 ± 0.3 3.5 ± 0.1 0.29 ± 0.02 1.6 ± 0.6 
MeHg 0.38 ± 0.06 0.06 ± 0.02 0.07 ± 0.02 0.23 ± 0.10 0.19 ± 0.11 0.51 ± 0.13 0.39 ± 0.20 0.33 ± 0.11 0.41 ± 0.18 0.70 ± 0.03 0.062 ± 0.022 0.061 ± 0.043 
MeHg_Se 0.69 ± 0.36 0.20 ± 0.06 0.16 ± 0.08 1.7 ± 1.0 0.44 ± 0.26 0.48 ± 0.10 0.71 ± 0.08 0.16 ± 0.10 0.75 ± 0.35 1.0 ± 0.5 0.45 ± 0.03 0.15 ± 0.04 
MeHg_R_Se 0.38 ± 0.06 0.06 ± 0.02 0.06 ± 0.01 0.23 ± 0.10 0.19 ± 0.11 0.24 ± 0.05 0.39 ± 0.20 0.33 ± 0.11 0.65 ± 0.10 0.70 ± 0.03 0.029 ± 0.023 0.034 ± 0.013 
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4.2.3. Glutathione peroxidase  
 
The contribution of GPx to TGPx activity was highest in the brain. GPx is capable of 
degrading the H2O2 produced in large amounts in the brain (Steinbrenner and Sies, 
2009) and thus assumes an important part of peroxidase activity in this organ. 
 
In fishes exposed only to Se, GPx activity in the brain was inhibited by the end of 
exposure. Albeit the activity of GPx is dependent on the Se status (Wu et al., 2003), 
higher doses are known to cause a decrease in GPx activity, namely in fish (Tallandini 
et al., 1996).  
 
In MeHg-exposed fishes, GPx activity in the brain was decreased significantly at the 
end of exposure (Figure 4.9 A). This should result from direct interaction between 
MeHg and Sec in the active site (Figure 4.10). On the other hand, Hg
2+
 exposure did not 
cause inhibition of GPx in the brain (Figure 4.9B). These results agree with the study by 
Bulato et al. ( 2007) that had previously shown that, contrary to TrxR2, the activity of 
purified GPx was not affected by Hg
2+
, thus excluding direct interaction with the Sec 
residue in its active site.  
 
Similar to that observed for TrxR, co-exposure to Se and MeHg did not avoid inhibition 
of GPx activity. This result agrees with the study of Glaser et al. (2010) and may arise 
from MeHg sequestering Se, making it unavailable to be a part of selenoenzyme 
synthesis (Ralston and Raymond, 2010). GPx activity was not significantly affected by 
mercury compounds in liver and kidney, similar to that reported by Monteiro et al. 
(2010), albeit in some cases Se depletion was verified (Figures 4.3 C-F).  
 
4.3. Histopathological consequences of TrxR inhibition 
 
The thioredoxin system is responsible for several key cellular functions that range from 
anti-oxidant defense to regulation of the cellular cycle (Carvalho et al., 2011) and loss 
of activity will result in apoptosis (Conrad, 2009). Mercury (II) was shown to be a 
stronger inhibitor of TrxR than MeHg and also produced the most extensive array of 
organ lesions with more widespread necrosis areas (Table 4.3). This result contrasts 
with the observations by Ribeiro et al. (2002) where Hg
2+
 failed to cause any significant 
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liver change in the artic charr, in comparison to MeHg. However, it should be stressed 
that Ribeiro et al. (2002), used oral administration of mercurials with food and in those 
circumstances Hg
2+
, is much less absorbed in the GI tract than MeHg (Clarkson and 
Magos, 2006). 
 
Exposure to mercury is known to lead to an increase in vacuole size and to the 
appearance of widespread areas of necrosis in the liver tissue (Liao et al., 2006; Wester 
and Canton, 1992) which is in agreement with the observations reported in this chapter. 
In the case of exposure to Hg
2+
and MeHg, although we observed full recovery of the 
activity of TrxR in the liver following depuration, the reversion of histopathological 
lesions and decrease in the ODI was not significant (Table 4.3). Possibly, cellular 
mechanisms downstream of the thioredoxin system were affected to such a degree that 
recovery of TrxR activity does not reflect in an immediate organ recovery and time will 
be needed to replace damaged cellular structures. When zeabra-seabreams were co-
exposed to Se and Hg
2+
 the severity of the lesions in the liver decreased (Table 4.3) 
while TrxR activity was kept at normal levels.  
 
The histopathological damages observed in the kidney of zeabra-seabreams agreed with 
the cellular changes commonly reported during exposure to mercurials including 
swelling and degeneration of cellular structures, loss of membrane integrity and 
eventual cellular necrosis (Zalups, 2000). In the kidney, TrxR activity was significantly 
affected (p<0.05) both during Hg
2+
 (42% inhibition) and MeHg (62% inhibition) 
exposure at d14 and the inhibitory effect remained throughout the entire experiment 
(Figure 4.6 C and D). Selenium showed no protective effect during co-exposure or on 
the recovery of TrxR activity during the depuration phase. The decrease in the renal 
toxicity (i.e. lower ODI; Table 4.3) of Hg
2+
 in the presence of Se could be possibly 
explained by the formation of inorganic inert complexes and the antioxidant role of Se 
in cellular pathways. It should also be stressed that, albeit TrxR activity did not recover, 
the cytotoxic effects (Table 4.3) of MeHg decreased with Se co-administration in part 
due to the lower MeHg accumulation in both organs, liver and kidney, which reflected 
in the ODI values (Table 4.3). Since TrxR presents a high affinity for mercurials, any 
available mercury will primarily bound the selenolthiol of its active site and therefore it 
is normal that the inhibition of TrxR is observed in cases where cito-/organ toxicity is 
largely decreased (Table 4.3). 
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Overall, these results show that the strong inhibition of TrxR activity is related with the 
histopathological alterations displayed in the liver and kidney of seabreams indicating 
the potential use of TrxR as a biomarker of effect of mercury toxicity. 
 
4.4. Importance of the Sec residue  
 
Selenols physiologically appear as selenolates (-Se
-
), and are more likely to interact 
with Hg
2+
 and MeHg since they have a lower pKa (5.3) than thiols (8.5) (Carvalho et 
al., 2008b). Thus, TrxR is much more sensitive to mercury compounds than Trx or GR. 
Likewise, the Sec residue in the active site of GPx would make it a potential target for 
mercury compounds (Bulato et al., 2007; Khan and Wang, 2009). However, our results 
indicate that in vivo GPx is much less vulnerable to mercury than TrxR. Albeit both 
enzymes have a Sec residue in the catalytic center (Figure 4.10), in GPx the Sec residue 
is close to a Gln and Trp residues (Toppo et al., 2009) while in TrxR the Sec residue in 
the open C-terminal region has three neighboring Cys residues (Zhong et al., 2000; 
Carvalho et al., 2008b). This accessibility increases significantly the reactivity of the 
active site of TrxR, namely its ability to bind electrophilic agents (Papp et al., 2007) 
such as mercury compounds (Figure 4.10). 
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Figure 4.10: Proposed mechanism of probable interaction between mercurials and 
selenoproteins TrxR and GPx, considering that both Hg
2+
 and MeHg bind the active site of 
TrxR, whereas the active site o GPx is targeted only by MeHg. Enzyme active structures are 
oversimplified for a matter of clarity. 
 
The results demonstrated that selenite interaction with mercury in vivo depends on the 
mercury compound considered and the organ analyzed. MeHg accumulation was 
reduced by co-exposure to Se but its toxic effects over antioxidant enzymes remained. 
Even though Hg
2+
 accumulated less than MeHg, it exerted a comparable inhibitory 
effect which could only be counteracted by Se in the liver. The thioredoxin system and, 
in particular, the selenoenzyme TrxR were severely inhibited by mercurial compounds. 
On the other hand, GPx activity was modestly affected by mercurials, indicating a less 
reactive active center toward Hg
2+
 and MeHg than TrxR. Thus, these results provide 
important evidence that TrxR is a main target for mercurial compounds in vivo and that 
Se supplementation has a limited ability to prevent such interaction, especially in the 
target organs such as the brain and kidney. 
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CHAPTER 5 – TOXIC PATHWAY OF MERCURIALS IN 
HepG2 CELLS WITH AND WITHOUT CO-EXPOSURE TO 
SELENIUM: FROM THE INHIBITION OF THE 
THIOREDOXIN SYSTEM TO CELL DEATH 
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1. BACKGROUND 
 
In the previous chapter (Chapter 4) a correlation between the inhibition of the 
thioredoxin system and organ damage in fishes was observed. Nevertheless, the 
temporal sequence of events from the decrease in Trx system activity to the triggering 
of cell death was not possible to establish in vivo. Since mercury is known to induce 
apoptosis (e.g. Chen et al., 2010; Kim and Sharma, 2004; Lu et al., 2010; Ndountse and 
Chan, 2008) and the thioredoxin system is known to be involved in apoptotic signaling 
(Saitoh et al., 1998), in this chapter it was studied how the inhibition of Trx system 
enzymes by mercurials related with the endpoints indicative of apoptosis, namely with 
the activity of caspase-3, which is the main apoptosis effector enzyme (Fan et al., 2004). 
Moreover, as apoptotic events may originate from the disruption of mitochondrial 
metabolism, it was investigated how mercury compounds interacted with the 
thioredoxin system in the mitochondria and how did it compare with the interaction at 
the cytosol. 
 
 
In Chapter 4 it was also observed in the liver of fishes, that co-exposure to selenite 
prevented the inhibition of TrxR and Trx by Hg
2+
, but not by MeHg. Selenium exposure 
per se produced an initial increase in TrxR activity, which led to the hypothesis that 
enzyme expression was amplified. However, protein expression studies were not yet 
possible to perform in zeabra-seabreams as the TrxR sequence for this species is not 
completely understood. Moreover, to evaluate the range of concentrations in which Se 
exerts a beneficial versus a deleterious pro-oxidant effect, demands for a significant 
number of experimental groups, than it would be feasible in vivo. Thus, in order to 
detail the molecular basis for the interaction between mercurials and selenium and its 
relation with the thioredoxin system, the work progressed in a liver cell line of human 
hepatoma (HepG2 cells. Enzymatic activity measurements were performed in different 
combinations of experimental conditions as described further below. The fact that TrxR 
is a selenoprotein which has been demonstrated to be a central target for mercury, led to 
the quantification of TrxR mRNA levels to evaluate how mercurial compounds and 
selenium affected its transcription, i.e. the quantity of protein available in cells. 
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2. EXPERIMENTAL PLAN 
 
The experimental plan for the work with HepG2 cells is illustrated in Figure 5.1. The 
work began with viability studies that allowed defining the relative toxicity of each 
compound (MeHgCl, HgCl2 and Na2SeO3) to HepG2 cells. The work proceeded with 
the measurement of Caspase-3 (the main effector caspase) activity following exposure 
to mercurials to check for differences in the triggering of apoptosis by MeHg and Hg
2+
. 
Subsequent to the results of these studies and in order to understand the differences 
observed between the two mercury compounds, it was evaluated how both compounds 
affected the thioredoxin system at the mitochondrial and cytosolic levels. In parallel and 
after evaluating viability (MTT assay), an experiment was conducted concerning the 
effects of co-exposure to Se on the interaction between mercurials and several 
antioxidant enzymes (TrxR; Trx; GR; GPx). The transcription of TrxR was further 
investigated by determining its mRNA levels.  
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Figure 5.1: Diagram of the experimental plan concerning studies with HepG2 cells. Details on 
the specific methodologies are given in Chapter 2.  
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3. RESULTS 
 
3.1. Cell viability assays  
 
The effects of mercurials and Se on the growth of HepG2 cells were assessed by the 
MTT cell viability assay. Methylmercury was more toxic to HepG2 cells than Hg
2+
, 
having a rather lower (> 8 fold) GI50 (2.1 vs. 16.2 µM) after 72 hours of exposure 
(Figure 5.2; Table 5.1). These results agree well with those reported by Carvalho et al. 
(2008b) for HeLa cells (2.9 and 20.6 µM after 72 h of exposure to MeHg and Hg
2+
, 
respectively).  
 
The GI50 values for Se (25.1 µM at 72h; Table 5.1) are in line with those previously 
reported for STAV-AB cells (epithellioid mesothelioma; 21 µM) (Nilsonne et al., 2006) 
and HepG2 cells (above 20 µM for 24 h exposure; Zou et al., 2008). However, the 
negative effects of Se on cell growth were already apparent at 10 µM after 24 h of 
exposure and at concentrations above 8 µM (Figure 5.2 C) for longer exposures (48 and 
72h).  
 
Based on these results, 8 µM was the maximum Se concentration selected for use in 
subsequent experiments for testing the effects of co-exposure to mercurials and Se on 
the thioredoxin system. 
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Figure 5.2: HepG2 cells were exposed to different concentrations of HgCl2 (A), MeHgCl (B) 
and Na2SeO3 (C) for 24, 48 and 72h after which viability was determined by the MTT assay. 
Data points represent the mean ± S.E. of 3-4 independent experiments. 
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Table 5.1: Values of GI50* reflecting the effect of mercurials and selenium on the viability of 
HepG2 cells at different time-points, as measured by the MTT viability assay. 
 
 GI50 (µM) 
Compound 
   
24h 48h 72h 
HgCl2 18.4 ± 3.2 33.4 ± 5.6 16.2 ± 4.6 
MeHgCl 1.5 ± 0.08 2.3 ± 0.34 2. 1 ± 0.26 
Na2SeO3 25.7 ± 3.9 29.6 ± 3.6 25.1 ± 6.2 
*GI50 – compound concentration that reduces cell growth in 50% 
 
 
3.2. Caspase-3 activity 
 
Caspase-3 activity was measured in HepG2 cells after 24 hours of exposure to different 
concentrations of MeHg and Hg
2+
 (Figure 5.3). Exposure to Hg
2+
 seemed to slightly 
hinder caspase-3 activity in a dose-dependent manner (10 % decrease at 10µM) (Figure 
5.3 A), which agrees to previous observations by Mccabe et al. (2005) in Jukart T cells, 
where no activation of pro-caspase-3 into caspase-3 was observed during exposure to 
the mercuric ion. On the other hand, exposure to MeHg led to an increase in caspase-3 
activity (Figure 5.3 B) at a concentration of 2.5 µM (14% above control p<0.05). These 
results agree with previous works that also showed increased caspase-3 activity in Cl1-0 
(human lung epithel; Lu et al., 2010) and SH-SY-5Y (human neuroblastoma; Ndountse 
and Chan, 2008) following exposure to MeHgCl cells.  
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Figure 5.3: Caspase-3 activity in HepG2 cells following 24h of exposure to different 
concentrations of HgCl2 (A) and MeHgCl (B). Data points represent the mean ± S.E. of 3 
independent experiments. * - significantly different from control (p<0.05). 
 
3.3. Effect of co-exposure to Se and mercurials on enzymatic activities 
 
Based on previous in vivo results (see Chapter 4) it was important to understand how 
co-exposure to Se influenced the interaction between mercurials and the thioredoxin 
system  as well as the range of concentrations where it was effective, avoiding the pro-
oxidant effects that also associated to Se supply (e.g. Nilsonne et al., 2006).  
 
The activities of TrxR and Trx were determined in cell lysates using the insulin 
reduction end-point assay (see Chapter 2). Control activities (i.e. in the untreated group, 
hereafter referred as C0) for TrxR was 46 pmol/mg protein and for Trx was 316 
pmol/mg protein. These activities are within normal values considering that HepG2 are 
 
0
20
40
60
80
100
120
0 0.5 1 2.5 5 10C
a
s
p
a
s
e
-3
 A
c
ti
v
it
y
 (
%
 C
o
n
tr
o
l)
HgCl2 (µM)
  
0
20
40
60
80
100
120
0 0.1 0.25 0.5 1 2.5C
a
s
p
a
s
e
-3
 A
c
ti
v
it
y
 (
%
 C
o
n
tr
o
l)
MeHgCl (µM)
  
      
  
140                    In vivo Mercury Interaction with the Thioredoxin System   
 
cancer cells. Exposure only to Se increased the activity of TrxR in a dose-dependent 
manner (Figure 5.4 and 5.5). 
 
 
Figure 5.4: Variation of TrxR Activity (% of Control) in HepG2 cells exposed to increasing 
concentrations of Se in the culture medium.  
 
 
After 24 h of exposure, both mercurials caused a dose-dependent inhibition of the two 
enzymes (Figure 5.5). Mercury (II) was a stronger inhibitor of TrxR activity than MeHg 
(45% and 29% inhibition at 2.5 µM of Hg
2+
 and MeHg, respectively) but inhibition of 
Trx was similar for both compounds (45 and 49 % at 2.5 µM of Hg
2+
 and MeHg, 
respectively). In HepG2 cells, Trx was the enzyme that showed a more significant 
decrease in activity upon MeHg exposure (49% inhibition for Trx vs. 29% inhibition for 
TrxR at 2.5 µM MeHg; Figure 5.5 B, D). Exposure to Hg
2+
 also affected more Trx than 
TrxR albeit the difference was less pronounced (62 % inhibition for Trx and 54% 
inhibition for TrxR at 5 µM Hg
2+
; Figure 5.5 A, C). This result contrasts with 
observations in HeLa cells (Carvalho et al., 2008b) and in vivo (Chapters 3 and 4) where 
TrxR was the enzyme most affected by mercury. 
 
Co-exposure to Se fully prevented the inhibition of TrxR by Hg
2+
 and inclusive led to a 
significant increase in activity (p<0.05; Figure 5.5 A and B). Co-exposure to 2 µM of Se 
increased TrxR activity proportionally with Hg
2+ 
concentration (Figure 5.5 A) but no 
further increase was verified with co-exposure to higher doses of Se (4 and 8µM). In the 
case of MeHg, the protective effect also existed but disappeared as Se concentration 
increased to 8 M, respectively (p<0.05; Table 5.2; Figure 5.5 B). .  
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In the case of exposure to Hg
2+
, Se fully prevented Trx inhibition (Figure 5.5 C), which 
agrees with previous results obtained in vivo in the liver (Chapter 4; Fig 4.7). This 
protection was remarkable at the highest concentration of Hg
2+
. No protective effects of 
Se co-exposure was observed for Trx activity with MeHg and the inhibition verified 
was independent of the selenium concentration added to the medium (Figure 5.5 D).  
 
 
Figure 5.5: Effects of co-exposure to Se on the inhibition of TrxR and Trx activities by 
mercurial compounds in HepG2 cells. Cells were exposed for 24 hours to either HgCl2 (A, C) or 
MeHgCl (B, D) and different concentrations of Na2SeO3 (0, 2, 4 and 8 µM) after which TrxR 
and Trx activities were measured. Data points represent the mean ± S.E. of 4-8 independent 
experiments.* significantly different from control (C0) (p<0.05); ** very significantly different 
from control (C0) (p<0.01); # - significantly different from the respective Se control; ## - very 
significantly different from the respective Se control (p<0.01). 
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Table 5.2: Variation of the percentage of inhibition of TrxR activity in HepG2 cells exposed to 
2.5 µM of MeHg relatively to the respective control group for Se exposure (0, 2, 4 and 8 µM). 
 
Se (µM)  Inhibition of TrxR activity (%)  
0 28 
2 3 
4 13 
8 37 
 
 
 
Selenium increased GPx activity above control levels (>130%) albeit at higher 
exposures (8 µM), no increase was verified. Exposure to Hg
2+
 (2.5 µM) decreased GPx 
activity to about 70% of control (Figure 5.6 A) which had not been seen in vivo 
(Chapter 4). Glutathione peroxidase activity was much less affected by MeHg (15% 
inhibition at 2.5 µM; Figure 5.6 B) than TrxR and Trx in agreement with previous 
observations in vivo (Chapter 4). Co-exposure to Se prevented GPx inhibition by Hg
2+
 
but the effect over MeHg was less obvious. 
 
Like in previous works with cells (Carvalho et al, 2008b) and in vivo (Chapters 3 and 4) 
no significant reduction in GR activity (Figure 5.6 C and D) was observed with all 
treatments. 
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Figure 5.6: Effects of co-exposure to Se on the inhibition of GPx and GR activities by mercurial 
compounds in HepG2 cells. Cells were exposed for 24 hours to either HgCl2 (A, C) or MeHgCl 
(B, D) and different concentrations of Na2SeO3 (0, 2, 4 and 8 µM) after which GPx and GR 
activities were measured. Data points represent the mean ± S.E. of 4-6 independent 
experiments. * Significantly different from control (C0) (p<0.05); ** very significantly different 
from control (C0) (p<0.01); # - significantly different from Se control; ## - very significantly 
different from Se control (p<0.01). 
 
 
3.4. Effect of MeHg and Hg2+ exposure on TrxR and Trx activities on the 
mitochondrial and cytosolic fractions of HepG2 cells 
 
Methylmercury showed to be more toxic than Hg
2+
 to HepG2 cells leading to a 
significant decrease in cell viability and to an increase in caspase-3 activity at 
concentrations as low as 2.5 µM (Figures 5.2 and 5.3; Table 5.1). Nevertheless, Hg
2+
 
had a stronger inhibitory effect on the thioredoxin system (see section 3.3). Thus, it was 
hypothesized that the difference observed in the cytotoxicity of the two compounds 
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might result from their different distribution within the cell (i.e. mitochondria vs. 
cytosol). In order to test this hypothesis, HepG2 cells were exposed to different 
concentrations of MeHg and Hg
2+
 for 24 hours and TrxR and Trx activities were 
measured in the mitochondrial and cytosolic fractions.  
 
The results were remarkably different for the two mercurials (Figure 5.7). Mercury (II) 
inhibited significantly the thioredoxin system within the mitochondrial fraction even at 
concentrations as low as 0.5 µM (Figure 5.7 A and C), while at the cytosolic fraction, 
inhibition was only observed at higher concentrations (5 µM). On the other hand, MeHg 
decreased simultaneously the enzymatic activities in both the cytosol and the 
mitochondrial fraction with Trx being more affected than TrxR (Figure 5.7 B and D).  
 
At 5 µM of Hg
2+ 
there was drop of 55% in the activity of TrxR in the mitochondrial 
fraction, while in the cytosolic fraction the reduction in TrxR activity was only 10% 
(Figure 5.7 A), whereas in the case of MeHg (2.5µM) TrxR activity was decreased in 
30% in the cytosol and 25% in the mitochondrial fraction (Figure 5.7 B). Likewise, 5 
µM of Hg
2+
 decreased Trx activity by 40% at the mitochondrial fraction and 30% at the 
cytosolic fraction (Figure 5.7 C) and exposure to the highest concentration of MeHg 
(2.5 µM) decreased in 45 and 50% the activities of Trx in the cytosolic and 
mitochondrial fractions (Figure 5.7 D), respectively,  
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Figure 5.7: Effects of mercurial compounds on the activity of TrxR and Trx in subcellular 
fractions of HepG2 cells. Cells were exposed for 24 hours to either HgCl2 (A, C) or MeHgCl (B, 
D). After differential centrifugation of cell lysates to separate the mithocondrial fraction, TrxR 
and Trx activities were measured in the mitochondrial (MF) and cytosolic (CF) fractions. Data 
points represent the mean ± S.E. of 4 independent experiments 
 
 
3.5. Effect of co-exposure to Se and mercurials on TrxR mRNA levels  
 
In order to assess if Se and mercurials affected the transcription of TrxR the total 
mRNA contents of TrxR1 and TrxR2 were analyzed. Results showed that while TrxR1 
mRNA was affected by exposure to both selenium and mercurials, the TrxR2 mRNA 
did not vary extensively with any treatment (Figure 5.8 A-D). 
 
The transcription of TrxR1 mRNA increased dose-dependently (up to 3-fold) following 
exposure to Se in the absence of mercurial compounds (Figure 5.8 A and B), in 
agreement with the observed for TrxR activity (Figure 5.4).  
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Figure 5.8: Effects of co-exposure to Se and mercurials on the mRNA levels of TrxR1 and 
TrxR2 in HepG2 cells. Cells were exposed for 24 hours to 2.5 and 5 µM HgCl2 (A, C) or 1 and 
2.5 µM MeHgCl (B, D) and different concentrations of Na2SeO3 (0, 2, and 4 µM) after which 
TrxR1 and TrxR2 mRNA levels were quantified by qRT-PCR. Data points represent the mean ± 
S.E. of 3-4 independent experiments. * Significantly different from control (C0) (p<0.05); ** 
very significantly different from control (C0) (p<0.01); # -Significantly different from control 
with 2 µM of Se(p<0.05); ## very significantly different from control 2 µM of Se (p<0.01); $ - 
Significantly different from control with 4 µM of Se(p<0.05); $$ very significantly different 
from control with 4 µM of Se (p<0.01). 
 
 
Interestingly, exposure to Hg
2+
 led, in most cases, to a significant increase in TrxR1 
mRNA levels (> 2-fold), while MeHg produced milder raises (1.5-fold) and only in the 
absence of Se (Figure 5.8 A-B). Co-exposure to low levels (2 µM) of Se and Hg
2+
 
increased even further TrxR1 mRNA (up to 6-fold). This synergistic effect over 
transcription was disrupted at higher levels of Se (4µM), particularly at a higher dose of 
Hg
2+
 (5 µM) (Figure 5.8 A). 
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4. DISCUSSION 
 
4.1.Effect of mercurials on cell viability and Caspase-3 activity 
 
The results of the MTT assay, show that MeHg is much more toxic (> 8 fold) to HepG2 
cells than Hg
2+ 
(section 3.1). This result agrees well with previous reports on the 
cytotoxicity of mercurials in K-562 cells (50 µM and 5 µM for Hg
2+
 and MeHg, 
respectively; Frisk et al., 2000), PC-12 cells (5 µM and 0.87 µM for Hg
2+
 and MeHg, 
respectively; Parran et al., 2001) and HeLa (20.6 µM and 2.9 µM for Hg
2+
 and MeHg, 
respectively) and HEK 293 cells (6 µM and 2.8 µM, respectively) (Carvalho et al., 
2008b). Since the MTT viability assay actually measures the capability of 
mitochondrias to reduce MTT and MeHg had such a strong effect over cell viability, it 
was investigated if the impairment of mitochondrial function by MeHg would trigger 
cell death mechanisms, namely apoptosis. In fact, a significant increase in the activity of 
caspase-3 was seen with exposure to 2.5 µM of MeHg which agrees well with the GI50 
value determined with the MTT assay. On the other hand, Hg
2+
 decreased caspase-3 
activity in a dose-dependent manner (Figure 5.3). As proposed by Macabe et al. (2005) 
this decrease in caspase-3 activity should be a consequence of the disruption of 
apoptotic signalling by Hg
2+
 and not result from its direct interaction with the Cys 
residue in caspase-3 (only observed at >20 µM Hg
2+
).  
 
4.2. Effect of co-exposure to selenium and mercurials on enzymatic activities 
 
In the absence of mercurials, the activity of TrxR increased proportionally to Se 
concentration in the culture medium (Figure 5.4) as it was seen in vivo with zeabra-
seabreams in early exposure (Chapter 4, Figure 4.6). 
 
Exposure to Hg
2+
 decreased significantly the activities of both TrxR (Figure 5.5 A) and 
Trx (Figure 5.5 C). MeHg also affected TrxR (Figure 5.5 B) and Trx (Figure 5.5 D) 
activities but to a lesser extent than Hg
2+
. Contrary to previous results in vitro (Carvalho 
et al., 2008b) and in vivo (Chapters 3 and 4), Trx was the enzyme more affected by both 
mercurials in HepG2 cells. These cells, similarly to normal liver cells, produce large 
quantities of Trx but, unlike normal hepatocytes, do not secret it into the extracellular 
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medium (Rubartelli et al., 1995). Thus, the high intracellular content of Trx in HepG2 
may explain why in these cells this enzyme is more affected by mercurials than TrxR.  
 
Co-exposure to selenium fully prevented the inhibition of TrxR and Trx by Hg
2+
 in 
agreement to what was observed with purified TrxR and HEK 293 cells (Carvalho et al., 
2011) and with the same enzymes in vivo in the liver (Chapter 4). Moreover, co-
exposure to selenium and Hg
2+
 resulted in higher activity of TrxR and Trx (Figure 5.5 A 
and C). However, as Se increased above 2 µM no further increases were observed 
during co-exposure to Hg
2+
 which agrees well with the observations for TrxR1 mRNA 
expression (section 3.5).  
 
When HepG2 cells were co-exposed to MeHg (up to 1 µM) and Se (up to 4 µM), TrxR 
activity was increased (up to 180 % of C0; Figure 5.5 B) indicating a protective effect of 
selenium, which contrasts with previous observations in vivo (Chapter 4) and with 
purified enzymes and HEK 293 cells (Carvalho et al., 2011). Nevertheless, as MeHg 
and Se concentrations increase this beneficial effect was lost and additive pro-oxidant 
effects became evident (Table 5.2).Co-exposure to Se failed to prevent the inhibition of 
Trx by MeHg, which agrees well with previous observations in vivo (Chapter 4). Trx 
showed the same pattern of inhibition by MeHg independently of the selenium amount 
supplemented to cells. Therefore Trx activity might be a better biomarker of effect for 
MeHg toxicity if the same behaviour is observed in less invasive samples more suitable 
for biomonitoring (e.g. blood samples). 
 
The present results show that, Hg
2+
 may decreased GPx activity to about 70% of C0 
(Figure 5.6 A) which had not been seen in vivo (Chapter 4). Since Hg
2+
 was previously 
shown to be incapable of inhibit purified GPx (Bulato et al., 2007), direct interaction 
with its active site is unlikely (see chapter 4). As suggested by Bulato et al. (2007) such 
inhibition results from Se depletion due to Hg
2+
 exposure. Our results seem to confirm 
this hypothesis since co-exposure to Se fully prevented the inhibition of GPx by Hg
2+
. 
On the other hand, GPx activity was much less affected by MeHg (Figure 5.6 B) when 
compared to TrxR. As previously reported in vivo, the differences in the active site 
structure and Sec accessibility are responsible for the higher sensitivity of TrxR to 
MeHg (Chapter 4).  
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4.3. Interaction between mercurials and the Trx system in the mitochondrial and 
cytosolic fractions. 
 
The cytosolic and mitochondrial Trx systems are both essential for cell survival and 
proliferation and disruption of activity is normally associated with the triggering of 
apoptosis through ASK-1 activation (Arnér, 2009). 
 
In HepG2 cells, exposure to Hg
2+
 affected mostly the Trx system at the mitochondrial 
fraction. This result is in line with the findings of Hansen et al. (2006b) that showed in 
HeLa cells that Hg
2+
 had a higher oxidative effect over Trx-2 than over Trx-1, 
indicating that it interfered primarily with mitochondrial functioning. Thus, following 
exposure to Hg
2+
 it would be expectable to observe an increase in apoptosis, more 
specifically in the activation of apoptosis effector caspase-3. The present results do not 
confirm this hypothesis since caspase-3 activity was decreased during exposure to Hg
2+
.  
 
Exposure to MeHg led to a similar decrease in the activity of the Trx system in both 
sub-cellular fractions. Presumably the extent of inhibition of both the mitochondrial and 
cytosolic Trx systems by MeHg is sufficient to disrupt metabolism and induce cell death 
(Hansen et al., 2006b). This fact may explain why MeHg is highly toxic and why an 
increase in capase-3 activity is observed upon exposure to cytotoxic concentrations of 
this compound. Also, other possibilities like, MeHg affecting other molecular targets 
besides the Trx system that normally would compensate its loss of activity (e.g. GSH) 
or, MeHg promoting the formation of deleterious Se-compromised forms of TrxR (i.e. 
SecTRAPS) cannot be totally discarded, but need to be further investigated.  
 
4.4. Effect of co-exposure to Se and mercurials on TrxR mRNA levels  
 
Exposure of HepG2 cells to increasing concentrations of selenium (0; 2 and 4 µM) led 
to proportionally higher levels of TrxR1 mRNA (2 to 3 fold). This was reflected in the 
increase of cellular TrxR activity (Figure 5.4), although it was not proportional to the 
transcription increase. This lack of proportionality was also observed by Erkhembayar 
et al. (2012) in the liver of rats that had suffered a partial hepatectomy and that were 
kept under a selenium rich diet. In a previous work, Gasdaska et al. (1999) suggested 
that the response of TrxR1 SECIS element is lower than the SECIS element of other 
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selenoenzymes like type 1 deiodinase, and thus TrxR1 protein levels might not increase 
as much as its mRNA does during exposure to high Se. Moreover, the rate of mRNA 
decay and post-translational auto-regulatory mechanisms might contribute to only a 
small fraction of the mRNA transcript being translated into protein (Wilkening et al., 
2003).  
 
Exposure to Hg
2+
 does not contribute to decrease the quantity of TrxR, as TrxR1 mRNA 
levels were 2 to 3-fold increased relatively to C0 (Figure 5.8 A). This might be the result 
of the activation by mercury of the NF-E2-related factor 2 (Nrf-2), which regulates 
transcription via an antioxidant response element (ARE) in the promoter region of 
human TrxR1 (Zhang et al., 2003). Also, the promoter region of TrxR1 gene has several 
AU-rich elements (AREs) that modulate a fast response of TrxR1 transcription to stress 
signals. If such an increase in the transcription of TrxR is proportionally reflected in the 
amount of protein expressed, it would mean that the observed inhibitory effect of Hg
2+
 
over TrxR is even greater than the activity analysis alone suggests. MeHg exposure 
increased only slightly the levels of TrxR1 mRNA (Figure 5.8 B). 
  
Co-exposure to Hg
2+
 and 2 µM of Se increased further TrxR1 mRNA levels. Thus, the 
increment in TrxR transcription seems to be an additional mechanism by which Se 
protects TrxR from Hg
2+
 in addition to its removal from TrxR active site as proposed by 
Carvalho et al. (2011). A possible explanation may be that Se provides the Sec 
necessary for the translation process to proceed, avoiding TrxR1 mRNA degradation 
(Zhang et al., 2003). As a result the levels of TrxR1 mRNA are higher during co-
exposure than when Hg
2+
 is provided alone. However, at 4 µM of selenium this 
synergistic effect was lost which means that the beneficial effects of Se over Hg
2+
 
exposure are within a narrow range of concentrations. Co-exposure to MeHg and Se did 
not change TrxR1 mRNA expression relatively to the controls (at the same Se 
concentration) (Figure 5.8 B), strengthening the fact that MeHg does not enhance to a 
large extent the transcription of this enzyme. 
 
TrxR2 mRNA was less responsive to both mercurials and to Se with no clear increases 
in mRNA levels (Figure 5.8 C and D). A similar result was obtained by Zhang et al. 
(2003) in HepG2 cells exposed to sulforaphane, where no increase in TrxR2 mRNA 
levels were observed, whereas TrxR1 mRNA presented a significant increase. These 
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authors suggested that this is due to the absence of ARE and AREs in the TrxR2 gene 
which hinder a similar response to the TrxR1 gene. This decrease in the transcription 
responsiveness, together with the fact that TrxR2 activity is affected by both mercurials 
(Figure 5.7 A and B) could mean that targeting of this mitochondrial enzyme is a key 
step in the development of mercury toxicity even where supra-nutritional amounts of Se 
are provided.  
 
Overall, these results show important differences between MeHg and Hg
2+
 concerning 
their toxicity to HepG2 cells. MeHg increased caspase-3 activity at a concentration 
close to the GI50 value but higher than the concentration at which inhibition of the 
thioredoxin system became apparent, which clearly suggests that the inhibition of the 
this system is an early event in MeHg induce apoptosis. On the other hand, Hg
2+
 did not 
activate caspase-3, albeit being a strong inhibitor of the Trx system. These differences 
observed between the two mercurials appear to be related with the fact that MeHg and 
Hg
2+
 affect differently the Trx system at the mitochondria and at the cytosol. The 
present results also show that the inhibitory action of MeHg and Hg
2+
 over TrxR is 
counteracted by exposure to Se. Nevertheless, higher levels of Se do not provide 
additional protection and some pro-oxidant effects were observed. In the case of Hg
2+
 
co-exposure to a low dose of Se increased TrxR1 mRNA and thus, the enhancement of 
TrxR expression is an additional mechanism by which Se antagonizes the toxic effect of 
Hg
2+
. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6 - GENERAL CONCLUSIONS AND FUTURE 
WORK PERSPECTIVES 
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GENERAL CONCLUSIONS 
 
In this work, the in vivo interaction between mercury compounds and the thioredoxin 
system was investigated in a fish species (zeabra-seabreams, Diplodus cervinus). 
 
The first results demonstrated that MeHg targets the thioredoxin system in the brain and 
liver of seabreams leading to loss of activity which is of outmost relevance for the 
understanding of its molecular mechanism of toxicity. The selenoenzyme TrxR was 
particularly sensitive to MeHg which can be attributed to the presence of a Sec residue 
in the open C-terminal region of the active site. This was confirmed by the lack of 
inhibition of glutathione reductase (GR), a homologous enzyme to TrxR but lacking the 
active site selenol. In fact, the slight increase observed in GR activity can be regarded as 
a compensatory mechanism for the loss of TrxR function. 
 
Interestingly, the toxicokinetics of MeHg influenced its interaction with the Trx system. 
In the liver, the Trx system was affected after 21 days of exposure to MeHg and 
cessation of exposure (at day 28) allowed the recovery of activity at day 42. However, 
in the brain MeHg accumulation displayed a lag time and inhibition was low at the end 
of exposure but increased to the end of the depuration period reaching its maximum by 
the end of experiment (14 days after exposure stop). This result is very significant from 
a toxicological point of view since it clearly shows the gap between exposure and the 
development of MeHg neurotoxicity. 
 
The next task of this work looked into the relation between exposure to mercurials 
(MeHg and Hg
2+
), the inhibition of TrxR and the severity of histopathological damage 
in the liver and kidney of zeabra-seabreams. The results confirmed previous results in 
vitro that inorganic mercury (Hg
2+
) was a stronger inhibitor of TrxR than MeHg. The 
stronger inhibition of TrxR by Hg
2+
translated in more extensive organ damage. 
Simultaneous exposure to sodium selenite prevented inhibition of TrxR by Hg
2+
 and 
reduced the severity of organ lesions, which confirmed the relation between inhibition 
of this enzyme and the histopathological effects. Recovery of TrxR activity during the 
depuration period did not reflect in a recovery of organ lesions. Because TrxR and the 
Trx system are upstream several metabolic pathways,their inhibition means that cellular 
mechanisms downstream will also be affected and recovery of TrxR activity does not 
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necessarily reflect in an immediate organ recovery and time will be needed to replace 
damaged cellular structures. 
 
The influence of in vivo co-exposure to mercurials and selenium on the thioredoxin 
system as also studied in this work. The results presented in this thesis showed that, the 
effect of the interaction between sodium selenite and mercury on the activity of the 
thioredoxin system was organ specific and varied according to the mercurial used 
(MeHg or Hg
2+
). Albeit the accumulation of MeHg was reduced in all organs by co-
exposure to selenium, it did not avoid the inhibition of TrxR and Trx by this compound. 
On the other hand, a protective effect of selenium was seen for Hg
2+
. In the liver of 
zeabra-seabreams, selenium fully prevented the inhibition of TrxR and Trx by Hg
2+
. 
However, in the brain and kidney no such protection was observed. 
 
Additionally, the results also confirmed that besides the presence of a selenol in the 
active site of TrxR, its position at the open C-terminus of the enzyme also contributes to 
the increased susceptibility of this enzyme to electrophilic agents such as mercurials. In 
fact, TrxR was shown to be much more sensitive to mercury compounds than another 
selenoenzyme, GPx1, usually referred as a good indicator of mercury toxicity.  
 
To enlighten some of the results obtained in vivo, namely to understand if the inhibition 
of the Trx system happens previously to the onset of apoptosis and to understand how 
does selenium prevent the inhibitory effects of mercury compounds over the thioredoxin 
system, the work continued with experiments in a cell model of human hepatoma, 
HepG2 cells to deeply study the underlying molecular events.    
 
MeHg was more cytotoxic to HepG2 cells than Hg
2+
, causing impairment of cell growth 
at lower concentrations and increasing caspase-3 activity, while Hg
2+
 did not.The 
effects over the Trx system in distinct sub-cellular fractions also differed between 
MeHg and Hg
2+
. MeHg affected simultaneously the Trx system in the cytosolic fraction 
and in the mitochondrial fraction while Hg
2+
 targeted primarily the thioredoxin system 
from the mitochondria.  
 
Both mercury compounds caused a decrease in the activities of TrxR and Trx, albeit in 
these cells Trx was more affected by MeHg than TrxR. Exposure to increasing 
                                                                 Chapter 6: Conclusions and Future Work      157 
 
concentrations of selenium prevented the inhibition of TrxR and Trx by Hg
2+
 as it had 
been seen in the liver in vivo. In general, co-exposure to selenium also protected TrxR 
activity from inhibition by MeHg in HepG2 cells, but it did not prevent Trx inhibition 
meaning that this enzyme might be a better indicator of MeHg toxicity, as the  activity 
responds to the presence of this xenobiotic regardless of the selenium status.  
 
TrxR1 mRNA reacted to selenium supplementation increasing up to 3-fold while TrxR2 
mRNA was kept unchanged. TrxR1 mRNA was increased by exposure to both mercury 
compounds, although Hg
2+
 more significantly than MeHg. Interestingly, low-doses of 
selenium in conjugation with Hg
2+
 increased even further (6-fold) TrxR1 mRNA. This 
result shows that, the protective role of selenium over TrxR1 inhibited by Hg
2+
, may be 
in part due to the increase in enzyme synthesis. 
 
Overall, the work developed for this thesis raised some new questions related to the 
mercury toxicity but it also provided answers to this research field. One was the 
confirmation that the thioredoxin system is an antioxidant system affected by mercurials 
before downstream cellular processes develop and raise toxic endpoints. The evidence 
was obtained with the in vivo studies described in chapters 3-4 and may have important 
repercussions for human health. Another important issue was the confirmation and 
clarification of the beneficial effects of selenium. The controversy of the antagonism of 
mercury toxicity by selenium compounds will probably continue, although, this work 
provides new evidence on the importance of this element at different levels: 1) synthesis 
of selenoproteins; 2) re-activation of inhibited enzymes; and also 3) development of 
pro-oxidant manifestations at higher levels of selenium supplementation. 
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FUTURE WORK PERSPECTIVES 
 
The results presented in this thesis raised interesting questions regarding the toxicity 
mechanism of mercury. Clarification of these questions will allow a better 
understanding of the molecular interactions of mercury, the role of the thioredoxin 
system in the development of toxicity and the differences in cytotoxicity between 
mercurials. Additionally, the complete understanding of the mechanism by which 
mercury toxicity develops is essential to the development and validation of appropriate 
biomarkers predictive of toxic effects. Some of the points needing enlightenment 
include: 
 
 
1) Better characterization of the interactions of mercurials with the Trx system at 
the sub-cellular level, namely to understand how the differential targeting of the 
cytosolic and mitochondrial Trx systems by MeHg and Hg
2+
 relates with 
differences in the biochemical pathways by which cell death is triggered. 
Besides evaluating caspase activity, this assessment should include an 
evaluation of which type of cell death is prevalent (apoptosis vs. necrosis), how 
ASK-1 is activated upon exposure to mercurials, how the mitochondrial 
metabolism is disrupted (e.g. monitoring cytochrome c release) and how does it 
relate with loss of activity of the TrxR2/Trx2 enzymes. 
 
2) Understanding the basis for the higher cytotoxicity of MeHg. This includes 
looking for additional molecular targets besides the Trx system that might 
promote a greater toxicity by MeHg. Also, is it possible that the formation of 
selenium-compromised forms of TrxR (SecTraps) plays a role in the greater 
toxicity of MeHg relatively to Hg
2+
? 
 
3) Given that mercurials are known to bind the reactive groups of Trx and TrxR 
would be interesting to study how the redox state of these enzymes is affected in 
cells. Moreover it would be important to understand, how those selenium 
supplementation change this interaction.  
 
 
4) The different response to selenium between the liver, kidney and the brain.  The 
apparent lack of protective effect of Se co-exposure over the inhibition of the 
Trx system by Hg
2+
in the brain is strikingly different form the observed in the 
liver and thus justifies a more thorough analysis of the molecular basis for such 
differences. Are these differences the result of the concentration of Se used in 
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the in vivo assays, or are there other underlying molecular events, such as the 
ability to de novo synthesize TrxR? 
 
5) In this thesis sodium selenite was used for testing the effects of selenium over 
mercury and the thioredoxin system. I would be interesting to study if other 
compounds such as selnocysteine or selenomethionine would produce the same 
effects;    
 
6) The use of the activity of Trx system as a predictive biomarker of toxic effects of 
mercurials. The current results showed a relation between the inhibition of TrxR 
and organ lesions in the liver and kidney. Nevertheless, it would be important to 
understand in vivo, the time sequence between the beginning of Trx system 
inhibition and the appearance of lesions in the organs namely at the CNS. 
Moreover, if TrxR/Trx activities are to be a suitable biomarker of toxicity it is 
important to relate changes in the activity at the bloodstream, with mercury and 
Trx system activity levels at the target organ.  
 
5) Since mercurials are known to stimulate the immune system in sensitive 
individuals at lower concentrations than those that cause other toxic effects, it 
would be interesting to investigate the doses of mercurials that determine the 
immune response and how they relate to the breakdown of anti-oxidant 
defences, namely of the Trx system. 
 
6) Finally, it is important to realize if the general human population exposed to 
mercury mostly through food, shows evidences of altered Trx activity in the 
blood and if it is related with the quantity and quality of fish consumption as 
well as with mercury exposure biomarkers, in particular blood and hair mercury 
levels. 
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APPENDIX 1 
 
  
 
Table A.1: Mortality (%) of zeabra-seabreams exposed repeatedly for 96 hours to 0, 10, 20 and 
40 µg L
-1
 of MeHg in water. 
 Fish Mortality (%) 
Time of 
exposure  
24 h 48h 72h 96h 
MeHg (µg L
-1
)     
0 0 0 0 0 
10 0 0 0 10 
20 0 47 77 87 
40 95 100 - - 
 
In this acute LC50 assay, cumulative exposure to 40 µg L
-1
 led to fish mortality. Hence it 
was decided to use 2 µg L
-1
 of MeHg as the maximum concentration in the sub-acute 
experiment (28 days of exposure) described in Chapter 3. Although theoretically this 
could result in a cumulative exposure greater than 40 µg L
-1
 by the end of the 
experiment, the lower concentration allows for fishes to excrete some of the mercury, 
thus avoiding that a deleterious level is reached. It should be pointed that no mortality 
was observed in the zeabra-seabreams exposed to MeHg as described in Chapter 3.  
 
 
